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One of the most traumatic personal medical problem is the phenomenon of sudden 
cardiac death (SCD).51 An individual's heart can cease to function, most often when the 
person appears to be in good health, and prompt SCD can occur without warning. The 
victim often experiences shortness of breath, sweating, and fatigue. When the heart stops 
pumping, blood flow diminishes to the brain and consciousness is lost within seconds. 
Gasping for air and seizures follow as death rapidly approaches.21 
The term 'sudden cardiac death' implies that breathing and the circulation of blood 
has stopped. This is usually caused from underlying heart desease such as atherosclerosis 
of the coronary arteries.21 Each year in the United States, more than 500,000 deaths 
occur in the adult population which are caused from the SCD syndrome. 51 More than 
80% of these deaths are due to ventricular fibrillation (VF; chaotic contraction of the 
heart with minimum pumping action) which is usually followed by ventricular 
arrhythmias. 36 The mechanism which triggers VF is unclear. Several suggested causes 
for this effect are: 1) myocardial ischemia (resulting from reduced blood flow to the 
heart muscle), 2) electrolytic imbalance, 3) platelet abnormalities in the blood, and 4) 
psychological stress.21 
Patients suffering from post-myocardial infarction usually experience ventricular 
tachycardia [VT; irregular beating pattern with an elevated heart rate and with blood flow 
reduced significantly).39 Today, there are a limited number of agents available for the 
treatment of lethal VT. Antiarrhythmic agents (AAA) seem to be effective in a number 
1 
of patients, but the efficacy of the agent depends greatly on the nature of the individual 
VT. 
Vaughan Willia~ Classification 
2 
Physicians have difficulties in prescribing anti.arrhythmic agents (AAA) to patients 
due to the many different symptoms observed. It might be mistakenly concluded that 
drugs within a particular classification are clinically similar and, if patients fail to respond 
to a drug in a given class, they would not respond to the others in that class. The 
Vaughan Williams83 approach to classify AAA was intended to be a classification of 
antiarrhythmic "actions" not of "drugs" The current classification is broken down into 5 
modes of action, with class I subdivided into three different categories. Table I illustrates 








VAUGHAN WILLIAMS CLASSIFICATION 
Action 
Sodium channel blockade 
Antagonism of sympathetic 
nervous system 
Increased refractoriness 










group. Class I AAA, such as lidocaine, block the sodium channel during the 
repolarization of the heart cells, which results in slowing of the conduction. The phase 0 
upstroke of the action potential in the electrocardiograph (ECG; Figure 1) is regulated by 
the sodium influx (via sodium channels) across the cell membrane. Antagonism of the 
sympathetic nervous system (i.e., propranolol) results in reduction of the heart rate and 
are class Il agents. Amiodarone is categorized as having class Ill action which increases 
refractoriness [prolongation of the action potential duration (APD)]. There is much 
evidence to indicate that a shortened APD is a significant factor in explaining high 
incidence of atrial fibrillation (AF). 27 
Originally, class I AAA were believed to have very similar actions but this was 
found untrue with most of the existing drugs. Although these agents differed in many 
activities, they all have one common property, that is "interferring specifically with the 
process by which depolarizing charge is transferred across the membrane (i.e., by fast 
inward depolarizing current carried by sodium ions)" _79 Significant differences in action 
among the class I agents caused Vaughan Williams to subdivided these drugs into class 
Ia, lb, and le. 
This subclassification (Table Il) was based on the effects each agent exerted on the 
following parameters: 1) QRS. complex14 of the electrocardiogram (Figure 1) is the point 
at which heart cells undergo depolarization. Two major electrical processes consisting of 
depolarization (activation) and repolarization (recovery) occur during muscular activity. 
QRS complex is defined as the time alloted for an polarized cell to become fully 
depolarized in which a sudden loss of semipermeability of the membrane around the cell 
so that there is a flow of ions across the cell; 2) Conduction of the heart is controlled by 
the ability of an agents to block sodium channels across the cell membrane; 3) Effective 
Refractory Period <ERP)1 4 is the time elapsed for the QRS complex of the 
electrocardiogram; and 4) A.f.U or the QT interval is the time the cell is allowed to 







Figure L Illustration of an Electrocardiogram (ECG) Output 
TABLEIJa 
CLINICAL SUBDIVISIONS OF CLASS I ANTIARRHYTHMIC DRUGS 




1. QRSb widen at high none in sinus 
concentration rhythm 
2. Conduction slowed at high none in sinus 
concentrations rhythm 
3. EJU>C lengthened lengthened in 
absolutely and relation to APD 
relative to APD 
4. Action Potential lengthened at shortened 
Duration high concentration 
a Reference 83. 
hQRS refers to the QRS interval of the electrocardiograph. 





widen at low 
concentrations 








most often experience reentry.14 For example, when an impulse in the cardiac con-
duction system is slowed due to failure to pass an ischemic area, the result is a premature 
contraction. This premature contraction can initiate atrial flutter or fibrillation.11,52 
The most important limitation to the current theory is the fact that many of the 
currently available drugs possess multiple class activity.1 Clinical studies have revealed 
that certain individuals have approximately an equal chance of responding to any agent, 
independent of their response to other drugs of one class. 86 Actions of AAA might be 
anticipated with a full understanding of the multiple actions of the agents and their 
metabolites, c~mbined with knowledge of their clinical pharmacology so that one might 
predict the factors influencing drug action.1,86 
There are a variety of clinical agents available for the management of heart 
arrhythmias. The following guidelines are the general basis for an agent's use: (1) 
knowledge of the electrophysiological mechanism, (2) knowledge of the 
electropharmacological properties of the agent and (3) an understanding of the 
pharmacokinetics. One of the most adverse side effects is the conversion of nonsustained 
VT (NSVT) to sustained ventricular tachycardia (SVT). Thus, the selection of the agent 
to eliminate the SVT can be critical or sudden death may result.39 
The CAST Study 
Until the mid 1980's, class I antiarrhythmic agents were the drugs of choice in the 
treatment of VT since most of the available clinical agents fell within this classification. 
The Cardiac Arrhythmia Suppression Trial (CAST) was designed to test antiarrhythmic 
drug therapy in the suppression of asymptomatic or mild symptomatic ventricular 
arrhythmias after myocardial infarction to determine if there occurred a reduction in the 
rate of death from arrhythmias. 63 Preliminary results of the CAST study were made 
public in 1989, and these findings changed the therapy of arrhythmias and directed 
researchers to new areas not previously explored. 
7 
Prior to the CAST study, results from the Cardiac Arrhythmia Pilot Study (CAPS)81 
showed that encainide (1), and flecainide (2) suppressed arrhythmias in the targeted 






sophisticated CAST study. Initial trials were to "identify patients that would respond to 
treatment with one of the drugs. Those who responded were then randomly assigned to 
receive either the therapy with the agent or with a placebo. The experiment comprised of 
2309 patients in which only 1727 showed suppression of their arrhythmias. Those 
patients were then assigned the blind therapy: 1455 were asigned to encainide, 
flecainide, or placebo, and 272 were assigned to moricizine. 64 
Surprisingly, the rate of death from arrhythmias in the group with the placebo was 
lower than the group receiving encainide and flecainide. Table Ill shows the number of 
deaths caused by arrhythmias and a nonarrhythmic cardiac event. 63 The adverse outcome 
in the patients could have reflected proarrhythmic properties of the two agents.35,50 Both 
agents were found to slow myocardial conduction velocity profoundly, an effect that 
might facilitate reentry.78 Reentry is defined as any irregular impulse in the heart cells 
which can·cause ventricular tachycardias to reoccur.14 One other possible explanation 
8 
for these results is that active ~etabolites of encainide could be eliminated slowly and 
thus accumulate and facilitate proarrhythmic effects.87 However, flecainide (2) is not 
known to form active metabolites. 87 The majority of the deaths not due to arrhythmias 
TABLE ma 
EVENTS IN 1455 PATIENTS RANDOMLY ASSIGNED TO 
RECEIVE ENCAINIDE (1), FLECAINIDE (2), 
OR MATCHING PLACEBO 
Variable 
Average exposure (days) 
Death from arrhythmia or cardiac arrest 
Other cardiac death 
Noncardiac or unclassified death or cardiac arrest 
Total deaths or cardiac arrests 
















were attributed to acute myocardial ischemia.63,64 Most physicians now believe that 
more of the clinically available agents should be subjected to the same kinds of studies. 
Class I Antiarrhythmic Agents 
Currently, the majority of the prescribed clinical AAA possess class I activity. Some 
examples include encainide (1), flecainide (2), lorcainide (3), quinidine (4), procainamide 
(S), disopyramide (6), lidocaine (7), tocainide (8), and mexiletine (9). These agents have 
NH 
1 (Encainide) 2 (Flecainide) 
4 (Quinidine) 5 (Procainamide) 














been found to be the most useful in the treatment of VT.39 Phannacology and clinical 
experiences have been extensively reviewed on these class I antiarrhythmic 
agents.11,15,39,41,46,52 Along with abolishing or reducing the rate of VT, these agents 
also have some other physiological features of interest. 
Quinidine (4) is a class Ia antiarrhythmic drug and has been the prototype of local 
anesthetic antiarrhythmic compounds. Reduction of V max (dV /dtmax or maximum rate of 
depolarization)ll is effected by the blocking of the activated sodium channel. This drug 
also prolongs the APO and produces a marked prolongation of atrial refractoriness with 
ventricular refractoriness being much less effected. This effect of quinidine has been 
explained by a decrease in potassium outward current.11,41 
Procainamide (5) has been a widely used class Ia antiarrhythmic agent which is 
popular because of easy administration, clinical efficacy, and patients tolerance. This 
drug has electrophysiological properties similar to those of quinidine in that it induces 
rate-dependent depression of V max and, therefore, needs more time to reach a steady state 
V max as compared to lidocaine.11,39,41 
Oisopyramide (6) is a class Ia agent and shares many electrophysiological and 
phannacological properties wtih quinidine and procainamide. It prevents induction of 
VT in about one third of patients but tolerance is limited primarily by anticholinergic side 
effects such as dry eyes and mouth and retention of urine. Limited use is also seen in 
patients with impaired left ventricular functions. 42 
Lidocaine (7) was originally developed as a local anesthetic and is still widely used 
for this purpose today. Arrhythmias are related to disturbances in the membrane ion 
potentials, and it is not surprising that local anesthetics have antiarrhythmic activity. 
After more than 25 years of clinical use, lidocaine is still considered to be the most 
effective agent against ventricular arrhythmias and has been termed as "the gold 
standard" by which all other antiarrhythmic drugs should be judged.11 Lidocaine (7) is a 
prototype of class lb agents in which it shortens the APO and refractoriness but prolongs 
11 
the recovery of exciteability relative to the change in repolarization.42 It differs from 
quinidine by having only a small effect on V max of normal cardiac fibers but markedly 
depresses V max in partially depolarized fibers as might result from myocardial 
ischemia. 42,46 
Tocainide (8), a class lb agent, has electrophysiological and hemodynamic effects 
similar to those of lidocaine (7). This drug has one advantage over lidocaine in that it 
possesses a high oral bioavailabilty with a mean half-life of 11 hours in humans. 
Effectiveness in the treatment of ventricular arrhythmias and ineffective against atrial 
arrhythmias _are the same results experienced from lidocaine.11,46 
Mexiletine (9) has been marketed in parts of Europe since 1976 and belongs to the 
family of local anesthetics which also function as antiarrhythmic agents. It has 
electrophysiological properties similar to lidocaine but in contrast has a much greater oral 
activity and a long elimination half-life.41 
Flecainide (2) has been marketed in Germany since 1982 and represents the first 
fluorine-containing antiarrhythmic agent. Clinical efficacy studies have shown the 
compound to be effective in suppressing ventricular and supraventricular arrhythmias.19 
Electrophysiological studies have shown that its primary effect is to slow the rate of rise 
of the action potential. 52 Due to the minor effects on the duration of repolarization and 
marked prolongation of cardiac conduction, flecainide has been categorized as a class le 
antiarrhythmic drug.11,41,52 After the preliminary results of the CAST study were made 
public, flecainide was removed from clinical use. 63,64 
Encainide (1) is a class le antiarrhythmic agent with combined electrophysiological 
effects of lidocaine and quinidine. These effects include rate-dependent decrease in 
Vmax, a decrease in APD, and an increase of the ERP:APD ratio.41 It has been proven 
effective in the treatment of ventricular and supraventricular arrhythmias.41 
Pharmacokinetic studies of encainide demonstrated the clinical importance of metabolites 
in antiarrhythmic drug action. The two main metabolites, 0-demethyl- and 3-methoxy-
12 
0-demethylencainide were found to be more potent in dog _and rabbit hearts than the 
parent compound)l,41 Low doses of 0-demethylencainide produced effects similar to 
those with lidocaine (7) while the effects of encainide (1) resemble those of 
quinidine.15,52 In view of the CAST study, it was concluded that the negative side 
effects of encainide outweighed the therapeutic benefit. Immediately after the results of 
the CAST study were made public, encainide (1) was removed from the market by the 
FDA. Other class I agents are currently undergoing a similar evaluation. 
Lorcainide (3) has been used in some European countries since 1981 and belongs to 
the class le antiarrhythmic agents having local anesthetic properties. The 
electrophysiological studies show similarities to that with flecainide (2) in that the 
maximum rate of depolarization is reduced and the APD is prolonged. Metabolites of 
lorcainide have been identified but were not as active as these derived from encainide 
(1).41 
Sparteine (10a) belongs to a group of naturally occurring lupine alkaloids and is 
categorized as a class I antiarrhythmic agent.68 Pharmacological action of sparteine has 
been the subject of contradictory reports and it's antiarrhythmic activity has only recently 
been established.11 Conclusions from the studies were that sparteine prolonged the APD 
10a 
and showed an increase in the refractory period in rats.11,68 The structure of sparteine 
10a is shown as the chair-boat conformation, but IR and NMR analysis concluded that in 
solution and in the liquid state conformer 10b is also present. 76 
13 
The inner rings of sparteine consist of a 3,7-diazabicyclo[3.3.l]nonane (called 
bispidine) moiety. Sparteine was shown to possess antiarrhythmic activity but the 
toxicity of the compound was high. It was believed that by changing substituents on the 
outer rings of sparteine with various groups to alter lipophilicity that the antiarrhythmic 
activity might be enhanced.60 In 1977, a series of 3,7-dialkylbispidines were synthesized 
by Ruenitz and Mokler.60 Testing of the compounds (using disopyramide as the clinical 
standard) employed a mouse-chloroform fibrillation assay. The results indicated that the 
potency of these agents was reasonably high, but the acute toxicities were a negative 
factor against their use as clinical agents. 60 Considering these results, slight structural 
modifications were incorporated into the framework of the bispidine system. 
Introduction of the N-benzamide functionality into compounds 11 had a dramatic effect 
(Table IV) upon the observed antiarrhythmic activity. Not only did these amides possess 
an increase in potency, but they were less toxic by more than two fold where compared to 
the dialkyl derivative cited earlier (Ruenitz and Mokler60). Several compounds were 
reported61 but Table IV illustrates only the most active (more active than the standard 
disopyramide) of the series synthesized.61 
Binnig developed several dispidine analogues 12 that were tested for antiarrhythmic 
·-
activity in guinea pigs and found to be quite active where compared to quinidine (4).9 
Table V illustrates a few examples of the most active derivatives. Unexpectedly, these 
compounds and their salts possessed calcium-antagonistic, antiphlogistic and 
thrombocyte aggregation-inhibiting properties.9 
Several 3,7-diazabicyclo[3.3.l]nonanes (DNBCN) 13 were prepared with an alco,iol 
or an ether functionality in the 9-position and showed enhanced activity (Table Vl).54 To 
assay for an antiarrhythmic effect, rats were pretreated intravenously with aconitine to 
induce arrhythmias. Tertiary amines 13 exhibited therapeutic activity several times more 
potent than lidocaine (7) with the added bonus of possessing a small amount of calcium 
antagonistic capability. Furthermore, it was noted that these agents had the capability 
TABLEIVa 












EDso C LD50 d T. I.e 
90 517 5.77 
14 
----------------------------------------------------------------------------· 
Ila CH3 H 85 621 7.29 
llb CH3 4-0CH3 78 463 5.93 
Ile CH3 4-Cl 49 535 10.89 
aReference 61. 
bMouse-chloroform fibrillation assay in adult mice. 
CEDso = Effective dose (µmole/kg ip) in which 50% are affected; mean potency. 
dLDso = Dose (µmole/kg ip) causing mortality in 50% of mice; mean toxicity. 
e"fherapeutic Index (T. I.) = LDso'EDso. 
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TABLE Va 
ANTIARRHYIBMIC PROPERTIES OF BISPIDINES 12 
N 
4 (Quinidine) 12 
Agent R ED5ob Max. Effect Dosec Toxic Dosed Qe 
4 42.7 215 464 
12a 15.6 215 464 
12b 20.2 100 215 
12c CH(Phh 20.4 215 464 
aReference 9. 
hEffective dose (mg/kg) for the increase by 50% in the duration of aconitine 
infusion. 





dDose (mg/kg) at which toxic side effects, such as cyanosis or electrocardiograph 
(ECG) change, occur. 




ANTIARRHYTIIMIC ACTIVITY OF BISPIDINES 13 
R" 
7 (Lidocaine) 13 






13a CH3 CH3 0 2C-2-Naphthyl 0.11 17.0 154 
13b CH3 CH3 02CPh 0.08 9.0 112 
13c CH3 CH3 OC6H4-4-Cl 0.9 52.0 58 
aReference 54. 
b Aconitine-induced arrhythmias in rats. 
CEffective dose (mg/kg) to restore normal sinus rhythm in 50% of rats tested. 
dDose (mg/kg) causing mortality in 50% of tested rats. 
e'fherapeutic Index (f. I.)= LD5ofED5o. 





of increasing the stimulus threshold (better known as an increase in the refractory period). 
This type of effect can ultimately lead to the abolishment of certain types of cardiac 
arrhythmias.11,54 
Our group has synthesized several 3-azabicyclo[3.3. l]nonane derivatives, and tested 
the antiarrhythmic efficacy using lidocaine as the standard. 8,13c These agents were 
evaluated in dog models in which the heart was impaired with surgically-induced 
myocardial infarctions. Antiarrhythmic activity was judged on ability of the agent to 
alleviate sustained ventricular tachycardia (SVT) generated by programmed electrical 
stimulation (PES) of the damaged heart cells. Electrophysiological studies have shown 
that polar groups (such as carbonyls and alcohols) at the 9-position greatly reduce the 
antiarrhythmic capabilities of selected agents. 8 In contrast, ketal 14e (X = Cl04) and 
thioketal 14g (X = Cl04) had good activity compared to polar groups as previously 
mentioned. Table VII illustrates the most active compounds synthesized in our 
laboratory. Activity is described as ability of an agent to prevent SVT in terms of 
nonsustained ventricular tachycardia (NSVT). Although the activity of these compounds 
appears to be almost the same, salt 14d (X = Cl04) was found to suppress the heart rate 
by 29% and to inhibit the induction of reentry of the VT, relative to lidocaine [(7); 
suppressed heart rate by only 11 %]. Interestingly, agent 14d (X = Cl04) increased the 
mean blood pressure which is an added feature since pressure decreases are commonly 
experienced during SVT. The electrophysiology· and pharmacology of 14d have been 
extensively studied.13 Compound 14a (X = Cl04) also had a significant effect on the 
reduction of the heart rate in dog models. 58 
Most of the examples of bispidines cited possess very good antiarrhythmic activity, 
and one might conclude that more attention should be focused on derivatives within this 
basic framework. Trends in useful activities for a series of such compounds can be seen, 
but serious problems may arise when trying to compare agents that have been screened by 
different methodologies. 
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ANTIARRHYTHMIC ACTIVITY OF 3-AZABICYCL0[3.3.l]NONANES 14 
14 
(Effect on S\TT) 
Compb R· y z 3mg/kg 6mg/kg 
7 (lidocaine) Reducedd Reduced 
----------------------------------------------------------------------------· 
14a CH(CH3)i NC(O)Ph CH2 NSW NSVT 
14b CH(CH3)i NCH2C6H4-3,4(0CH3)i CH2 NSVT NSVT 
14c CH(CH3)i NCH2Ph CH2 NSVT NSVT 
14d NCH2Ph s CH2 NSVT NSVT 
14e NCH2Ph s · C(OCH3)2 NSVT NSVT 
14f NCH2Ph CHC02Et CH2 NSVT NSVT 
14g NCH2Ph CHC02Et C(SCHi)2 NSVT NSVT 
14h NCH2Ph Se CH2 NSVT NSVT 
aReference 8. 
hX = Cl04, Cl, Br, citrate, fumarate, HS04. 
csVT = Sustained ventricular tachycardia induced by programmed electrical 
stimulation (PES) of infarcted dog heart. 
dReduced sustained ventricular tachycardia. 
CNSVT = Nonsustained ventricular tachycardia (or abolished VT). 
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Most antiarrhythmic agents cited to this point appear to be primarily class I agents by 
the Vaughan Williams classification.83 The CAST51,63,81 study demonstrated some of 
the negative side effects (such as proarrhythmias) associated with certain class I drugs. 
With this evidence, many researchers have been prompted to consider the synthesis of 
agents that possess different modes of action, namely class II, class III, class IV, or 
combinations thereof. 
Class II Antiarrhythmic Agents 
The major electropharmacological effects of beta-adrenergic receptor blocking drugs 
(class II) is shunting the catecholamine-induced increase in automaticity.52 
Catecholamines play a critical role in the propagation of abnormal action potentials (e.g., 
during ischemia). Blockade of such effects might explain some of the responses observed 
with beta-adrenergic blocking drugs in the prevention of sudden cardiac death, bearing in 
mind that other explanations are also possible. A number of such agents are known, 
including propranolol (15) and pronetalol (16) which display quinidine-like properties in 
slowing the phase O upstroke velocity (slowing APO) at high concentration in vivo.13 
15 16 
Propranolol (15) is a class II antiarrhythmic agent which was introduced in 1964 for 
the treatment of anginia pectoris, cardiac arrhythmias, and hypertension.15 Since that 
time, electrophysiological and pharmacological studiesll,15,52 of 15 have been extensive 
One particular action observed was the shortening of the APD in vitro57 and in humans.19 
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Pronetalol (16) was found to possess properties similar to those of propranolol. A 
comparative study between 15 and 16 was carried out by BlacklO to determine which 
agent had the greatest effect as a class II antiarrhythmic agent. Propranolol is a more 
active sympathetic P-receptor antagonist while the metabolitic half-lives and LD5o's of 
the two agents were found to be very similar.18 In mice, the acute toxicity effects of 
pronetalol (16) were attributed to a nonspecific action on the central nervous system 
because the acute LDso's for the (S)-(+)-isomers (inactive) and (R)-(-)-isomers (active) 
were the same as that for the racemate.10 Propranolol (15) was concluded to be a better 
antagonist ('3-receptor) but was devoid of intrinsic sympathomimetic activity as judged 
by decreased resting heart rates in anesthetized cats. 
A detailed explanation on the design and use of P-blockers has been reviewed.3 
Recently researchers have concluded that agents which tend to shorten the APD are less 
attractive.63,86 Today, antiarrhythmic drugs are designed with probable potential to 
prolong the action potential duration as is seen with class III agents. 
Class III Antiarrhythmic Agents 
In the treatment of life-threatening VT and ventricular fibrillation (VF), there exists a 
need for antiarrhythmic agents that express their salutary effects by prolonging 
repolarization (class III) rather than by strictly inhibiting myocardial conduction (class I) 
through blocking the fast sodium channels.72 Numerous studies have indicated that 
prolongation of the APD and effective refractory period (ERP), without any change in the 
conduction velocity, support an important mechanism in the prevention and termination 
of developing atrial and ventricular fibrillation. 74 Many class III AAA possess the ability 
to prolong the APD and ERP, but the structures of most agents are quite heterogenous. 
The efficacy, potency, and antiarrhythmic spectrum of action are not uniform, and the 
ionic mechanisms by which the agents delay repolarization are also frequently different. 
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As a result, members of class ill AAA vary markedly in their physiological profiles but 
appear to have in common the ability to prolong ventricular repolarization and ERP. 
Bretylium (17), which has been labelled a prototype class ill antifibrillatory drug, 
was originally introduced as an antihypertensive agent in 1959.11 In the mid 1960's, 17 
became the first drug shown to exert pronounced antifibrillatory effects as demonstrated 
in humans. The mechanism of action was suggested from the use of isolated Purkinje 
fibers and ventricular muscle in which the APD and ERP were both prolonged without 
altering the ERP/APD ratio.40 By measuring the fibrillation threshold, it was possible to 
compare antifibrillatory action of several other antiarrhythmic agents and bretylium (17). 
Results indicated that bretylium (17) was the only agent to increase the threshold and also 
the only drug that was positively inotropic.4 Inotropic agents produce an increase in 
cardiac output and central aorta pressure without impairing flow to regional circulation or 









treatment of life-threatening ventricular fibrillation and tachycardia when first-line agents 
such as lidocaine (7) and procainamide (5) fail using normal doses. 
An effective but rather nonspecific class III antiarrhythmic agent is amiodarone (18) 
which was initially developed for itsantianginal properties.11 Control of ventricular and 
supraventricular tachyarrhythmias has been achieved with this potent agent, and 
amiodarone (18) is, in most cases, the only agent effective in controlling SVT.66 The 
22 
major electrophysiological effects of 18 are the prolongation of the APO in atrial and 
ventrical muscle and the ability to increase atrial, atrioventricular nodal, and ventricular 
effective refractory periods.75 The effects on the sinus node function, as seen in the 
isolated rabbit preparation, is the prolongation of the APO where the drug's adrenergic 
blocking action contributes to the sinus slowing.30 
A pure class III drug should not directly alter the conduction time (phase O upstroke) 
in cardiac tissue. Oral administration of 18 revealed an increase in the AH interval 
(parameter measured from ECG; AH interval represents the AV nodal conduction time) 
due to prolongation of atrial effective refractory periods, that is, in lengthening of the 
relative refractory periods of the atrioventricular node in response to a series of action 
potentials. 25 Other studies have shown that 18 induces slight increases in the HV and 
QRS intervals as revealed by detailed electrophysiological studies on the mechanism of 
action pertaining to the QT interval prolongation and the effect on ventricular 
arrhythmias.31 These findings indicate that amiodarone (18) has more than just class ill 
antiarrhythmic action, but the class II (Ji-blocking) activity is not as pronounced 53 
In 1960, the development of sotalol (19) was described, and it was found to be 
unique in that it possessed a combined class II ((3-adrenergic blockers) and class ill 
(similar to amiodarone) antiarrhythmic effects. Clinical trial studies of sotalol (19) 
0 r d ~N-....../ N 
H3CS02HN H 
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revealed significant electrophysiological effects by increasing the basic sinus length, 
sinus node recovery time, and the effective and functional refractory period of the 
atrioventricular node.85 It was noted that these effects are consistent with class II agents, 
23 
and no class m action was observed. Echt and co-workers20 compared intravenous 
sotalol (19) and intravenous propranolol (15) in 17 patients. Results indicated that 19 
(but not 15) prolonged atrial and ventricular effective refractory periods, lengthened the 
APO, and lengthened the QT interval. These findings affirm that sotalol (19) possesses 
both class II and class m antiarrhythmic activity. 
Sudden cardiac death can be the end result of lethal ventricular arrhythmias as 
indicated earlier. Senges and co-workers67 assessed the efficacy of sotalol (19) in 18 
patients with SVT. In each patient, the arrhythmias were induced by PES in the 
controlled studies. Sotalol (19) prevented the induction of sustained VT in 12 of the 18 
patients (67%) and therefore was considered an effective agent in the treatment of 
sustained ventricular tachycardia. 
Currently there is no selective class m agent available for clinical use. Amiodarone 
(18), a class m agent, is a nonspecific drug and is the only one approved for therapeutic 
applications. However, recent reports have described the synthesis and biological activity 
of a number of potent and selective class m antiarrhythmic agents.45,49 
Lumma and co-workers45 prepared a series of benzamide derivatives in an attempt to 
achieve selective class ill antiarrhythmic activity. Screening of the compounds [such as 
sematilide (20)] were carried out in vitro on isolated canine Purkinje fibers to determine 
the effects on APO at 95% repolarization (AP095) and the maximum rate of 
repolarization (V max), Active compounds must prolong AP095 and functional refractory 
period (FRP) by 20% (C20) with a minimal effect on V max in order to have selective class 
III electrophysiological action. All the compounds tested displayed no significant 
decrease in V max and the conduction times were essentially unchanged. 
Structure-activity relationships indicated that exchanging the methyl group on the 
sulfonamide moiety in 20 with another alkyl group greatly decreased the activity.45 
When the N-H hydrogen of the sulfonamide functionality was replaced with a methyl 
group, the activity was completely abolished. In view of its overall profile, including low 
24 
toxicity (LD50 - 250-300 mg/kg, ip, mouse), compound 20 (sematilide) was further 
developed for therapy involving ventricular arrhythmias. 
A similar electrophysiological experiment, using isolated canine Pur.kinje fibers, was 
described by Morgan and co-workers49 for a family of benzamides to determine their 
selective class ill activity using sematilide (20) as a standard. As mentioned earlier, a 
compound is considered to have selective class ill effects if it increases APD by 20% 
without causing a significant ~ 10%) decrease in V max. Results illustrated in Table VIII 
indicate that several of the agents tested have selective class ill action with agent 21a 
being equieffective for in vivo and in vitro models as compared to 20. 
Structure-activity relationships indicate that the imidazole moiety can be a suitable 
replacement for the sulfonamide group to enhance class ill AAA.49 Substitutions on the 
imidazole ring resulted in active agents, but attachment of the imidazole functionality to 
the benzene ring via C(2) of the imidazole ring resulted in very weak class III activity 
relative to 21a. Substitution of different groups in these benzamide systems also gave 
varied activities. 
Many reseachers have focused attention on the synthesis of agents possessing 
specific characteristics. Recently some (aryloxy)propanolamine12 derivatives and 
another family of benzamides22 were reported. Testing of these agents was the same as 
described earliei49 with the results that selected compounds in each series showed 
marked activity where compared· to sotalol (19). Table IX and Table X illustrate the 
findings which led to the conclusion that 22a, 22c and 23a possess potent and selective 
class III action with the ability to prevent SVT. These three agents were considered 
sufficiently effective to be submitted for clinical trials. 
Along with compounds 21, 22, and 23 already mentioned, several others have 
demonstrated very good antiarrhythmic activity. These include agents 24 (E-4031),55 25 




INTRACELLULAR ELECTROPHYSIOLOGY OF 
4-(lH-IMIDAZOLE-1-YL)BENZAMIDES 21 
20 (Sematilide) 
dlfJflff\ ~o 1 · N 
N~ \ J '" \ N-R 
, I 
R R" 21 
Nb ' " "' C20 APD95 (µM) R R R [Ranget 
18 4.4 [1.9-11] 
25 
----------------------------------------------------------------------------· 
21a 3 H H CH2CH2NEt2 2.9 [2.2-3.4] 
21b 4 CH3 H CH2CH2NEt2 NR 
21c 4 H 1-Naph CH2CH2NEt2 0.4 [0.2-0.6] 
21d 4 H H H2C-o N 3.0 [2.2-4.5] 
I 
/\ ET 21e 2 H N, 0.9 [0.7-1.0] 
'--..../ Ph 
BReference 49. 
bNumber of experiments. 
CConcentration (interpolated) of test compound which caused a 20% increase in 
APD95. Lowest and highest values given in brackets. NR = not reached. 
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TABLEIXa 
ANTIARRHYTHMIC ACTIVITY OF (ARYLOXY)PROPANOLAMINES 22 
OH 
19 (Sotalol) 
Comp X ' R dose mg/kg Nb AERPC Acr<1 
19 2.5 (iv) 5 42 -5 
5.0 (iv) 5 57 -7 










hNumber of experiments. 
c AERP: atrial effective refractory period. 




























· dose mg/kg Nb Acr1 Comp X R R AERPC 
19 (sotalol) 2.5 5 42 -5 
5.0 5 57 -7 
----------------------------------------------------------------------------· 
23a S02 CH3 CH3 
23b co CH3 CH3 
23c S02 CHrCH2 
24d co CHrCH2 
aReference 22. 
hNumber of experiments. 
c AERP: atrial effective refractory period. 









eoata reported as percent change from pre-drug state. 
5 40 -6 
5 53 -5 
2 18 -1 
2 44 -3 
2 22 3 
2 40 -3 
5 33 -10 
5 63 -10 
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activities of the three have been found to be similar to that of sotalol (19) but most have a 
higher efficacy. The literature contains many agents which have shown excellent class III 
action, but most are not presently in clinical trials because the activity displayed was less 
than that of 19. Examples are certain spiro derivatives23 27 and certain bis(arylalkyl)-
amine17 compounds 28. Since the CAST study, there has been a surge towards the 
development of drugs with selective class III action. 




3,7-diheterabicyclo[3.3.l]nonanes (DHBCN), was found to have slight class I action but 
predomin-ately class III activity. Tedisamil (29) prolonged the APO, the QT interval, and 
the refractory period and thus followed the criteria for class III action. 7 Structure-activity 
relationships of this compound were not totally described, however, and there was no 
rationale for the observed class III action. Many antiarrhythmic agents in the family of 
DHBCNs previously reported8,9,54,60,61 were stated to possess only class I activity. For 
this reason the basic 3,7-diheterabicyclo[3.3.l]nonane ring structure cannot be totally 
responsible for the observed class III action. One reasonable explanation is the presence 
of the spiro ring across the 9-position or the cyclopropylmethyl groups in the 3- and ?-
positions. It is not known if 29 has a CC+:ZCB equilibrium in solution but it is likely so 
from other work in our laboratory. 
30 
Class IV Antiarrhythmic Agents 
Calcium antagonists are widely recognized as agents with a .great impact on both 
pharmacology and clinical therapy for cardiovascular disease and are classified as class 
IV antiarrhythmic agents. These drugs terminate paroxysmal supraventricular 
tachycardia (sudden onset and termination of arrhythmias that are triggered by ventricular 
premature contractions) and control the ventricular response to atrial flutter and 
fibrillation. 52 Cardiac arrhythmias result from disorders of impulse conduction and 
formation, or a combination of both mechanisms. Salutary effects of these agents in 
supraventricular arrhythmias are believed to be due to the slowing down of the Ca+2 
channel-dependent conduction in the AV node with a prolongation of AV nodal 
refractory period. 65 Control of ventricular arrhythmias by a calcium antagonist is still 
speculative. In patients with ischemic heart desease (myocardial impairment due to 
imbalance between coronary blood flow and myocardial requirements caused by changes 
in coronary circulation), such agents prevent genesis of certain dysrhythmias by reversing 
coronary vascoconstrictions which possibly may prevent the incidence of sudden cardiac 
death;65 
Verapamil (30) is considered the best example of a class IV (calcium antagonist) 
antiarrhythmic agent (Table XI). Electrophysiological effects70 of verapamil (30) are 
noted as described above in which the slow inward current carried by calcium is blocked. 
TABLEXl8 
ELECTROPHYSIOLOGICAL ACTIONS OF 
VERAP AMIL (30) AND DILTIAZEM (31) IN HUMANS 

































A VN, atrioventricular node; other electrocardiograph (ECG) intervals 
have the usual connotations: +,increase;-, decrease; 0, no effect. 
31 
32 
This agent has received much attention, and the results of pharmacology studies are well 
documented.16 Another agent which possesses very similar action to that of verapamil 
(30) is diltiazem (31). The electrophysiology and pharmacology data on 31 have shown 
this agent to be a selective class IV antiarrhythmic agent.11,26 Table XJ84 illustrates the 
overall electrophysiological actions of the Class IV antiarrhythmic agents 30 and 31. 
Antiarrhythmic Agents Possessing Multiple Class Action 
One of the newest trends in the synthesis of more potent antiarrhythmic agents is to 
introduce a combination of different class actions into one molecule. The literature has 
only revealed the preparation of single agents possessing both class II and class III 
activity. Broader therapeutic benefits are the proposed major advantages to be expected 
for these types of drugs. Such compounds could have potent class III action and balanced 
J3-blocking (class II activity) effects without significantly affecting cardiac conduction. 
Ideally, these agents would be potentially useful against reentrant and catecholamine-
dependent arrhythmias at doses below those causing J3-blocking-mediated hypotension 
and cardiac depression.11,15 One characteristic action of class II agents is the slowing of 
heart conduction. (3-Blockers enhance the depression of conduction at higher dosages but 
exert a much diminished effect at lower concentrations.15,52 
Lis and co-workers44 reported a series of (aryloxy)propanolamines possessing class 
11/111 antiarrhythmic activity. Several compounds were tested, and the results indicated 
that agents 32 (S-isomer), 33, 34, and 35 had good efficacy [compared to other 
derivatives of 33-35] even as racemic mixtures (Table XII). These agents prolonged the 
APD and had minimal effects on the rate of rise of phase O of the action potential (V max). 
(3-Receptor selectivity was determined using canine cardiac tissue in which varied 
activity was observed.44 Compounds 32-35 were chosen in view of their established and 
useful pharmacological profiles.44 Drug efficacy was determined using mongrel dog 
models (Table XII). These studies concluded that agent 32 (S-isomer) was more potent 
Comp 
TABLEXIIa 
ANTIARRHYTHMIC EFFICACY OF 19 AND 32-35 
no. eff.b dose range eff. dosec HRd 
no. tested mg/kg, iv mg/kg, iv 
BPe 





32 7/8 0.1-3.0 0.3 (6) -2 4 
33 8/8 0.3-3.0 1.0 (5) 9 3 
34 5/6 1.0-10 1.0 (4) -3 13 
35 7/8 1.0-10 1.0 (4) 1 -4 
aReference 66. 
bNumber of animals in which sustained ventricular tachycardia (SVT) or 
ventricular fibrillation (VF) was not inducible after drug administration 





CEffective dose of the test compounds and the number of animals for which this dose 
was effective in parenthesis. 
dPercent change in heart rate from control at effective dose. 
epercent change in blood pressure from control at effective dose. 
f Percent change in function refractory period (FRP) from control at effective dose. 
34 
than sotalol (19), which was used as a standard, and merit further investigation as a 
combined class II/Ill antiarrhythmic drug. 
Arylpiperazine derivatives of 36 were recently reported56 to contain multiple class 
action as described previously.44 These compounds possessed activity similar to agent 
0 
cY~~NHSOCH 6 2 3 
~ 36 
32, but the efficacy was less pronounced. It was noted that structural modification was 
probably needed to obtain more potent agents.44 
Most of the agents reported herein do not possess only one mode of action. Several 
agents are classified in one category but show slight effects of the other classes. From 
experimental evidence, it is clearly evident that more work is needed to prepare agents 
with multiple class action. Compound 32 shows good promise as a therapeutic AAA due 
to its selective action and low toxicity levels.44 
From the evidence given herein, the latest developments in AAA have been the 
incorporation of multiple class action into a single compound. Most of the limited work 
has focused on the development of agents possessing class 11/IIl some of which have 
shown promise as effective antiarrhythmic drugs.44,56 Recently, Hondeghem and 
Snyders34 made suggestions on the development of antiarrhythmic drugs with novel 
electrophysiological profiles. They hypothesized that an ideal drug would have the 
ability to block the fast sodium channel with fast diastolic recovery (class lb) and use 
dependent prolongation of the APD, that is, the agent would only prolong the action 
potential at an accelerated heart rate. Agents which block the potassium channel are 
35 
indicated as having use dependent prolongation of the action potential duration.34 The 
term use dependence implies that the agent prolongs the action potential at accelerated 
heart rates with no prolongation of the APO observed at lower heart rates. 
Biological Data of 3,7-Diheterabicyclo[3.3.l]nonanes 
Some 3,7-diheterabicyclo[3.3.l]nonanes (DHBCNs) have reported good anti-
arrhythmic activity as described earlier. 8 It was recently suggested that certain 
antiarrhythmic properties of these class lb agents could originate from the inhibition of 
myocardial Na+, K+-ATPase activity.Ba Chemical structure and lipophilicity have also 
been reported to have a strong influence on Na+, K+-ATPasel3a and DHBCNs are 
lipophilic. The DHBCNs were tested using guinea pig myocardial Na+, K+-ATPase and 
Mg+2-activated A TPase in comparison to lidocaine (7) and tedisamil (29). The inhibitory 
effects of these agents are significant and interesting in many respects. As previously 
mentioned, compound 14d was found to increase blood pressure during sinus rhythm. 
Increased blood pressure may be explained by the inhibitory effects 14d has on the Na+, 
K+-ATPase activity.13a Inhibitory effects on ATPase activity correlates well with the 
retention time in reversed-phase HPLC and the molar refractivity (MR) of the DHBCN 
derivatives (Table XIII). Greater inhibitory effects on the Na+, K+-ATPase activity were 
seen with lower MR values. The nonpolar nature of these compounds is measured by log 
P values in which the nonpolarity is relatively proportional to the retention time in 
reversed-phase HPLC. Lipophilic properties often play an important role in the inter-
action between the therapeutic agent and the receptor site. More interaction between a 
specific receptor and the agent was found with the less polar compounds.13a Compound 
44 was the only agent that possessed specific inhibition of Mg+2 activated A TPase. This 
type of activity may coincide with the DHBCN chelating properties with Mg+2. 
Significant inhibition on myocardial Mg+2-activated A TPase may be associated with the 
Na/Mg exchange to the intracellular Mg+2 ions of the myocardial cells.13a More effort in 
36 
TABLEXma 
MOLAR REFRACTNITY (MR), LOG P, RETENTION TIME (RT), AND IC5ob FOR 
DHBCNDERIVATIVES Na+,K+-ATPase AND Mg++-ATPase ACTIVITTES 
(MEAN± SD; n = 6) 
RT IC50 for Na+,K+ 
Compds MR logP (min) ATPase(nMt 
7 (lidocaine) 7.17 2.26 24.30 0.547 ± 0.041 
14a (SAZ-VII-23) 7.95 0.75 11.35 1.219 ± 0.125 
14b (GLG-111-93) 9.15 1.79 18.06 0.702 ± 0.074 
14d (BRB-1-28) 6.96 2.31 15.85 0.789 ± 0.047 
29 (tedisamil) 9.50 3.95 15.91 0.792 ± 0.060 
37 (GLG-N-17) 8.24 2.48 24.30 0.547 ± 0.041 
38 (GLG-N-57) 8.61 0.49 20.49 0.618 ± 0.023 
39 (GLG-111-70) 8.77 1.68 15.87 0.744 ± 0.055 
40 (SAZ-VII-22) 8.44 1.54 16.53 0.776 ± 0.036 
41 (GLG-N-74) 9.65 -0.08 6.03 1.315 ± 0.103 
42 (GLG-111-96) 8.28 0.88 11.78 1.341 ± 0.130 
43 (GLG-ID-86) 10.52 1.78 9.91 · 1.562 ± 0.105 
44 (GLG-N-44) 8.32 0.08 7.50 no signif. effect 
aReference 13a 
hICso = Concentration required to inhibit 50% of the enzyme activity. 
CnM = 10-9 moles/liter. 
IC50 for Mg++ 
ATPase (nMt 
0.433 ± 0.027 
1.217 ± 0.103 
0.426 ± 0.054 
0.324 ± 0.040 
0.378 ± 0.010 
0.433 ± 0.027 
0.433 ± 0.049 
0.507 ± 0.035 
0.501 ± 0.076 
1.010 ± 0.060 
1.137 ± 0.103 
0.810 ± 0.063 






















41 (GLG-IV-74) 42 (GLG-ill-96) 
NHS02CH3 
~o.-
43 (GLG-ill-86) 44 (GLG-IV-44) 
searching for specific Mg+2 A TPase inhibitors is warranted since no agents of this type 
are currently available.13a 
Interestingly, lidocaine (7) and tedisamil (29) were found to possess similar results as 
compared to the DHBCN derivatives in terms of Na+,K+-ATPase and Mg+2-ATPase 
activities. Specific inhibitory effects and their relationship with respect to 
electrophysiological actions are yet to be determined. These AAA (14a,41,42,44) 
produced a significant inhibition on myocardial Mg+2-activated A TPase and could lead to 
a possible link between Na/Mg exchange and intracellular Mg+2 ions of the myocardial 
cells.13a 
39 
Several members of the 3,7-diheterabicyclo[3.3.l]nonanes have displayed potent 
antiarrhythmic activity with low toxic and low proarrhythmic effects. 8 These results 
might suggest that more attention be focused on this area. From such model systems, 
examined to date, it should be possible to design more potent AAA considering the 
structure-activity relationships uncovered thus far. 
CHAPTER II 
RESULTS AND DISCUSSION 
Several members of the 3,7-diheterabicyclo[3.3.l]nonane (DHBCN) family have 
been found to exhibit good pharmacological properties in a variety of assays which are 
used to demonstrate such activity.8,9,54,60,61 This group of heterocycles has displayed 
excellent antiarrhythmic action in the 1-4 day infarcted dog heart with the use of 
lidocaine (7) as the clinical standard. 8 Canine cardiovascular systems are considered the 
Lidocaine 
7 
8 1 2 
17\ 
7 X Z 9 Y 3 
\_\_/ 
6 5 4 
DHBCN 
closest models for these assays in comparison to the human cardiovascular system. Any 
ability that these agents demonstrate in preventing lethal arrhythmias, which could result 
in sudden cardiac death, is meritorious. Presently, DHBCNs are known to possess class I 
activity, and testing for other class actions in this family is only now being initiated.24 
Slight structural modifications in the 3- and ?-positions of DHBCN can significantly 
alter the observed class I antiarrhythmic activity.8,9,60,61 Introduction of specific 
40 
41 
functional groups can be effective in providing agents with more than one mode of 
action.44,56 Further structural modifications might enhance antiarrhythmic activity in 
this family of heterocycles. 
One ancillary objective of this research was to develop methodology to obtain a 
series of 3,7-diheterabicyclo[3.3.l]nonan-9-ones which could be converted to 3,7-
diheterabicyclo[3.3.l]nonanes and hydroperchlorates for the determination of potential 
antiarrhythmic activity. A modified Mannich type condensation, starting with ketones 
4Sa and 4Sb, made it possible to prepare 3,7-diheterabicyclo[3.3.l]nonan-9-ones 46a and 
X 
0 0 X y 
45 46 
X X y 
a NCH(CH3)i a NCH(CH3)i NCH(CH3)i 




R y R y 
a CH(CH3)i NCH(CH3)2 37 CHrcPr NCH2Ph 
b CHrcPr NCH2Ph 48 CH(CH3)i NCH(CH3)i 
c CHrcPr NH 
42 
46b. Reduction of the ketones led to the corresponding amines 47a and 47b and the 
respective hydroperchlorates 37 and 48. Masking of the carbonyl has been found to aid 
in the antiarrhythmic properties of specific agents.8 Thioketals 49a and 49b were 









38 and 43, respectively. Interestingly, thioketal salt 38 possessed excellent activity and is 
presently undergoing further testing. 
Another major objective was to synthesize a series of amides and certain salts with 
varying substituents on the aromatic ring and at the 7-position in the bicyclic ring. 
Possibly, these modifications might enhance the antiarrhythmic activity. It had been 
speculated that the amide group would increase hydrophilicity of an agent for better drug 
formulation. 61 
Amides 39 and 50 were prepared using amine 47c, and hydroperchlorates 42 and 51 
were also obtained from their respective amides 50 and 39. Amide 39 has been found to 
have good class lb antiarrhythmic activity in dog models and possesses some moderate 











Another series of amides 52a, 52d; and 52f was prepared with substituents (N02, F) 
in the para position of the aromatic ring. Additional reactions were carried out on amides 














varied substituents. Most of the amides were converted to their respective 
hydroperchlorates [41, 53a, b, c, d, e, fJ though a few hydrochlorides (54a, 54b, 54c) 
were obtained. Amides 53c was found to have excellent antiarrhythmic activity and 













We have developed methodology for the alkylation of certain secondary amines to 
give N-alkyl derivatives of DHBCN. Reaction of 52j with the 4-F-C6I4C(O)CH2Cl 







gave 55a which was reduced to racemic alcohol 55b. Alcohol 55b is hypothesized to 
have multiple class AAA. Hydrochloride 56 was also prepared for comparison of its 
antiarrhythmic activity with that of the known hydroperchlorate 14d. 
Synthetic Methodology 
A double Mannich condensation62 of ketones 45a and 45b was utilized (Scheme I) to 
prepare 3,7-diheterabicyclo[3.3.l]nonan-9-ones 46. Condensation of 45a or 45b, a 
primary amine, paraformaldehyde, acetic acid, and one half an equivalent (with respect to 























a NCH(CH3)2 ·NCH(CH3)i 
b NCH2Ph NCHrcPr 
R y 
37 CHrcPr NCH2Ph 
48 CH(CH3)i NCH(CH3)i 
46 
and 46b (76.1 %) as a crystalline solid. It had been previously discovered that the 
addition of HCl increased the yield of ketones prepared by the Mannich condensation 
from 25% to 56%.89 It is speculated that the pH plays a critical role in the reaction 
kinetics, perhaps in accelerating formation of the intermediate iminium ion. Recently, it 
was found that the addition of a second equal portion of paraformaldehyde after 10 h of 
reflux increased the isolated yields of 46 from 56-57% to 69-76%. This phenomenon is 
not completely understood, but one possible explanation might be that some 
paraformaldehyde is removed during the reaction via the formation of side products. 
Wolff-Kishner reduction of ketones 46 in the presence of KOH, hydrazine (95%), 
and triethylene glycol at high temperature (-200°C) gave amines 47a and 47b as oils. 
Characterization of these amines via NMR and IR analyses was completed, and the oils 
were used without further purification. Salts 37 and 48 were obtained upon treatment of a 
chilled (-5°C) solvent solution of 47a or47b with HCl04 (60%). 
Modified conditions for the double Mannich reaction were employed to prepare 
reported ketones 57 to determine if isolated yields could be increased. Ketones 57a, 57b, 
TABLE XIV 
ISOLA TED YIELDS OF KETONES 57a, 57b, AND 57c 
BY PREVIOUS AND NEW METHODS 
@ 
y 
X y Previously Yield obtained 
reported yield by new method 
57a NCH(CH3}2 NCH2Ph 57.2%8 73.5% 
57b NCH3 NCH2Ph 45.0%b 72.8% 
57c NCH2Ph NCH2Ph 58.2%c 69.1% 
aReference 89. bReference 6. CReference 9a 
and 57c were all synthesized with isolated yields being increased by as much as 30% 
(Table XIV) or more. 
47 
Masked derivatives 49 from ketones 46 were prepared as shown in Scheme II with 
water being removed via a Dean-Stark trap. Thioketals 49 were isolated as oils which 
were quickly characterized and converted immediately to hydroperchlorates 38 and 43 (in 












38 CH(CH3}i NCH(CH3)i 
43 CHrcPr NCH2Ph 
yields are possibly due to impurities that are present in the thioketals 49 prior to salt 
formation. The salts precipitated out of solution while protonated precursors to 38 and 43 
were possibly soluble in the solvents. 
In our work, several new amide derivatives were anticipated to have potential AAA 
due to earlier reports of amides possessing this activity.9,61,89 Debenzylation of 47b was 
effected with ammonium formate and Pd/C (10%) in boiling methanol to give the 
secondary amine 47c as an oil (91.8%) which was used without further purification after 
spectroscopic identification. Ammoniun formate acts as a hydrogen source in the 
reaction, and this method (Scheme III) has only been recently examine<f.59,89 The order 
of addition seems to be very important in this reduction. After the Pd/C is placed in the 













addition of the amine and ammonium formate to give the best yields. 
48 
R 
Amine 47c was acylated using a modified Schotten-Baumann procedure88 in which 
the amine was stirred at RT with an appropriate acid chloride in a biphasic reaction 
mixture of H2CCl2 and NaOH (10%) to give crude amides 39 and 50. Flash 
chromatography using neutral alumina afforded the desired product 50 as an oil (82.4%) 
while amide 39 was isolated as a solid (83.1 % ) and did not require further purification. 
Amides 39 and 50 were then converted to their respective hydroperchlorates 51 (70.9%) 
and 42 (65.1 %). 
49 
A key intermediate in the synthesis of amides 52a, 52d, and 52f was amine 52j 







delineated in forthcoming schemes. Several derivatives prepared from these amides were 
found to possess good antiarrhythmic activity with indications of multiple class action. 29 
Ketone 57a was reduced (Scheme IV) using standard Wolff-Kishner conditions to 
afford amine 58. Debenzylation was effected using conditions described earlier to give 
secondary amine 52j as an oil. Amine 52j was acylated using Schotten-Baumann 
conditions (described in the preparation of amides 39 and 50) to give amide 52a (94.3%) 
as a light yellow solid. The N02 group in amide 52a was reduced to a primary amine 
with TiCl3 (12% solution in HCI) at RT in H20/acetic acid (1:1) and gave 44 (86.2%). 
TiCl3 acts as a complexing agent in this redox reaction.77 This reduction of aromatic 
N02 groups under mild conditions, although recently discovered,77 is not fully 
understood. Formation of dihydrochloride 54a from amide 44 was achieved following 
the procedure mentioned herein. 
Hydrochloride 54b was prepared directly from amide 52a via the generation of 
HCl(g) by dropwise addition of sulfuric acid into a flask containing solid NaCl. The gas 
formed was passed through a CaC}i drying tube and subsequently into a chilled (-5°C) 
50 
SCHEME IV 
y y y 
OLN~ H2NNH2 I(N~ 10%Pd/C I(N~ KOH/IEG HC~Nl!i 2oo·c H3COH/a 
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solution of amide 52a to give salt 54b (74.9%). This hydrochloride was found to be 
extremely soluble in water (>20 mg/ml) which might allow for better agent uptake when 
administered to a patient. 
Conversion of amine 44 to sulfonamide 52c [off white solid (90.6%)] occurred 
(Scheme IV) with methanesulfonyl chloride and pyridine in H2CC!z.48 Amide 52c was 
treated with HCl04 or HCl in the usual manner to give hydroperchlorate 41 and 
hydrochloride 54c in good yields, respectively. The sulfonamide group could be 
responsible for class III AAA.22,55 In a similar manner, amide 44 was acylated (Scheme 
V) using acetyl chloride via Schotten-Baumann conditions to give amide 52b as a 
crystalline solid which was spectroscopically identified and used without further 






Introduction of the imidazole moiety into amide 52d (Scheme VI) to give 52e 
resulted in the an agent which possessed class lb/Ill action Several synthetic approaches 
were attempted before obtaining the correct conditions in which the product formed and 
was isolable. Nucleophilic substitution on the aromatic ring of benzamide 52d was 
achieved in the presence of imidazole, K2C03, DMSO, and 18-crown-6 at a contant 






H2CCl:z/RT ~ N 
imidazole/DMS7 K2CQ3'18-crown-6 


















Dihydroperchlorate 53c was prepared by the methods previously described. The modest 
yield of Sle is likely due to the weak electron withdrawing ability of the amide 
functionality in 52d which only mildly promotes diplacement of the F atom. 
Nucleophilic aromatic substitutions are known to proceed at a much higher yield with 
stronger electron withdrawing substituents.5 It should be noted that in relation to other 
nucleophilic aromatic substitutions involving amides, the yield reported for 52e is among 
the highest recorded for an amide.5 For example, the reaction of 4-fluorobenzamide with 
piperidine gave 4-piperidinylbenzamide in a yield of only 30%.5 
53 
Since the reaction of 52d resulted in a modest yield of Sle, attempts were made to 
initiate a convergent synthesis to prepare 52e. Saponification (Scheme VII) of ester S949 
using NaOH pellets in H3COHIH20, followed by acidification with cone HCl, gave 
SCHEME VII Q~ 
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carboxylic acid 60. Conversion of 60 to acid chloride 61 was attempted using SOC12 at 
RT, but, after workup, spectroscopic analysis indicated the presence of only starting 
material. The same reaction was attempted again by heating the reaction mixture for 4 h, 
but identical results were realized. Another method involved isolation of sodium salt 62 
after saponification of ester S9. Salt 62, pyridine, and oxalyl chloride, were allowed to 
react at 5°C. Infrared analysis of the reaction mixture indicated the presence of only 
starting material 62. The experiment was repeated and, after stirring the mixture with 
oxalyl chloride, another equal portion of oxalyl chloride was added. Workup yielded 
54 
only recovered 62. One might suspect that the acid chloride may be self destructing to 
some degree by reacting with a nitrogen atom in the imidazole ring. 
1\e synthesis of amide 52f was realized (Scheme VID) with a modified Schotten-
Baumann procedure starting with amine 52j and acid chloride 65 prepared from acid 64 

















p-aminobenzamide 52g using TiCl3 by methods described for the synthesis of amide 44. 
Compound 52g was then converted (Scheme IX) to the N-acetyl derivative 52h and 
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55 
yields by the usual addition of HCI04 to chilled (-5°C) solutions of the respective amides 
S2h andS2i. 
Alkylation (Scheme X) of amine S2j was more difficult than originally anticipated. 
Several methods were examined before conditions were discovered in which product 
4-F-C614C(O)CH2Cl (66) 
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were discovered. Amine Slj was added to a solution of a-chloroketone 66 and Nal in 
acetonitrile which gave, after an elaborate workup, a-aminoketone 55a as an off-white 
solid (86.1 % ). Replacement of fluorine in 55a by an imidazole moiety, as described in 
the conversion of 52d~52e, was not successful. Amine SSa in the presence of 
57 
imidazole, K2C03, DMSO, and 18-crown-6 failed to react under a variety of conditions. 
The carbonyl group in SSa was expected to be more electron withdrawing than the 
amide function in 52d.5 The lack of reaction of SSa is not completely understood at this 
time. One possible explanation is that K2C03 at l l0°C might be a strong enough base to 
extract a proton from the position alpha to the C=O group, thus significantly reducing the 
activation of the carbon bearing F and possibly initiating aldol type side reactions. The 
reaction of SSa was carried out using a variety of conditions (various amounts of 
reagents) and using the large, hindered base 2,2,6,6-tetramethylpiperidine. This hindered 
amine was reasoned to be less effective in removing the hindered alpha protons adjacent 
to the carbonyl group in SSa. Unfortunately, the results were unchanged, and starting 
material 55a was recovered with no generation of ketone 67 which remains unknown. 
Reduction of the ketone 55a with LiAlILi in THF at RT gave racemic alcohol 55b 
(Scheme X). Attempts to prepare salts of 68 and 69 resulted in the formation of oils from 
both systems, and solidification was not achieved. Spectral analysis suggests that the 
carbonyl group of 68 was converted to a 1,1-diol which may be the reason solidification 
did not occur although, interestingly, solid salts of 3,7-diheterabicyclo[3.3.l]nonan-9,9-
diols are known. 8a Compound 69 exhibited an 0-H stretch in the IR indicating the 
presence of the alcohol moiety in the starting material. Although a protonated amine may 
be formed, but no solid material has been isolated to date. 
Using identical conditions as in 66 + 52j ~ 55a, amine 52j, Nal, and cx.-bromoketone 
70 failed to react, with only starting material being recovered. As previously cited, 
Br 
70 






several different reaction regimes were attempted before the current procedure to prepare 
amine 55a was discovered. These same conditions were examined with 52j and 70 but 
did not lead to 71. This reaction is still being investigated. 
One of the most biologically active compounds our laboratory has reported 13 is 
hydroperchlorate 14d. The synthesis of the intermediates8a are critical to the formation 
of related hydrochloride 56. Reduction of ketone 72 (Scheme XI) using standard 
conditions afforded amine 73 in a good yield (88% ). Hydroperchlorate 14d was prepared 
by addition of HCl04 to a chilled (-5°C) solution of amine 73. Similar conditions were 
SCHEME XI 
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required for salt 56, but the addition of HCl(g), generated as described for other 
hydrochlorides, gave the very water soluble 56. Increased water solubility can enhance 
agent uptake and distribution when administered to patients for treatment of potentially 
lethal arrhythmias. 
Several derivatives, namely 37, 38, 39, 41-43, 53c, 54a, 54b, 54c, and 56 have been 
screened by Dr. Scherlag of the VA Medical Center/OHSC in Oklahoma City for 
antiarrhythmic activity in dog models. Pharmacological studies are being performed by 
Dr. Sangiah and Chun-Lin Chen of the OSU College of Veterinary Medicine on 
compound 53c which was found to be a very effective antiarrhythmic agent24 Detailed 
procedures for the aforementioned compounds are described in the Experimental Section. 
59 
NMR Properties of Amides in the 3,7-Diheterabicyclo[3.3.l]nonane Family 
NMR spectroscopy and X-ray crystal analyses are crucial tools needed to identify the 
conformational preferences of 3,7-diheterabicycl[3.3.l]nonanes in solution and in the 
solid state, respectively. Analyses of this type can be useful in understanding biological 
properties and possibly an agent's mode of action. While X-ray crystal analysis gives a 
positive confirmation of the structure in the solid state, extrapolation to the major 
conformers present in solution must be exercised with caution. One study seemed to 







other work has indicated that these systems often take on one preferred conformation. 2,28 
Definite proof for a particular DHBCN conformation in solution remains difficult. It is 
our intent to give a rational explanation concerning conformational preferences in 
solution for a series of related amides and their respective hydroperchlorates. These 
findings are supported by NMR data and help to substantiate the conclusions from 
previous work. 2,28,80 
The 1 H and 13C NMR spectra on a series of amides synthesized in the current work 
were found to have several unique features which suggest certain conformational 
properties. Simple model amides, such as N-benzoylated piperidines 74, apparently 
prefer flattened chair conformations in solution as assessed by analysis of variable 









exhibit effects similar to those seen in these simple systems. Conformational preferences 
may be due, in part, to a minimum energy arrangement in which of the p orbital of the 
carbonyl 7t system and the lone pair on nitrogen overlap (atoms attached to the amide 
system will assume a nearly. planar arrangement). Resonance forms of this familiar 
phenomena are illustrated for 39. 
<\__ /~ R N N--(' 
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Rotational barriers in related benzamide systems have been reported to be 
approximately 14-16 kcal/mol via lH and 13C NMR experiments.33 Amides 39, 44, 50, 
52a-i demonstrate this effect in that all the carbon signals in the 13C NMR spectra are 
nonequivalent (thus the energy barrier to rotation of the amides is not reached at RT). 
The NMR assignments (Tables XV, XVI) are based on related systems and further 
supported by COSY (Figure 2) and HETCOR 2D (Figure 3) NMR analysis of 39. 
Spectral analysis using 2D NMR techniques was found to be helpful in making 
structural assignments for 39. Correlations between the carbons and hydrogens in 39 
where determined in an easy manner using a HETCOR 2D experiment (Figure 3). Amide 
39 displayed some complicated long range splitting patterns which where dissected using 
a COSY experiment (Figure 2) 
TABLE XV 
lH NMR SPECTRAL DATA FOR AMIDES 39, 44, so, 52 a-ea (6 VALUES) 
R R' 
2 1 8 39 C(O)C6lti-4-Cl CHz-cPr {[)-R' 44 C(O)C6lti-4-NH2 CH(CH3)z SO C(O)Ph CHz-cPr S2a C(O)C6lti-4-N02 CH(CH3)z S2b C(O)C6lti-4-NHC(O)CH3 CH(CH3)z 
52c C(O)C6lti-4-NHS02CH3 CH(CH3)z 
4 5 6 52d C(O)C6lti-4-F CH(CH3)z 
52e C(O)C61ti-4-(1H-imidazol-1-yl) CH(CH3)z 
Cpd H(l) H(5) H(9) H(2,4,6,8) CH(CH3)z CH3 NCH2-cPr cPr-CH cPr-CH2 
39 2.02 1.73 1.73 2.24, 2.96, 3.03, 3.28, 3.75, 4.83 2.02, 2.24 0.91 0.12, 0.54 
44 1.91 1.67 1.67 2.41, 2.72, 3.02, 3.31, 3.83, 4.70 2.59 0.98 
so 1.98 1.74 1.74 2.23, 2.94, 3.01, 3.28, 3.78, 4.79 - 1.98, 2.23 0.92 0.49, 0.92 
S2a 1.61 1.34 1.34 2.04-2.32, 2.67, 2.94, 3.20, 3.39, 2.32 0.56, 0.69 
-
S2b 1.96 1.96 1.74 2.42, 2.48, 2.71, 3.04, 3.30, 3.79, 4.76 2.56 0.94, 1.03 -
S2c 1.98 1.69 1.79 2.42, 2.51, 2.74, 3.03, 3.32, 3.78, 4.76 2.60 0.97, 1.08 -
S2d 1.95 1.71 1.71 2.41-2.72, 3.03, 3.31, 3.72, 4.47 2.71 0.96, 1.07 -
S2e 1.81 1.81 1.68 2.45, 2.57, 2.77, 3.09, 3.38, 3.76, 4.79 2.63 0.96-1.14 -




13c NMR SPECTRAL DATA FOR AMIDES 39, 44, 50, 52 a-ea (PPM) 
R R' 
2 1 8 39 C(O)C6f4-4-Cl CH2-cPr 
RG=>-R· 44 C(O)C6H4-4-NH2 CH(CH3h 50 C(O)Ph CHi-cPr 52a C(O)C6H4-4-N02 CH(CH3h 52b C(O)C6H4-4-NHC(O)CH3 CH(CH3)i 
52c C(O}C~4-4-NHS02CH3 CH(CH3)i 
4 5 6 52d C(O)C6f4-4-F CH(CH3h 
52e C(O}C~4-4-(1H-imidazol-1-yl) CH(CH3h 
Cpd C(l) C(5) C(9) C(2) C(4,6,8) CH(CH3)i CH3 NCHi-cPr cPr-CH cPr-CH2 NC=O 
39 29.01 29.41 32.10 46.59 52.16, 58.10, 58.38 64.25 8.29 3.21, 4.43 169.06 
. 
44 29.15 29.79 32.25 46.61 52.59, 54.22 54.22 16.81, 18.79 
-
170.47 
50 28.64 29.01 31.72 46.02 51.74, 57.71, 57.98 63.84 7.95 2.85, 4.11 169.68 
52a 28.81 29.57 32.04 46.55 51.79, 52.31, 54.85 54.26 15.89, 19.46 167.58 
52b 29.05 29.65 32.20 46.70 52.24, 52.85, 54.63 54.24 16.29, 19.24 170.19 
52c 28.89 29.55 32.05 46.76 52.11, 52.52, 54.54 54.19 16.26, 19.16 
-
169.63 
52d 28.97 29.69 32.16 46.59 52.12, 52.49, 54.65 54.65 16.26, 19.18 
-
169.07 
52e 29.03 29.78 32.26 46:72 52.15, 52.61, 54.82 54.38 16.33, 19.41 
- 168.80 
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Figure 3. HETCOR Spectrum of Amide 39 
°' ~ 
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For example, the axial and equatorial protons in the 2-, 4-, 6-, and 8-positions of the 
bicyclic ring display a doublet of a doublet as a splitting pattern. Geminal coupling 
created the large doublet (2JH-H = 13.1 Hz) and this doublet was split into doublets by 
virtue of vicinal coupling (3JH-H = 3.8 Hz). Vicinal coupling is believed to be the reason 
for the observed complexed splitting patterns. 
In contrast, the NMR spectra of the amide salts were found to be completely different 
in that the nonequivalency seen in the unprotonated amides was not observed in the 
protonated species. Carbons at the 2-, 4-, 6-, and 8-positions of the bicyclic ring and the 
isopropyl methyl groups (41, 53a,b,c,d,e,f, 54a,b,c) diplayed three very broad singlets in 
the 13C NMR spectra at RT. The lH NMR (Tables XVII) and 13C NMR (Tables XVIID 
assignments illustrate the observed differences in the salts as compared to the 
unprotonated amides. 
To assess the conformational changes, a variable temperature study of the 13C NMR 
resonances of selected amide salts 51, 5 3 b, and 53d was performed within the 
temperature range of -35 to 60°C, and the results have been tabulated in Table XIX. At 
-35°C, the spectra became very complex in that all of the carbon signals became 
nonequivalent (same effect seen in the unprotonatedforms at RD while at 60°C the broad 
13C signals seen at RT became relatively sharp singlets. These results imply that spectra 
of the amide salts reflect an average conformation at 60°C while a preferred conformation 
is observed at -35°C. Thus the barrier to amide rotation is much lower in the amide salts 
compared to that in the unprotonated amides. 
An explanation of this effect can be viewed by analysis of previous work in this 
field.6,8 An X-ray diffraction analysis of hydroperchlorate 14d revealed a chair-chair 
form, as was true for many salts of 3,7-diheterabicyclo[3.3.l]nonanes due to internal 
hydrogen bonding between the proton and the lone pair of electrons on the other 
heteroatom. 6,8 However, NMR studies could not eliminate the presence of a small 
TABLE XVII 
lH NMR SPECTRAL DATA FOR HYDROPERCHLORATES 41, 42, 53a-c, 54a, 54ba (6 VALUES) 
R R' 
2 1 8 
41 C(O)C6~-4-NHS02CH3 CH(CH3)i 
~0/" 42 C(O)Ph CHrcPr Sl C(O)C6~-4-Cl CHrcPr RN 9 ""+ :X- S3a C(O)C6~-4-NHC(O)CH3 CH(CH3)i U R' S3b C(O)C6~-4-F CH(CH3)i S3c C(O)C6H4-4-(1H-imidazol-1-yl) CH(CH3)i 
4 5 6 S4a C(O)C~-4-NH2 CH(CH3)i 
S4b C(O)C~4-4-N02 CH(CH3)i 
Cpd H(l) H(5) H(9) H(2,4,6,8) Ar-H CH(CH3)i CH3 NCHrcPr cPr-CH cPr-CH2 X 
41b 2.24 2.24 1.87 3.18-3.55 7.24, 7.37 3.18-3.55 1.32 Cl04 
42 2.24 2.24 1.83 3.21, 3.71, 4.08 7 .41 2.98 1.19 0.52, 0.81 Cl04 
Sl 2.33 2.33 1.85 3.29, 3.74, 4.09 7.36, 7.48 
- -
3.03 1.18 0.51, 0.82 Cl04 
S3a 2.33 2.33 1.82 3.16, 3.29, 4.10 7.22, 7.57 3.55 1.38 
- Cl04 
S3b 2.29 2.29 1.81 3.34, 3.52 7.17, 7.38 3.34 1.38 - Cl04 
SJcb 3.03 3.03 2.34 3.23-3.97 7.66, 7.96 3.23-3.97 1.33 - Cl04 
54aC 2.49 2.49 2.03 3.40-3.67 7.62 3.40-3.67 1.45 -
-
Cl 
S4bc 2.52 2.52 2.03 3.39-3.67 7.71, 8.36 3.39-3.67 1.44 
-
Cl 






13C NMR SPECTRAL DATA HYDROPERCHLORA TES 41, 42, 53a-c, 54a, 541Ja (6 VALUES) 
R R 
2 1 8 41 C(O)CJl4-4-NHS02CH3 CH(CH3h 
"[)/" x-
42 C(O)Ph CH2-cPr 
51 C(O)CJl4-4-0 CH2-cPr u9 ~+ 53a C(O)CJl4-4-NHC(O}CH3 CH(CH3)i 
R' 53b C(O)CJl4-4-F CH(CH3)i 
4 5 6 53c C(O)C6H4-4-(1H-imidazol-1-yl) CH(CH3)2 54a C(O)CJ14-4-NH2 CH(CH3)2 
54b C(O)CJl4-4-N02 CH(CH3)2 
Cpd C(l) C(5) C(9) C(2,4,6,8) CH(CH3)2 CH3 NCHrcPr cPr-CH cPr-CH2 NC=O X 
41b 27.59 27.59 27.59 59.53 59.53 26.48 172.62 004 
42 26.45 26.45 27.76 62.56 62.56 5.27 5.27 172.69 004 
51 27.89 27.89 29.0S 57.42, 63.89 64.08 6.40 4.94 173.85 004 
S3a 28.01 28.01 29.22 50.42, 53.92 61.14 16.90 175.02 004 
S3b 27.89 27.89 28.99 50.34, 53.52 60.96 16.72 174.13 004 
SJi 26.42 26.42 27.36 59.64 59.64 171.49 004 
54a• 29.84 29.84 30.14 52.19, 55.26 63.65 18.83 177.42 a 
54bc 29.36 29.36 29.36 49.42, 54.01 63.38 19.82 175.77 a 
















VARIABLE TEMPERATURE 13C NMR SPECTRAL DATA OF 
HYDROPERCHLORA TES 51, 53b, 5Jda (PPM) 
R Clo4- R R' 
I 16~H 51 CHi-cPr C(O)C6H4-4-Cl 53b CH(CH3)i C(O)C6H4-4-F 
N 53d CH(CH3)i C(O)CH2C6H4-4-N02 .. R' 
IC 
C(l) C(5) C(9) C(2) C(4,6,8) .CH(C.H3)i NQ-C..I 
28.34 28.34 29.38 50.39 50.39, 58.01 - 5.03, 6.63 
28.01 28.01 29.16 bs, 50.00 (bs, 50.00, 57.47) - (bs, 4. 77), 6.48 
27.27 27.58 28.75 46.98 51.99, 55.45, 58.15 - 3.24, 5.75, 6.24, 63.62 
28.36 28.36 29.38 50.59 50.59, 54.27 17.59, 61.52 -
27.89 27.89 28.99 bs, 50.20 (bs, 50.20, 53.30) (bs, 16.72), 60.96 
-
27.69 27.69 28.88 47.53 50.04, 52.28, 55.99 14.45, 18.86, 60.79 -
28.19 28.19 28.90 48.97 48.97, 54.34 17 .08, 61.39 -
27.84 27.84 28.58 bs, 49.20 (bs, 49.20, 53.90) (bs, 16.77), 61.01 -
25.87 26.11 26.74 45.49 48.00, 50.67, 52.72 14.31, 15.82, 59.11 -













concentration of a CB form in solution for 14d. Obviously, a CC conformation for the 
amides will induce hydrogen bonding between an N-H proton and the lone pair of 
electrons on the nitrogen atom of the amide function. This may result in the loss of 
double bond character of the amide N-C(O) bond and thus lead to increased rotation at 








to. the hybrid in the amide-salts than in the simple amides. Variable temperature studies 
showed that at higher temperatures the carbonyl is more deshielded than at lower 
temperatures (carbonyl assumes more ketone characteristics at higher temperatures) in the 
13CNMR. 
The 15N NMR spectral analysis (Table XX) provided information regarding the 
location of protonation in hydroperchlorate 37. Assignments were based upon simple 
piperidine43 systems and previous work from our laboratory. NMR spectra of 39, 57b, 
and salts 41 and 51 were helpful in providing insight into the RT conformer. As 
mentioned earlier, it was thought that the amide salts existed predominantly in the CC 
TABLE XX 
15N NMR SPECTRAL DATA (PPM)a of 37, 39, 42, 46b, 51, 52d 
z~Y 
5 6 
Cpd X y z N(3) N(7) 
+ 37c N(H)CHz-cPrd · NCHzPh CH2 55.18 49.22 
39b NC(())C6H4-4-Cl NCHz-cPr CH2 119.74 40.55 
+ 42c NC(())Ph N(H)CHz-cPrd CH2 108.49 50.50 
46bb NCH2-cPr NCHzPh C(()) 37.74 36.17 
+ 
sic NC(())C6H4-4-Cl N(H)CHz-cPrd CH2 109.19 49.82 
52db NC(())C6H4-4-F NCH(CH3)z CH2 119.65 40.78 
aAn spectra were obtained at RT using an 8 M 15Nf14.N()3 external standard 
(19.73 ppm) which was cross-referenced to liquid NH3 at O ppm (reference 43). 
hDCCl3. 
CDMS{)-lf6. 
<Icounterion is Cl()4-. 
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conformation in solution at RT. As seen in Table XX, amide 39 had an N(3) signal at 
119.74 ppm while the corresponding salt 51 displayed an N(3) signal at 109.19 ppm that 
was more shielded. This is an opposite effect to that seen in salts of DHBCN containing 
two tertiary nitrogen atoms. For example, the 15N spectrum of ketone 46b has an N(3) 
signal (37.74 ppm) while N(7) is located at 36.17 ppm. Reduction of 46b and conversion 
of the intermediate diamine to salt 37 followed. Salt 37 has two nitrogen resonances 
a a 
highly deshielded [N(3) = 55.18 and N(7) = 49.22 ppm] compared to those in 46b. Salts 
like 37 often exhibit strong deshielding of the nitrogen atom possessing the proton while 
the other nitrogen atom is mildly deshielded probably because of hydrogen bonding. 
Shielding of the nitrogen atom [N(3)] of the amide linkage in salt 51, as compared to the 
N(3) nitrogen of the amide linkage in 39, can be partially explained by the intensity of the 
electron deficit existing on the N(3) nitrogen atoms. Hydrogen bonding with the lone 
pair on nitrogen has two effects on the system: 1) the amount of double bond character of 
the C-N bond is significantly reduced and thus the amount of C(O)-N bond rotation 
should increase, and 2) since the lone pair is involved in hydrogen bonding, the partial 
positive charge on the amide nitrogen in 51 will be diminished in comparison to the 
partial positive charge in the unprotonated amide 39. 
Conformational preferences of our 3,7-diheterabicyclo[3.3.l]nonanes in solution are 
72 
difficult to establish absolutely, but an accumulation of data from various spectral 
techniques support the assignment of the structures illustrated in the thesis.6,8 Currently, 
' 
compounds 46b and 53c have been submitted for X-ray analysis which should establish 
the most stable conformation in the solid state. Preliminary analysis of the X-ray 
diffraction data indicates that 46b is a BC system while the salt 53c is a CC form. 
Achieving a better understanding of the conformational properties of DHBCN may help 
explain some of the observed biological actions. 
Antiarrhythmic Activity 
The antiarrhythmic properties of 14b, 14d, 37-39, 41-43, 53c, 54a, 54b, 54c, and 56 
have been evaluated by Dr. Scherlag at the V AMC/OHSC in Oklahoma City, Oklahoma. 
The compounds were studied in fifteen anesthetized mongrel dogs which were examined 
after the occlusion of the left anterior descending coronary artery and after the dogs were 
allowed to recover for 24-96 h.8,24,58 Tbs occlusion results in a transmural myocardial 
infarction of the heart in which accelerated idioventricular rhythms are observed 
interdispersed with the beats of the normal sinus rhythm. Electrical output of the heart is 
monitored using a 12-lead electrocardiogram (ECG) to ascertain the presence and the 
extent of myocardial infarction. Induction of sustained ventricular tachycardia (SVT is 
defined as a series of ventricular beats which are usually uniform at a rate of 250 
73 
beats/min or more) was initiated using programmed electrical stimulation (PES) which 
followed with the test agents at doses of 3 and 6 mg/kg and which were administered 
intravenously (i.v.). The agent's ability to terminate SVT or to prevent the induction of 
SVT was measured in all experiments. Lidocaine (7) was used as the standard for 
comparison purposes since it is currently the agent of choice in the treatment of SVT.46 
Lidocaine 
7 
Several parameters were measured in the experiment to determine the different class 
actions of each agent. These parameters include MBP (mean blood pressure), HR (heart 
rate), AH interval (Atrial His-bundles; measured conduction time), HV interval (His to 
ventricular activation; measures sodium channel action), QT interval (time to complete 
the process of depolarization and repolarization), VERP (ventricular effective refractory 
period; time elapsed to complete the QRS complex of the ECG), and the ability of each 
agent to prevent sustained ventricular tachycardias. Prolongation of the VERP, AH, HV, 
and the QT intervals suggests that a particular agent possesses some class III 
antiarrhythmic activity. This does not mean that all of these parameters must ·be 
prolonged in order to obtain such action but such was found with many agents claiming 
class ill activity.12,17.22,23,32,38,45,49,55 In the experiments performed, lidocaine (7) was 
found to exhibit no class III action and only reduced the rate of sustained ventricular 
tachycardia (SVT). Lidocaine is known to possess class lb action.42 
Several of the DHBCN agents tested were shown to possess excellent antiarrhythmic 
74 
activity in dog models. Effects on the class m parameters varied between agents and 
nearly all of which abolished the VT at the 3 and 6 mg/kg dosage levels. Specifically, 
four compounds (38, 39, 42, 53c) exhibited outstanding activity in the animal models. 
The best compound synthesized to date in our laboratory is dihydroperchlorate 53c. 
This agent slightly reduced the MBP but the effect was only short lasting. Salt 53c also 
Y. ao4- ,H 
N+ . . FN + JG:pV ao.-
o 
53c (GLG-V-13) 
significantly reduced the HR and prolonged the VERP, AH, HV, and the QT intervals.29 
From the accumulated data (Table XXI), it was concluded that this agent possessed class 
lb/III AAA. Presently, 53c is undergoing detailed electrophysiological studies by Dr. 
Papp in Hungary at the Szent-Gyorgyi University Medical School. A three generation 
toxicity study on mice is currently underway with the research being directed by Dr. 
Sangiah in the Physiological Science Department of the Oklahoma State College of 
Veterinary Medicine. Results of both studies are pending. 
Tedisamil (29) is a known K+ current blocker,7 and GLG N-57 (38) shows some 





29 (Tedisamil) 38 (GLG-N-57) 
TABLEXXI 
ANTIARRHYTIIMIC PROPERTIES8 OF THE MOST ACTIVE DHBCN 14b, 38, 39, 42, AND 53c 
HR.b MBpc QT intervald AH intervale HV intervalf VERP8 
Cpd preh posti pre post pre post pre post pre post pre post 
7 (lidocaine) NEi NE 105 84 NE NE NE NE NE NE NE NE 
14b (GLG-III-93) 150 110 110 55 NM' NM 64 70 NE NE 170 230 
38 (GLG-IV-57) 154 105 61 76 136 i70 56 75 30 40 140 180 
39 (GLG~III-70) 125 105 88 98 215 250 60 68 NE NE 170 220 
42 (GLG-III-96) 120 . 111 92 83 NE NE 65 70 NE NE 170 190 
53c (GLG-V-13) 152 110 94 84 222 288 57 66 30 37 142 . 187 
aAntiarrhythmic properties are compared to lidocaine using doses (3 mg/kg) in which SVT was 
non-inducible in the DHBCN system while lidocaine only reduced the rate of the VT. 
hHR = Heart rate (beats/min). 
tMBP = Mean blood pressure (mm Hg) .. 
dQT interval= Time (msec) required for the cell to undergo depolarization and repolarization. 
e AH interval = (msec) measures conduction time. 
fHV interval = (insec) measures sodium channel action. 
gVERP = (msec) elapsed time to complete the QRS complex of ECG. 
hPre = drug free; measurements before administration of agent. 
iPost = post drug; measurements after the administration of agent. 
jNE = no effect. 
kNM = not measured. ...J 
UI 
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observed activity for 38 which was much different than that reported for 29.7 In the 
experiment and after administration of 38, the MBP increased while the HR was reduced 
with a prolongation of the VERP, HV, and QT interval (Table XXI). SMVT was found 
to be noninducible after 3 and 6 mg/kg doses of 38, and SVT was successfully terminated 
with 6 mg/kg i.v. These studies suggested that 38 is not only able to prevent but also to 
terminate PES-induced SMVT. 
Three other compounds (14b, 39, and 42) were found to have excellent 
antiarrhythmic activity. All of these compounds possess similar actions with some 
variation in the degree of effectiveness in terms of the class III parameters measured. 
One interesting property common to 14b and 42 is the simultaneous lowering of the HR 
y CI04-
k: 
14b (GLG-ill-93) , I 
~ 
39 (GLG-III-70) 42 (GLG-III-96) df? 
Cl 
and the MBP which suggests that these agents may possess Ca+2 channel blocking action 
(class IV AAA).7 The data for all these agents (14b, 39, and 42) are also illustrated in 
Table:XXI. 
The other eight agents tested showed good class lb antiarrhythmic activity while their 
effects on the class III parameters were modest to weak (Table XXII). After the 
administation (3 mg/kg, i.v.) of 37, a marked drop in the MBP and the HR was observed. 
This agent had no effect on any of the class ill parameters measured. Interestingly, 
TABLEXX:11 
ANTIARRHYTIIMIC PROPERTIES3 OF 3,7-D1HETERABICYCL0[3.3.l]NONANES 
Cpd HRh MBpc QT intervald AH intervalc HV intervalf VERP8 NSVTh 
14d (BRB-1-28) NEi INCj NE NE INC INC 3 mg/kg 
37 (GLG-N-17) DECk DEC NM1 NM NM NM NM 
41 (GLG-N-74) NE DEC NE NE NE NE 3mg/kg 
43 (GLG-Ill-86) NE NE NE NE NE NE NE 
54a (GLG-V-22) DEC DEC INC INC NM INC 6 mg/kg 
54b (GLG-V-18) DEC DEC INC INC NM INC 6 mg/kg 
54c (GLG-V-26) NE NE NE NE NE NE 3 mg/kg 
56 (GLG-N-78) NE INC NE NE INC NE 3 mg/kg 
aAntiarrhythmic properties were compared to lidocaine (3 and 6 mg/kg i.v.) in that 
lidocaine only reduced the rate of the VT and possessed no other class action. 
bHR = Heart rate (beats/min). 
CMBP = Mean blood pressure (mm Hg). 
dQT interval = Time (msec) elapsed for a cell to undergo depolarization and repolarization. 
e AH interval = (msec) measures conduction time. 
fHV interval = (msec) measures sodium channel action. 
gvERP = (msec) elapsed time to complete the QRS complex of the ECG. 
hNSVT = NonSustained Ventricular Tachycardia; SVT not inducible at indicated dosage. 
iNE = no effect. 
jJNC = increased in comparison to drug free state. 
koEC = decreased in comparison to drug free state. 































compounds 54a and 54b all possessed this similar action (decrease MBP and HR; class 
IV action) but with varying effects on the class ID action parameters (Table XXII). 
Agents 54a and 54b abolished SVT at the 6 mg/kg dose with no pronounced effect 
seen at 3 mg/kg. Compound 54b decreased the MBP (95 mm Hg to 70 mm Hg) with fast 
recovery. The compound induced a lowering of HR (130 beats/min to 110 beats/min) 
which had a lasting effect of 2 h. It also prolonged HV (35 to 50 msec), VERP (160 to 
230 msec), and QT (220 to 260 msec). Similar activities were seen with compound 54a 
but the effects were less pronounced. 29 
A comparison of hydroperchlorate 14d and hydrochloride 56 revealed closely related 
activities. Salt 14d induced a significant prolongation of the HV interval (30 to 40 msec) 
and the VERP (142 to 163 msec) while prolongation by 56 of the HV interval (30 to 35 
msec) was less pronounced with no effect on the VERP. Agent 14d prevented 
electrically induced sustained monomorphic ventricular tachycardia (SMVT) in 2 of the 6 
dogs tested. Salt 14d, however, markedly slowed the rate of SMVT in the other 4 dogs 
while 56 had no effect. Both agents 14d and 56 induced a proarrhythmic effect in the 
same 2 dogs out of 6 which were tested (the initial VT was abolished, but a new VT was 
generated). It should be noted that SMVT was not inducible in the drug-free state which 
indicates that the 2 dogs were not good candidates for the study. 
In agents tested (Tables XXi and XXI), one common characteristic feature was that 
all demonstrated physiological properties coincide with class lb antiarrhythmic action. 
Many of these agents were suspected to possess more than one type of class action. 
Table xxm is a summary of the electrophysiological data which categorizes the DHBCN 
examined according to specific class actions. The results indicated in Table xxm are 
not absolutely definitive evidence that the agents possess specific class activities. Further 
electrophysiological studies in vitro are required to positively confirm the class actions. 
We have recently synthesized several antiarrhythmic agents with the objective to 
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by = agent displayed properties which suggest this type of action. 
CN = agent gave no indication of possessing such action. 































53e, 53f, and 55b, is currently in progress or will be undertaken. It is predicted that these 
new agents will exhibit class II, class ill, and possibly class IV antiarrhythmic activity 
along with maintaining the already existing class lb action. 
Structure-Activity Relationships 
One way to design potential antiarrhythmic agents is by evaluating structure activity 
relationships (SAR) in families of compounds. After such agents are synthesized and 
activity data are obtained, modifications of the structures can be meaningful to enhance a 
biological response and, hopefully, lower the toxicity. With respect to the DHBCN 
family, SAR have been developed to a fair degree from an accumulation of 
antiarrhythmic data from infarctions induced in dog models. It has been our intent to 
examine the SAR data discovered in the aforementioned work and draw some 
conclusions as to which functional groups are important for useful antiarrhythmic 
activity, a minimum of proarrhythmic effects, and multiple class action. 
Work by Morgan and co-workers49 implied that the imidazole group might be a 
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suitable replacement for the sulfonamide moiety to induce class III activity. We prepared 
compounds 41 and 53c which differ in structure only with the imidazole or the 
sulfonamide groups in the para postion. The animal screens revealed that 53c possessed 
strong class III action as cited previously (Table XXI, page 75). However, agent 41 
sho,wed only moderate class lb action and exhibited no class III antiarrhythmic activity. 
It appears that the imidazole group possesses better activity in this particular 3,7-
diheterabicyclo[3.3.l]nonane derivative. The hydroperchlorates were considered to be 
the preferred salts in view of the reduced activity of hydrochloride 56 when compared to 
the corresponding hydroperchlorate 14d. These findings may only be characteristic of 
these particular systems and may vary in other DHBCN systems. Additional examples 
are needed in order to affirm or reject these results. 
We developed methodology to obtain hydrochlorides of a few selected 3,7-
diheterabicyclo[3.3.l]nonanes in hopes of improving water solubility. After preparing 
salt 56, the activity was compared to the known hydroperchlorate 14d to investigate any 
differences between the two salts. Salt 14d was found to have better class lb AAA than 
56, and 14d also prolonged the action potential duration and had a longer lasting effect as 
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compared to 56. This same kind of evaluation was performed on compounds 41 and 54c 
in which slightly different results were obtained. Agent 41 displayed no class III action 
but had modest class lb AAA while 54c did not effect any of the electrophysiological 
properties (HV, AH, VERP, QRS, and QT) measured. The rationale for the enhanced 




In previously reported work,8a thioketal 14g was found to have good class lb 
antiarrhythmic activity in the dog model. On the supposition that 38 and 43 would 
exhibit similar action, syntheses were initiated and completed. All three agents possess a 
variety of functional groups, and we had hoped to establish some SAR involving the 








both class lb and class III AAA in dog models. On the other hand, compound 43 
possessed no AAA but instead caused acute heart failure in the dog model after 
administration of 3 mg/kg. From these results, several conclusions can be drawn. 
Obviously, the different functional groups in 14g and 43 influence activity. Ester 14g is a 
known BC form,6b and thus its good activity was unexpected. Apparently the spiro-ring 
unit fused at C(9) is not detrimental to activity, however, at least in 14g and 38. Of 
course, we can not eliminate the possibility that the particular dog model used with 43 
may have been exceptionally vulnerable to sudden death for unidentified reasons. It is 
always necessary to use several dog models to substantiate activity by an agent. 
To evaluate SARs involving the isopropyl group and the cyclopropylmethyl group, a 
series of DHBCNs containing the cyclopropylmethyl moiety were prepared.Sa Salts 14c 
and 37 were tested and found to have class lb action, but agent 37 also showed a dramatic 






lowering of the heart rate and the blood pressure. These findings suggest that 37 may 
have some Ca+2 channel blocking action. Compounds which possess the ability to block 
Ca+2 channels are sometimes categorized as class N antiarrhythmic agents.11 
Amides 39 and 42 also contain a cyclopropyl function. The activities of 39 and 42 
were compared to the antiarrhythmic properties of amides 14a and 40 which possess 
y CI04- ~ y 
~04 JC; 16N 16N K;: N 
14a 39 40 42 
Cl Cl 
isopropyl groups instead of cyclopropylmethyl moieties All four agents exhibited good 
class lb activity, but compounds 39 and 42 were also found to have class III action. 
Compounds 14a and 40 were only tested for their class lb activity, and thus a completely 
fair comparison of all four agents is not possible at this time. It appears that changing the 
isopropyl group to the cyclopropylmethyl group does not effect the class lb action. 
However, the cyclopropyl group may induce the observed class III action in compound 
39. Agents 14a and 40 should therefore be tested for class III activity. This would give 
an indication of which functional group induced the best specific class of antiarrhythmic 
action. 
Currently, several compounds are undergoing electrophysiological testing in which 
many structural modifications are employed. N-Acetylprocainamide (75) has been found 





Conceivably, the incorporation of an N-acetyl group could generate class ID action in the 
DHBCN family. Compound 53a was prepared with this specific purpose in mind. The 
results from the testing are pending. 
Another potential variable to enhance the antiarrhythmic activity of the DHBCN 
agents could be the distance between the carbonyl group of the amide and the aromatic 
ring as observed in 53e and 53f. The effect of the extra CH2 group in 53e and 53f on 
antiarrhythmic activity will be compared with that of compounds 41 and 53a. Several 




53a NHC(O)CH3 R 53e NHC(O)CH3 53f NHS02CH3 
ring may enhance class Il antiarrhythmic activity .11,72,73 
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As mentioned earlier, sotalol (19) is an antiarrhythmic agent which has multiple class 
action (class II/111).20 Structure activity relationships already developed in this series of 
compounds led to the conclusion that an ethanolamine moiety might be responsible for 
the observed class Il action. 20,67 ,85 Recall that class IT antiarrhythmic activity refers to 
the slowing of conduction and increasing the effective refractory period. I I Alcohol 55b 
with the ethanolamine function might well possess class Il action along with the expected 
class lb AAA. Screening for such activity is in progress. 
y 
OH 16N Ny OH 
H3CSQiHN 
19 55b F 
From all of the preceding structure-activity relationships observed, it can be 
concluded that class lb activity is inherent in the basic 3,7-diheterabicyclo[3.3.l]nonane 
system. Structural modifications at the 3- and 7-positions can enhance class lb action and 
can add class ID activity. Proper alterations in the functional groups attached to nitrogen 
can produce a multiple class antiarrhythmic activity in a single agent. This muliplicity of 
action may well be the method of choice in the future treatment of life-threatening 
arrhythmias which often lead to the "sudden death syndrome".21,51 Further SAR studies 
in this family of compounds will be helpful in future work for developing more potent 
and less toxic anitarrhythmic agents with multi-class antiarrhythmic activity. 
Suggestions for Future Work 
The need for more potent, selective, and less toxic antiarrhythmic agents is 
significant in spite of the CAST study63,64 which has reduced public confidence in the 
88 
use of antiarrhythmnic agents in general. The synthesis of such compounds can be 
guided by structure-activity relationships which have been developed to date in a series of 
DHBCN agents. The low toxicity of some DHBCN in rats has been very encouraging.29 
Several thioketals in the family of DHBCN have been prepared as previously 
mentioned. Hydroperchlorate 14d is known to have good antiarrhythmic activity.Sa It 
would be worthwhile to evaluate the effect of masking the 9-position with the thioketal 
group such as in 76 to determine the influence on the activity. The same concept could 
14d 
S H CI04 
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prepared thioketals 38 and 43. 
As cited earlier, disalt 53c exhibited multiple class (lb and Ill) antiarrhythmic 
activity. Agent 39 is believed to possess some class ID action along with very good class 
89 
lb anti.arrhythmic activity. The synthesis of amides 78 and 79 would provide agents with 






C}Q" + I 4 H 
function (present in agents 53c and 41, respectively). These structural modifications may 
very well enhance class ID action associated with these individual functional groups and 
possibly result in greater drug selectivity of action with respect to tissue from which 
arrhythmias are generated. Likewise, amides 80 and 81 which also incorporate the 
imidazole and sulfonamide groups are reasonable candidates to possess good 
90 
antiarrhythmic activity but their useful properties could also be due to the propyl group 





Recently, Morgan and co-workers44 described the synthesis of (aryloxy)propanol-
amine derivatives which displayed class II/Ill AAA. Structure activity relationships 
suggest that the aryloxy group may be responsible for the observed class Il action. 
RHN-,\__/-0-R' 
(Aryloxy)propanolamine function 
Synthesis of related derivatives could start with the secondary amine 52j (Scheme Xll). 
Modified Schotten-Baumann conditions using 2-chloroacetyl chloride would give amide 
82. Displacement of the chloride via an SN2-type reaction using hydroxide ion should 
yield the corresponding a-hydroxy ketone 83. Salt formation from 83 and treatment 
thereof with 4-fluoronitrobenzene should provide 84. Utilizing procedures similar to 
those described to obtain 41 and 53a will generate 85-87 from 84. It is postulated that 
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antiarrhythmic activity on the basis that the 3,7-diheterabicyclo[3.3.l]nonane system 
alone possesses class lb action.6,8,24 Class Il activity may be achieved by the 
(aryloxy)ethanolamine function in view of the class Il activity reportedl2,44 to be 
associated with the (aryloxy)propanolamine group. The ethanolamine moiety is believed 
to be responsible for the class Il AAA observed in .several different agents.11,20,67 
Imidazole and sulfonamide functionalities have been implicated in the. enhancement of 
class m antiarrhythmic activity.22,32,45,49,55 
Developing agents which possess multiple class action has become the major area of 
interest in the preparation of potential antiarrhythmic agents. Synthesis of salts 88 and 89 
could possibly possess class lb (3,7-diheterabicyclop[3.3.l]nonane ring), class Il 
(ethanolamine moiety), and class III (imidazole or sulfonamide groups) activity. 
Attempts to obtain 88 and 89 have been described (pages 55-57) without success to date. 
A key intermediate in the synthesis of 88 is ketone 55a which has been prepared. It 
was discovered that the displacement of the fluorine group in ketone 55a was difficult. 
Previous attempts to synthesis 67 led to the isolation of starting material 55a. Preferential 
removal of the acidic proton in imidazole without generation of the anion on the carbon 
next to the C=O group may be achievable with exceptionally large and hindered bases 
such as 2,6-dimethylpyridine, diisopropylamine, 2,6-dimethylpyrrolidine and 
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diisobutylamine. These reagents have yet to be appraised in this proposed reaction. 
y y 
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2,6-dimethylpyridine or diisopropylamine or 2,6-dimethylpyrrolidine 
If ketone 67 could be isolated, reduction to 88 should not be difficult since ketone 
55a was smoothly reduced to the corresponding alcohol 55b with LiA1}4. Such a 
reduction of ketone 67 to the intermediate alcohol should probably be carried out with 
NaBI4 since LiA1}4 can reduce C=N linkages (such as present in imidazole) to CH-
NH.47 An approach to a possible chiral precursor of 88 from 67 may be realized using 
Baker's yeast. (I) Selective production of one enantiomeric alcohol over the other is 
y 
N 1. NaBli4 or Bakers Yeast 




theoretically feasible. Salt 88 would be obtainable directly from the chiral precursor in 
the usual manner as illustrated. Racemic sotalol (19) is prescribed for the treatment of 
lethal arrhythmias but d-sotalol is the active enantiomer.11,55 
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The synthesis of the agent 89 presents a challenge. Attempts to prepare precursor 71 
using 52j, Nal, and a-bromoketone 70 resulted in the recovery of amine 52j, as 
previously mentioned. Ketone 71 could possibly be obtain by generating the sodium salt 
0 1. Nal/H 3CCN 
Br 40"C/30min 
t?' I 2. 52j/H3CCN 
~ N02 
70 
1. NaH/l'HF f 
2.70/TIIF 
52j 
of 52j with NaH followed by addition of a-bromoketone 70. Upon isolation of ketone 
71, reduction of the nitro group (Scheme XIII) to the amine should follow using Ti Cl 3. 77 
Formation of the sulfonamide derivative 90 should proceed via conditions already 
established.48 Reduction of ketone 90 with mild reagents such as NaBI4 or Baker's 
yeast could lead to the corresponding racemic or enantiomeric alcohol, respectively. 
SCHEME XIII 
1. TiCl3 
Y J 1.NaBH4 + 004- or Baker's Yeast N,H 2.HCl04 
N~OH 
I " 
89 ~ NHS02CH3 
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It is quite possible that any attempt to reduce 90 using LiAlf4 could result in cleavage of 
the sulfonamide group.47 Salt 89 should be isolable using standard conditions. Both 88 
and 89 are excellent candidates to possess multi-class antiarrhythmic activity. 
The projected antiarrhythmic agents above with the indicated modifications may 
prove to have novel activity. Very recent developments of new antiarrhythmic agents 
have focused attention on preparing compounds which possess multiple class action. 
Several compounds from our group were found to have multiple class action with the best 
agent being 53c. The suggested new agents 78, 80, and 86-90 in the DHBCN family may 
display even. greater multiple class and tissue specific antiarrhythmic action as well as 
useful properties for facile formulation and drug distribution in view of the increased 
hydrophilic nature of the structures. 
CHAPTERill 
EXPERIMENTAL SECTION 
General Information: Melting points were obtained on a Thomas-Hoover melting 
point apparatus, an Electrothermal IA9100 digital melting point apparatus, and were 
uncorrected. IR spectra were recorded on a Perkin-Elmer 681 as KBr pellets or as films. 
All NMR spectra were taken on an V~an XL-300 BB spectrophotometer with lH and 
13C being observed at 299.94 and 75.43 MHz, respectively. All 2-D and 15N 
experiments were performed on an XL-400 NMR unit with lH, 13C, and 15N being 
observed at 399.99, 100.6, and 41.2 MHz, respectively. Chemical shifts for lH and 13C 
NMR spectra were reported in 6 or ppm downfield from TMS [(CH3)4.Si)], while 15N 
NMR signals were reported in ppm downfield from NH3 (liquid, 0 ppm) using 8 M 
15NH4N03 (19.73 ppm) as an external reference. Data have been reported as follows: 
chemical shifts (in 6 values or ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, qn = quintet, m = multiplet, bs = broad singlet, bd = broad doublet), coupling 
constants (in Hz), and assignments. Mass spectral data were recorded on a VG analytical 
instrument model ZAB-2SE. Elemental analyses were performed by Galbraith 
Laboratories, Knoxville, TN 37921. 
Syntheses were performed under an atmosphere of N2 with magnetic stirring unless 
otherwise specified. The following reagents were obtained commercially and used 
without further purification: (aminomethyl)cyclopropane (Aldrich), 2-chloro-4'-fluoro-
acetophenone (Aldrich), glacial acetic acid (Dupont), hydrazine (95%, Fisher), 
hydrochloric acid (Mallinckrodt), imidazole (Aldrich), isopropylamine (Aldrich), LiA1}4 
(95%, Aldrich), 4-nitrobenzoyl chloride (Aldrich), 4-nitrophenylacetic acid (Aldrich), 
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methanesulfonyl chloride (Aldrich), Pd/C (10%, Alfa), paraformaldehyde (Fisher) 
perchloric acid (60%, Baker), potassium carbonate (EM Science), potassium hydroxide 
(85%, Baker), PTSA (Fisher), sodium azide (Fisher), sodium chloride (Mallinckrodt), 
sodium hydroxide (97%, Fisher), sodium iodide (Fisher), titanium trichloride (12% TiCl3 
in HCl, Aldrich), and 18-crown-6 (Aldrich). The following compounds required 
distillation prior to use: benzoyl chloride (bp 46°C/l.O mm Hg, Eastman), benzylamine 
(bp 57-59°C/4.25 mm Hg, Lancaster), 4-chlorobenzoyl chloride (bp 40°C/l0 mm Hg, 
Aldrich), 1,2-ethanedithiol (bp 144-146°C, Aldrich), 4-fluorobenzoyl chloride (82°C/20 
mm Hg, Aldrich), N-benzyl-4-piperidone (bp 134°Cn.o mm Hg, Aldrich), and N-
isopropyl-4-piperidinone (bp 100-101 °C/27 mm Hg mm Hg, Lancaster), and pyridine 
(l 14°C, Fisher). Ammonium formate (Baker) was recrystallized from methanol (mp 118-
1200C). Reagent grade solvents were used without further purification and 
chromatographic separations were done on silica gel ("Davisil 62", 60-200 mesh, 
Davison Chemical) and alumina (neutral, 70-230 mesh, Merck). Caution: Although no 
difficulties were experienced in handling hydroperchlorates, extreme care should be used 
at all times and all the work should be carried out in the hood behind a protective shield 
since salts of this nature are potentially explosive. 
7-Benzyl-3-cyclopropylmethyl-3, 7-diazabicyclo[3.3.l]nonane Hydroper-
chlorate (37). A 250-mL, Erlenmeyer flask was equipped with a magnetic stirrer and an 
ice bath. To a chilled (5°C, ice bath) solution of amine 47b (4.41 g, 16.31 mmol) in dry 
ether (150 mL) was added HCl04 (60%, 3.41 g, 20.39 mmol) dropwise over a period of 
15 min. The mixture was allowed to stir an additional 15 min at 0-5°C. A white 
precipitate formed and was filtered and washed with cold ether (30 mL). The solid was 
recrystallized (H3COH, 30 mL), and white needles were collected and washed with cold 
H3COH (25 mL) and dried (Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 4.3 g (71.1%) 
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of salt 37; mp 190-191 °C. IR (KBr) 3060, 3005 (ArH), 2910, 2820 (C-H), 1100 (Cl-0), 
735, 710 (C-H out of plane, mono) cm-1; lH NMR (DMS0-'4;) 6 0.46 [m, 2 H, (CH2)ax, 
cyclopropyl ring], 0.62 [m, 2 H, (CHi)eq, cyclopropyl ring], 1.07 [m, 1 H, (CH), 
cyclopropyl ring], 1.64 [d, J = 11.4 Hz, 1 H, H(9)axl, 1.77 [d, J = 11.4 Hz, 1 H, H(9)eq], 
, ' 
2.42 [d, J = 11.1 Hz, 2 H, H(6,8)axl, 2.85 (d, J = 7.2 Hz, 2 H, CH2-cyclopropyl),,3.09 [m, 
·,. 
\ 
4 H, H(2,4)ax, H(6,8)eq], 3.54 [bs, 4 H, Oh-Ar, H(2,4)eq], 7.31-7.43 (11!, 5 H, Ar-H); 
13c NMR (DMS0-d6) ppm 3.87 (CH2, cyclopropyl ring), 6.07 (CH, cyclopropyl ring), 
27.46 [C(6)], 29.58 [C(l,5)], 57.01, 56.84 [C(2,4,6,8)], 60.56 (CH2-Ar), 61.49 (NCH2-
cyclopropyl)., 127.57, 128.39, 129.32, 136.49 (Ar-C); 15N NMR (DMS0-d6) ppm 49.22 
[N(7)], 55.18 [N(3)]. Mass spectral (EI) data calcd for C1sH27ClN204 mlz (M+): 
270.2096 (-HCl04). Found: 270.2093. Anal. Calcd for C1sH27ClN204: C, 58.29; H, 
7 .34. Found: C, 58.39; H, 7 .30. 
3, 7-Diisopropyl-9,9-(1,3-dithiolan-2-yl)-3, 7-diuabicyclo[3.3.l]nonane Hydro-
perchlorate (38). Into a 250-mL, Erlenmeyer flask equipped with a magnetic stirrer and 
an ice bath was placed thioketal 49a (8.06 g, 26.82 mmol) in dry ether (100 mL), and the 
solution was cooled to 0-5°C in an ice bath. To the stirred solution was added HCl04 
(60%, 5.61 g, 33.52 mmol) dropwise over a period of 15 min . After stirring an 
additional 15 min at 5°C, the solution deposited a white precipitate which was filtered 
(suction) and washed with cold ether (25 mL). Recrystallization (hot H3COH, 50 mL) 
afforded, after drying (Abderhalden, 80°C/0.2 mm Hg, P205, 12 h), hydroperchlorate 38 
as white needles (3.15 g, 29.3%); mp 222.0-223.0°C. IR (KBr) 2980, 2920, 2820 (C-H) 
cm·l; lH NMR (DCCl3) 6 1.18 (d, J = 6.4 Hz, 12 H, CH3 isopropyl), 2.31 [bs, 2 H, 
H(l,5)], 3.32-3.57 [m, 15 H, N-H, H(2,4,6,8)ax-eq, C-H isopropyl, S-CH2]; l3C NMR 
(DCCl3) ppm 16.78 (CH3 isopropyl), 39.29 [C(l,5)], 41.23 (S-CH2), 52.29 [C(2,4,6,8)], 
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54.64 (C-H isopropyl), 70.22 [C(9)]; Anal. Calcd for C1sH29ClN2S204: C, 44.93; H, 
6.99; S, 15.99. Found: C, 45.10; H, 7.33; N, 6.91; S, 15.80. 
3-( 4-Chlorobenzoyl)-7-cyclopropylmethyl-3, 7-diuabicyclo[3.3.l]nonane (39) 
A 100-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
condenser with N2 inlet, a 25-mL addition funnel, and two glass stoppers. To a mixture 
of amine 47c (4.03 g, 22.35 mmol) in H2CCl2 (25 mL) and 10% NaOH (22.41 g, 55.88 
mmol) was added dropwise a solution of 4-chlorobenzoyl chloride ( 4.30 g, 24.59 mmol) 
in H2CC!i (15 mL) over a period of 30 min. Stirring (magnetic) of the mixture was 
continued for an additional 3 h under N2. To the heterogenous mixture was added H20 
(100 mL) and two layers separarated. Further extracts (H2CC!i, 3 x 50 mL) of the 
aqueous layer were combined, dried (Na2S04, 1 h), filtered and concentrated (rotary 
evaporator) to give a viscous yellow oil. Flash chromatography of the oil was performed 
on neutral alumina (50 g, 60-mL fritted funnel, aspirator) using hexanes:ethyl acetate 
(60:40) as the eluent. The filtrate was concentrated (rotary evaporator) and then placed 
on vacuum pump overnight (RT/0.2 mm Hg) to give 4.18 g (83.1 %) of an off-white solid 
39; mp 67-68°C. IR (l{Br) 3090, 3005 (ArH), 2920, 2880, 2770 (C-H), 1635 (NC=O), 
760 (C-H out of plane, para) cm·l; lH NMR (DCCl3) 6 0.12 [m, 2 H, (CH2)ax, 
cyclopropyl ring], 0.54 [m, 2 H, (CHi)eq, cyclopropyl ring], 0.91 [m, 1 H, (CH), 
cyclopropyl ring], 1.73 [m, 3 H, H(5), H(9)], 2.02 [m, 2 H, H(l), CH2-cyclopropyl], 2.24 
[m, 3 H, H(4)ax, H(6)ax, CH2-cyclopropyl], 2.96 [d; J = 10.5 Hz, 1 H, H(6)eq], 3.03 [d, J 
= 13.2 Hz, 1 H, H(2)ax], 3.28 [m, 2 H, H(8)ax, H(4)eq], 3.75 [d, J = 13.2 Hz, 1 H, H(8)eq], 
4.83 [d, J = 13.2 Hz, 1 H, H(2)eq], 7.39 (s, 4 H, Ar-If); 13C NMR (DCCl3) ppm 3.21, 
4.43 (CH2 cyclopropyl), 8.29 (CH cyclopropyl), 29.01 [C(l)], 29.41 [C(5)], 32.10 [C(9)], 
46.59 [C(2)], 52.16, 58.10, 58.38 [C(4,6,8)], 64.25 (NCH2-cyclopropyl), 128.15, 128.28, 
134.40, 135.90 (Ar-C), 169.06 (NC=O); 15N NMR (DCCl3) ppm 40.55 [N(7)], 119.74 
100 
[N(3)]; Mass spectral (EI) data calcd for C1sH23CIN20 mlz (M+): 318.1499. Found: 
318.1498. Anal. Calcd for C1sH23ClN20: C, 67.81; H, 7.27; N, 8.79. Found: C, 67.53; 
H, 7.25; N, 8.72. 
3-[ 4-(Methylsulfonyl)amino ]benzoyl-7-isopropyl-3, 7-diuabicyclo[3.3.l]nonane 
Hydroperchlorate (41). To a 250-mL Erlenmeyer flask equipped with a magnetic stirrer 
and an ice bath was added sulfonamide 52c (3.1 g, 8.48 mmol) dissolved in EtOH (95%, 
50 mL), and the resulting solution was chilled (5°C). With stirring, HCl04 (60%, 1.77 g, 
10.60 mmol) in EtOH (5 mL) was added dropwise over a period of 15 min, and stirring 
was continued an additional 10 min at this temperature. The white precipitate was 
suction filtered and recrystallized from warm H20 (25 mL) to give 1.97 g (49.9%) of 
white platelettes of 41; mp 267-268°C. IR (KBr) 3260, 3120 (N-H), 3010 (Ar-H), 2940, 
2880 (C-H), 1630 (NC=O), 1100 (Cl-0) cm-1; lH NMR (DMS0-li6) o 1.32 (dd, J = 6.1 
Hz, 2 H, CH3 isopropyl), 1.69-1.87 [dd, 2 H, H(9)], 2.24 [m, 2 H, H(l,5)], 3.06 (s, 3 H, 
S02CH3), 3.18-3.55 (m, 9 H, ring protons, C-H isopropyl), 7.24 (bd, 2 H, Ar-H), 7.37 
(bd, 2 H, Ar-H), 7 .93 (bs, 1 H, N-H), 10.05 (s, 1 H, CH3S02N-H); 13C NMR (DMS0-lf6-) 
ppm 26.48 (CH3 isopropyl), 27.59 [C(l,5,9)], 59.53 [bs, C-H isopropyl, C(2,4,6,8), 
CH3S02], 118.12, 128.81, 130.60, 139.53 (Ar-C), 172.62 (NC=O); Mass spectral (EI) 
data calcd for C1sH2gClN3S07 mlz (M+): 365.1773 (-HCl04). Found: 365.1775. Anal. 
Calcd for C1sH2sClN3S07: C, 46.40; H, 6.06; N, 9.02; S, 6.88. Found: C, 46.40; H, 
6.01; N, 8.94; S, 7.07. 
3-Benzoyl-7-cyclopropylmethyl-3, 7-diuabicyclo-[3.3.l]nonane Hydroper-
chlorate (42). A 250-mL Erlenmeyer flask was equipped with a magnetic stirrer and an 
ice bath. To a chilled (5°C, via ice bath) stirred solution of the amide 50 (7.15 g, 25.14 
mmol) in dry ether (120 mL) was added dropwise a solution of HCl04 (60%, 5.26 g, 
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31.43 mmol) over a 10-min period followed by stirring for an additional 10 min. Filtered 
salt 42 (a white solid) was washed with dry, cold ether (60 mL). The white solid was 
recrystallized (hot H3COH, 160 mL) and filtered hot and then allowed to cool to RT. 
Filtration and drying (Abderhalden, 0.2 mm Hg/80°C, 12 h) afforded 6.30 g (65.1 %) of 
pure salt 42; mp 236.0-237.0°C. IR (KBr) 3150 (N-H), 3020 (Ar-H), 2840, 2880 (C-H), 
1630 (NC=O), 1095 (Cl-0) cm·l; lH NMR (D3CCN) l> 0.52 [d, J = 3.1 Hz, 2 H, 
cyclopropyl CHi ax1, 0.81 [d, J = 2.7 Hz, 2 H, cyclopropyl Ol.2 eq], 1.19 (m, 1 H, 
cyclopropyl C-H), 1.83 [bd, 1 H, H(l)], 2.24 [bd, 3 H, H(5,9)], 2.98 (d, J = 6.2 Hz, 2 H, 
CH2 cyclopropyl), 3.21 (m, 4 H, ring protons), 3.71 (bs, 2 H, ring protons), 4.08 (bs, 2 H, 
ririg protons), 7 .41 (m, 5 H, Ar-H); nc NMR (D3CCN) ppm 5.27 (cyclopropyl CH2), 
26.45 [C(l,5)], 27.76 [C(9)], 62.56 [C(2,4,6,8), CH2-cyclopropyl], 126.95, 128.22, 
129.33, 136.98 (Ar-C), 172.69 (NC=O); 15N NMR (DMSO-d6) ppm 50.05 [N(7)], 
108.49 [N(3)]; Mass spectral (El) data calcd for C1sH25ClN205 mlz (M+): 284.1888 (-
HCI04). Found: 284.1888. Anal. Calcd for C1sH25ClN205: C, 56.18; H, 6.55. Found: 
C, 55.92; H, 6.57. 
7-Benzyl-3-cyclopropylmethyl-9,9-(1,3-dithiolan-2-yl)-3, 7-diazabicyclo[3.3.1]-
nonane Hydropercblorate ( 43). Into a 250-mL Erlenmeyer flask equipped with a 
magnetic stirrer and an ice bath was placed thioketal 49b (6.44 g, 17.86 mmol) in dry 
ether (100 mL), and the solution was cooled to 0-5°C (ice bath). To the stirred mixture 
was added dropwise perchloric acid (60%, 3.73 g, 22.32 mmol) over a period of 15 min. 
After stirring an additional 15 min at 5°C, a white precipitate formed and was filtered 
(suction) and washed with cold ether (25 mL). Recrystallization was effected by 
dissolving the white solid in hot H3COH (50 mL) to afford, after drying (Abderhalden, 
80°C, 0.2 mm Hg, P205, 12 h), hydroperchlorate 43 (3.34 g, 40.6%) as white needles; mp 
147.5-149.0°C. IR (KBr) 3090, 3010 (ArH), 2940, 2850 (C-H), 1100 (Cl-0), 735, 705 
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(C-H out of plane, mono) cm-1; lff NMR (DCCl3) o 0.59 [m, 2 H, (CH2)ax, cyclopropyl 
ring], 0.68 [m, 2 H, (CH2'kq, cyclopropyl], 0.98 (m, 1 H, C-H cyclopropyl ring), 2.26 [bs, 
2 H, H(l,5)], 3.01 [m, 4 H, H(2,4)ax, CH2-cyclopropyl], 3.31-3.46 [m, 8 H, H(6,8)ax, 
H(2,4)eq, SCH2], 3.73 (s, 2 H, Ar-CH2), 3.92 [d, J = 13.1 Hz, 2 H, H(6,8)eq], 7.28-7.45 
(m, 5 H, Ar-H); 13C NMR (DCCl3) ppm 4.29 (CH2, cyclopropyl ring), 6.10 (CH, 
cyclopropyl ring), 39.19, 39.35 (SC82), 41.73 [C(l,5)], 56.12 [C(2,4)], 56.92 [C(6,8)], 
60.96 (Ar-C82), 60.99 (C82-cyclopropyl), 69.42 [C(9)], 128.04, 128.57, 129.89, 135.09 
(Ar-C); Mass spectral (EI) data calcd for C2o829C1N204S2 mlz (M+): 360.1694 (-
HCl04): Found: 360.1703. Anal. Calcd. for C2off29ClN204S2: C, 52.10; 8, 6.34; N, 
6.08; S, 13.91. Found: C, 51.98; 8, 6.30; N, 5.81; S, 14.05. 
3-(4-Aminobenzoyl)-7-isopropyl-3,7:.diazabicyclo[3.3.l]nonane (44). To a 500-
mL, Erlenmeyer flask equipped with a magnetic stirrer was added amide 52a (9.17 g, 
28.90 mmol) in Ac08/H20 (1:1, 100 mL). To. this solution was added in one portion 
TiCl3 (12%, 195.0 g, 202.3 mmol), and the mixture was stirred at RT for 7 min. The 
deep purple solution was basified (p8-12) with 20% Na08 until a dark blue color 
persisted. Extraction (H2CCl2, 4 x 90 mL) was followed by washing with 820 (2 x 100 
mL) and brine (100 mL). After drying (Na2S04, 2 h), the solution was filtered and 
concentrated (rotary evaporator) to give 7.34 g (86.2%) of an off-white solid 44; mp 149-
1500C. IR (KBr) 3340, 3220 (N-8), 3060, 3020 (Ar-8), 2980, 2920, 2800 (C-8), 1640 
(NC=O) cm-1; 18 NMR (DCCl3) o 0.98 (bs, 6 8, CH3 isopropyl), 1.67 [m, 3 8, 8(5), 
8(9)], 1.91 [s, 1 8, 8(1)], 2.41 (bs, 2 8, ring proton), 2.59 (m, 1 8, C-H isopropyl), 2.72 
(s, 1 8, ring proton), 3.02 (bs, 2 8, ring protons), 3.31 (d, 1 H, ring proton), 3.83 (bs, 3 H, 
NH2, ring proton), 4.70 (bd, 1 8, ring proton), 6.62 (d, 2 H, Ar-H), 7.19 (d, 2 H, Ar-H); 
13C NMR (DCCl3) ppm 16.81, 18.79 (C83 isopropyl), 29.15, 29.79 [C(l,5)], 32.25 
[C(9)], 46.61 [C(2)], 52.59, 54.22 [C(4,6,8), C-H isopropyl], 114.10, 127.21, 128.68, 
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147.18 (Ar-C), 170.47 (NC=O); Anal. Calcd for C17H25N30: C, 71.05; H, 8.77; N, 
14.62. Found: C, 70.67; H, 8.82; N, 14.28. 
3, 7-Diisopropyl-3, 7-diazabicyclo[J.3.l]nonan-9-one ( 46a). A 500-mL, three-
necked, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, a 
250-mL addition funnel, a condenser with N2 inlet, and a glass stopper. A mixture of 
isopropylamine (8.87 g, 150.0 mmol) HCl (37%, 7.39 g, 75.0 mmol), glacial acetic acid 
(9.01 g, 150.0 mmol) and parformaldehyde (9.46 g, 315.0 mmol) in deoxygenated (dry 
N2 was bubbled through the solvent for 2 h) H3COH (125 mL) was stirred at reflux for 
15 min under N2. A solution of N-isopropyl-4-piperidinone (45a, 21.18 g, 150.0 mmol), 
and glacial acetic acid (9.01 g, 150.0 mmol) was added dropwise over a period of 1.5 h, 
which was followed by a period of boiling for an additional 23 h. After the initial 10 h of 
heating, more paraformaldehyde (9.46 g, 315.0 mmol) was added in one portion to the 
mixture after which reflux was continued for an additional 13 h. After cooling to room 
temperature, concentration (rotary evaporator) of the solution (after 23 h) gave an orange 
oil which was redissolved in H20 (150 mL), and extracts (ether, 2 x 100 mL) thereof 
were discarded. The aqueous layer was chilled (5°C) in an ice bath and made basic 
(pH-12) with NaOH pellets. Extraction (H2CCl2, 3 x 75 mL) gave a solution which was 
dried (Na2S04, 2 h), filtered, and concentrated (rotary evaporator) to give a viscous, 
reddish-orange oil. Distillation of the oil under reduced pressure (l 10-120°C/10·5 mm 
Hg) gave 22.53 g (67.3%) of a light yellow oil 46a. IR (film) 2975, 2910, 2830 (C-H), 
1735 (C=O) cm·l; lH NMR (DCCl3) o 1.02 (d, J = 6.5 Hz, 12 H, CH3 isopropyl), 2.58 
[m, 2 H, H(l,5)], 2.87 [m, 6 H, H(2,4,6,8)ax, C-H isopropyl], 3.04 [dd, J = 10.1 Hz, 4 H, 
H(2,4,6,8)eq]; 13C NMR (DCCl3) ppm 17.90, 18.02 (CH3, isopropyl), 46.82 [C(l,5)], 
53.17 (C-H isopropyl), 53.27, 53.36 [C(2,4,6,8)], 215.18 [C(9)]. Anal. Calcd for 
C13H24N20: C, 69.60; H, 10.78; N, 12.49. Found: C, 69.39; H, 10.61; N, 12.21. 
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7-Benzyl-3-cyclopropylmethyl-3,7-diuabicyclo-[3.3.l]nonan-9-one ( 46b ). A 
500-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
heating mantle, a 250-mL addition funnel, a condenser with N2 inlet, and a glass stopper. 
A mixture of (aminomethyl)cyclopropane (4.44 g, 62.4 mmol), HCl (37%, 3.07 g, 31.2 
mmol), glacial acetic acid (3.75 g, 62.4 mmol) and parformaldehyde (3.94 g, 131.04 
mmol) in deoxygenated (N2 bubbled in for 2 h) CH30H (125 mL) was stirred at reflux 
for 15 min under N2. A solution of N-benzyl-4-piperidinone (45b, 11.8 g, 62.4 mmol) 
and glacial acetic acid (3.75 g, 62.4 mmol) was added dropwise over a period of 1.5 h. 
After 10 h at reflux, the mixture was treated with additional paraformaldehyde (3.94 g, 
131.04 mmol) in one portion. Heating at reflux was continued for another 19 h. Upon 
cooling to RT, concentration (rotary evaporator) of the solution gave a orange oil which 
was dissolved in H20 (100 mL). Extracts (ether, 2 x 75 mL) of the aqueous solution 
were discarded. The aqueous layer was chilled (5°C) in an ice bath and made basic 
(pH-12) with NaOH pellets. Extraction (H2CCl2, 3 x 75 mL) gave a solution which was 
dried (Na2S04, 2 h), filtered, and concentrated (rotary evaporator) to a viscous, reddish-
orange oil. Distillation of the oil under reduced pressure (175-190°C/lQ-5 mm Hg) gave 
13.54 g (76.3%) of 46b as an light yellow oil which solidified upon standing at -l0°C; 
mp 56.0-57 .5°C. This solid was recrystallized (hot pentane) to give an analytical sample; 
mp 58.5-59.5°C. IR (KBr) 3090, 3070, 3030 (Ar-H), 3005 (C-H, cyclopropyl), 2975, 
2910, 2830 (C-H), 1740 (C=O), 1600, 1495 (ArC=C), 740, 710 (C-H out of plane, mono) 
cm-1; lH NMR (DCCl3) B 0.12 [m, 2 H, (C-H)ax, cyclopropyl ring], 0.51 [m, 2 H (C-
H)eq, cyclopropyl ring], 0.89 [m, 1 H, (C-H), cyclopropyl ring], 2.32 (d, J = 9.8 Hz, 2 H, 
CH2-cyclopropyl), 2.59 [m, 2 H, H(l,5)], 2.81 [dd, J = 10.8 Hz, J = 5.6 Hz, 2 H, 
H(6,8)ax], 2.94 [dd, J = 10.8 Hz, J = 6.8 Hz, 2 H, H(2.4)ax], 3.04 [dd, J = 10.8 Hz, J = 3.2 
Hz, 2 H, H(6,8)eq], 3.12 [dd, J = 10.8 Hz, J = 3.2 Hz, 2 H, H(2,4)eq], 3.57 (s, 2 H, 
CH2Ph), 7.38-7.22 (m, 5 H, Ar-H); 13C NMR (DCCl3) ppm 3.76 (CH2, cyclopropyl 
ring), 8.53 (CH, cyclopropyl ring), 46.76 [C(l,5)], 58.19 [C(2,4)], 58.36 [C(6,8)], 61.11 
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(CH2Ph), 61.85 (CH2-cyclopropyl), 127.08, 128.22, 128.66, 138.54 (Ar-C), 214.85 
[C=O]; 15N NMR (DCCl3) ppm 36.17 [N(7)], 37.74 [N(3)]; Mass spectral (EI) data 
calcd for C1gH24N20 m/z (M+): 284.1188; Found: 284.1190. Anal. Calcd for 
C1gH24N20: C, 76.02; H, 8.51; N, 9.85. Found: C, 76.19; H, 8.46; N, 9.99. 
3,7-Diisopropyl-3,7-diazabicyclo[3.3.l]nonane (47a). A 200-mL, jacketed flask 
was equipped with a magnetic stirrer, a heating mantle, a condenser, a lower take-off 
condensor with N2 inlet, and two glass stoppers. To a solution of ketone 46a (5.90 g, 
20.3 mmol) in triethylene glycol (60 mL) was added KOH pellets (85%, 13.89 g, 210.9 
mmol) and hydrazine (95%, 3.55 g, 105.19 mmol). The stirred mixture was heated at 
160-170°C for 4 h under N2 via the use of boiling tetralin (bp 207°C) in the jacket. 
Cooling the solution to RT (1 h) was followed by addition of chilled H20 (100 mL). 
Extraction (ether, 4 x 50 mL) was followed by washing the combined extracts with 10% 
NaOH (100 mL), and satd NaCl (100 mL) and then drying (Na2S04, 2 h). Filtration and 
concentration (rotary evaporator) of the solution gave a light yellow oil 47a (4.48 g, 
81.1 %) which was placed on a vacuum pump overnight (RT/0.2 mm Hg). IR [(film) 
2975, 2900, 2820 (C-H) cm·l] analysis of compound showed no carbonyl absorption as 
present in the starting material 46a, and thus 47a was used without further purification to 
prepare salt 48. 
7-Benzyl-3-cyclopropylmethyl-3, 7-diazabicyclo-[3.3.l]nonane ( 47b ). A 200-
mL, jacketed flask was equipped with a magnetic stirrer, a heating mantle, a condenser, a 
lower take-off condensor with N2 inlet, and two glass stoppers. To a solution of ketone 
46b (9.53 g, 33.51 mmol) in triethylene glycol (100 mL) was added KOH pellets (85%, 
17.7 g, 268.08 mmol) and hydrazine (95%, 4.52 g, 134.04 mmol). The stirred mixture 
was heated at 160-170°C for 4 h under N2 via the use of boiling tetralin (bp 207°C) in the 
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jacket. Cooling the solution to RT (1 h) was followed by addition of chilled H20 (100 
mL). Combined extracts (ether, 4 x 80 mL) of the suspension were first washed with 
10% NaOH (80 mL) and saturated NaCl (80 mL) and then dried (Na2S04, 2 h). 
Filtration and concentration (rotary evaporator) gave a light yellow oil 47b (8.99 g, 
98.2%) which was placed on a vacuum pump overnight (RT/0.2 mm Hg). IR (film) 
3090, 3010, 3005 (ArH), 2920, 2780 (C-H), 735, 700 (C-H out of plane, mono) cm·l; lH 
NMR (DCCl3} 6 · 0.14 [m, 2 H, (CHVax, cyclopropyl ring], 0.51 [m, 2 H, (CH2)eq, 
cyclopropyl ring], 0.94 [m, 1 H, (CH}, cyclopropyl ring], 1.52 [dd, J = 19.8 Hz, 2 H, 
H(9)], 1.91 [m, 2 H, H(l,5)], 2.20 (d, J = 6.6 Hz, 2 H, CH2-cyclopropyl), 2.33 [dd, J = 
10.7 Hz, J = 3.6 Hz, 2 H, H(6,8)ax], 2.41 [dd, J = 10.8 Hz, J = 4.8 Hz, 2 H, H(2,4)ax], 
2.76 [d, J = 10.5 Hz, 2 H, H(6,8)eq], 2.85 [d, J = 10.5 Hz, 2 H, H(2,4}eq], 3.49 (s, 2 H, Ar-
CH2), 7.21-7.45 (m, 5 H, Ar-H); 13C NMR (DCCl3) ppm 3.90 (CH2, cyclopropyl ring), 
8.72 (CH, cyclopropyl ring), 29.43 [C(9)], 30.22 [C(l,5)], 57.68 [C(2,4)], 57.90 [C(6,8)], 
62.75 (Ar-CH2), 64.04 (CH2-cyclopropyl), 126.38, 127.92, 128.62, 139.74 (Ar-C). IR 
and 13C NMR spectra confirmed the absence of the ketone carbonyl, and thus the oil was 
used without further purification to prepare salt 37 and secondary amine 47c. 
3-Cyclopropylmethyl-3,7-dia7.abicyclo[3.3.l]nonane (47c). A 200-mL, three-
necked, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, a 
condenser with N2 inlet, and two glass stoppers. The flask was initially flushed with N2 
for a period of 15 min. Palladium-on-carbon (Alfa, 10%, 0.997 g, 30 mg of 
catalyst/mmol of the amine) was added in one portion, and the system was flushed with 
N2. Dry and deoxygenated H3COH (90 mL) was slowly poured over the catalyst 
(CAUTION: catalyst can ignite in the presence of air). To the stirred solution were added 
amine 47b (8.99 g, 33.24 mmol) and anhydrous HCOiNli4 (5.24 g, 83.1 mmol), and the 
resulting mixture was boiled under N2 for 30 min. Cooling the mixture to RT, and 
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filtering through a celite pad, was followed by concentration (rotary evaporator) of the 
resulting solution to give an off-white, viscous oil. The oil was then dissolved in H20 
(100 mL) and made basic (pH-12) using 10% NaOH pellets. Combined extracts (CCl4, 4 
x 60 mL) of the aqueous solution were dried (Na2S04, 1 h), filtered (gravity) and 
concentrated (rotary evaporator) to give a yellow oil 47c (5.50 g, 91.8%); IR (film) 3300 
(N-H), 3090, 3010 (CH2 cyclopropyl), 2900, 2860, 2780 (C-H) cm-1; lH NMR (DCCl3) 
6 0.13 [m, 2 H, (CHi>ax, cyclopropyl ring], 0.52 [m, 2 H, (CHi>eq, cyclopropyl ring], 
0.87 [m, 1 H, (CH), cyclopropyl ring], 1.64 [m, 2 H, H(l,5)], 1.82 [m, 2 H, H(9)], 2.07 
(d, J = 6.6 Hz, 2 H, CH2-cyclopropyl), 2.31 [d, J = 11.1 Hz, 2 H, H(6,8)u], 2.94 [d, J = 
13.8 Hz, 2 H, H(2,4)axl, 3.09 [d, J = 13.2 Hz, 2 H, H(6,8)eq], 3.17 [d, J = 11.1 Hz, 2 H, 
H(2,4)eq], 4.09 [bs, 1 H, (N-H)]; 13C NMR (DCCl3) ppm 3.76 (CH2, cyclopropyl ring), 
8.76 (CH, cyclopropyl ring), 29.87 [C(9)], 33.23 [C(l,5)], 52.45 [C(6,8)], 59.51 [C(2,4)], 
64.32 ( CH2-cyclopropyl). The 1 H NMR spectrum was void of aromatic protons , and thus 
the oil was used without further purification to prepare amides 39 and 50. 
3,7-Diisopropyl-3,7-diazabicyclo[3.3.l]nonane Hydroperchlorate (48). A 250-
mL, Erlenmeyer flask was equipped with a magnetic stirrer and an ice bath. To a chilled 
(5°C, ice bath) solution of amine 47a (3.4 g, 16.16 mmol) in dry ether (50 ml) was added 
HCl04 (60%, 3.4 g, 20.2 mmol) dropwise over a period of 15 min. The mixture was 
allowed to stir an additional 15 min at 0-5°C. A white precipitate formed and was filtered 
and washed with cold ether (30 mL). The solid was recrystallized (H3COH, 30 mL), and 
white- needles were collected, washed with cold H3COH (25 mL), and dried 
(Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 3.63 g (72.3%) of salt 48; mp 211-212°C. 
IR (KBr) 3560 (0-H), 3400 (N-H), 2985, 2940, 2850 (C-H), 1090 (Cl-0) cm·l; lH NMR 
(D3CCN) 6 1.14 (d, J = 6.2 Hz, 12 H, CH3 isopropyl), 1.80 [bs, 2 H, H(l,5)], 2.21 [bs, 2 
H, H(9)], 2.97 (d, J = 11.9 Hz, 4 H, ring protons), 3.19 (m, 2 H, C-H isopropyl), 3.28 (d, J 
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= 12.2 Hz, 4 H, ring protons); 13c NMR (D3CCN) ppm 17.11 (CH3 isopropyl), 28.56 
[C(l,5)], 31.41 [C(9)], 54.26 [C(2,4 6,8)], 56.13 (C-H isopropyl). Mass spectral (El) data 
calcd for C13H27N204Cl mlz (M+): 210.2096. Found: 210.2096. Anal. Calcd for 
C13H27N204Cl: C, 50.24; H, 8.76; N, 9.01. Anal. Calcd for C13H27N204Cl· 0.2 H20: 
C, 49.66; H, 8.78; N, 8.91. Found: C, 49.33; H, 8.52; N, 9.31. 
3, 7-Diisopropyl-9,9-(1,3-dithiolan-2-yl)-3, 7-diazabicyclo[3.3.l]nonane ( 49a). 
A 250:-mL, single-necked, round-bottomed flask was equipped with a magnetic stirrer, 
condenser with a N2 inlet, a Dean-Stark trap, and a heating mantle. After addition of 
ketone 46a (8.0 g, 35.66 mmol), 1,2-ethanedithiol (33.59 g, 356.6 mmol), p-toluene-
sulfonic acid (16.28 g, 85.58 mmol) and benzene (200 mL), the resulting mixture was 
heated at reflux for 40 h. The solvent (benzene) was then removed through a Dean-Stark 
trap, and the resulting oil was dissolved in H20 (100 mL) and transferred to a separatory 
funnel. The aqueous layer was extracted (ether, 2 x 100 mL), the extracts being 
discarded. Basification (pH-12) was achieved using 10% NaOH followed by extraction 
(ether, 4 x 75 mL) and washing with NaOH (1 N, 90 mL) and brine (90 mL). After 
drying (Na2S04, 2 h) the solution, evaporation (rotary evaporator) afforded 8.06 g 
(75.2%) of a light yellow oil 49a; IR (film) 2905, 2800 (C-H) cm-1; lH NMR (DCCI3) 6 
1.03 (d, J = 12.5 Hz, 12 H, CH3 isopropyl), 2.26 [bs, 2 H, H(l,5)], 2.62 (d, 4 H, ring 
protons), 2.77 (m, 2 H, C-H isopropyl), 2.89 (d, J = 12.7 Hz, 4 H, ring protons), 3.08 (s, 4 
H, S-CH2); 13C NMR (DCCI3) ppm 17.97 (CH3 isopropyl), 37.39 [C(l,5)], 43.11 (S-
CH2), 51.20 [C(2,4,6,8)], 53.21 (C-H isopropyl), 70.89 [C(9)]. Spectral analysis (IR and 
13C) of the oil did not show the presence of a carbonyl group as present in 46a, and thus 
the thioketal was used without purification to prepare 38. 
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7-Benzyl-3-cydopropylmethyl-9~-(1,3-dithiolan-2-yl)-3,7-diazabicydo[3.3.1]-
nonane (49b). A 250-mL, single-necked, round-bottomed flask was equipped with a 
magnetic stirrer, condenser with a N2 inlet, a Dean-Stark trap, and a heating mantle. 
After addition of ketone 46b (6.0 g, 21.09 mmol), 1,2-ethanedithiol (19.87 g, 210.9 
mmol), p-toluene-sulfonic acid (9.63 g, 50.6 mmol) and benzene (120 mL), the resulting 
mixture was heated at reflux for 30 h. The solvent (benzene) was removed through a 
Dean-Stark trap, and the resulting oil was dissolved in H20 (100 mL). The aqueous layer 
was extracted (ether, 2 x 50 mL), and these extracts were discarded. Basification of the 
aqueous solu_tion (pH-12) was achieved using an aqueous 10% NaOH solution. This new 
solution was extracted (ether, 4 x 75 mL), and the extracts were then washed with NaOH 
(1 N, 90 mL) and saturated NaCl (90 mL). After drying (Na2S04, 2 h), the organic 
solution was evaporated (rotary evaporator) to afford 6.44 g (84.7%) of 49b, a light 
yellow oil; IR (film) 3080, 3010, 3000 (ArH), 2905, 2800 (C-H), 730, 705 (C-H out of 
plane, mono) cm-1; lH NMR (DCCl3) 6 0.14 [m, 2 H, (CH2)ax, cyclopropyl ring], 0.51 
[m, 2 H, (CH2)eq, cyclopropyl ring], 0.92 [m, 1 H, (CH), cyclopropyl ring], 2.15 [m, 2 H, 
H(l,5)], 2.27 (d, J = 5.5 Hz, 2 H, CH2-cyclopropyl), 2.73-2.84 (m, 8 H, ring protons), 
3.14 (s, 4 H, SCH2), 3.53 (s, 2 H, Ar-CH2), 7.24-7.46 (m, 5 H, Ar-H); 13c NMR 
(DC03) ppm 3.83 (CH2, cyclopropyl ring), 8.60 (CH, cyclopropyl ring), 37.93, 37.98 
[C(l,5)], 43.51 (SCH2), 56.56 [C(2,4)], 56.67 [C(6,8)], 61.68 (CH2-Ar), 62.49 (CH2-
cyclopropyl), 71.91 [C(9)], 126.60, 128.02, 128.62, 139.34 (Ar-C). Thioketal 49b was 
used without further purification to prepare salt 43. 
3-Benzoyl-7-cydopropylmethyl-3,7-diazabicyclo-[3.3.l]nonane (50). Into a 100-
mL, three-necked, round-bottomed flask equipped with a magnetic stirrer, 25-mL 
addition funnel, a condenser with N2 inlet, and a glass stopper were placed the amine 47c 
(5.50 g, 30.51 mmol) and NaOH (10%, 30.60 g, 76.28 mmol) in H2CCl2 (25 mL). A 
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solution of benzoyl chloride (4.72 g, 33.56 mmol) in H2CCh (15 mL) was added 
dropwise over a period of 0.5 h under N2. The mixture was allowed to stir an additional 
3 h. Addition of H20 (50 mL) was followed by extraction with H2CC!i (3 x 50 mL). 
Combined extracts were dried (Na2S04, 1 h), filtered, and concentrated (rotary 
evaporator) to give a yellow oil. Flash chromatography of the oil was performed on 
neutral alumina (50 g, 60-mL fritted funnel, suction) with ethyl acetate as the eluent. The 
filtrate was concentrated (rotary evaporator) and placed on a vacuum pump overnight 
(RT/0.2 mm Hg) to give 7.15 g (82.4%) of amide SO as an oil. IR (film) 3090, 3005 (Ar-
H), 2920, 2860, 2775 (C-H), 1630 (NC=O), 715 (C-H out of plane, mono) cm-1; lH 
NMR (DCCl3) a 0.11 [bd, 2 H, cyclopropyl CH2 {ax)], 0.49 [m, 2 H, cyclopropyl CH2 
(eq)], 0.92 {m, 2 H, cyclopropyl C-H), 1.74 [m, 3 H, H(5,9)], 1.98 [bs, 2 H, H(l), CH2 
cyclopropyl], 2.23 [bs, 3 H, H{4,6)ax, CH2 cyclopropyl], 2.94 [d, 1 H, H(6)eq], 3.01 [d, 1 
H, H(2)axl, 3.28 [m, 2 H, H(8)ax, H(4)eq], 3.78 [d, I= 12.2 Hz, 1 H, H(8)eq], 4.79 [d, I = 
12.1 Hz, 1 H, H(2)eq], 7.38 (m, 5 H, Ar-H); 13C NMR (DCCl3) ppm 2.85, 4.11 
(cyclopropyl CH2), 7.95 (cyclopropyl C-H), 28.64, 29.01 [C(l,5)], 31.72 [C(9)], 46.02 
[C(2)], 51.74, 57.71, 57.98 [C(4,6,8)], 63.84 (CH2 cyclopropyl), 126.13, 127.64, 128.07, 
137.20 (Ar-C), 169.68 (NC=O). Benzamide SO was used without further purification to 
prepare salt 42. 
3-( 4-Chlorobenzoyl)-7-methylcyclopropyl-3, 7-dia7.a-bicyclo[3.3.l]nonane 
Hydroperchlorate (51). A 125-mL Erlenmeyer flask equipped with a magnetic stirrer 
and an ice bath. To a chilled (5°C, via ice bath) solution of amide 39 (1.0 g, 3.14 mmol) 
in ether (30 mL) was added HCl04 (60%, 0.66 g, 3.92 mmol) dropwise over a period of 
15 min. The suspension was stirred an additional 10 min at this temperature followed by 
filtration. This white solid was recrystallized from H3COH (25 mL) which was followed 
by filtration and drying (Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 0.93 g (70.9 % ) as 
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white needles of 51; mp 231-232°C. IR (KBr) 3180 (N-H), 3095, 3020 (Ar-H), 2950, 
2880 (C-H), 1620 (NC=O), 1090 (Cl-0) cm-1; lff NMR (D3CCN) o 0.51 [d, J = 3.2 Hz, 
2 H, (CH2)ax cyclopropyl ring], 0.82 [d, J = 3.6 Hz, 2 H, (CHi)eq cyclopropyl ring], 1.18 
(m, 1 H, C-H cyclopropyl), 1.85 [bd, 1 H, H(9)], 2.33 [bs, 3 H, H(l,5,9)], 3.03 (d, J = 6.2 
Hz, 2 H, CH2 cyclopropyl), 3.29 (m, 4 H, ring protons), 3.74 (bs, 2 H, ring protons), 4.09 
(bs, 2 H, ring protons), 7.36 (d, 2 H, Ar-H), 7.48 (d, 2 H, Ar-H); 13C NMR (D3CCN) 
ppm 4.94, 6.40 (cyclopropyl CH2), 27.89 [C(l,5)], 29.05 [C(9)], 57.42, 63.98, 64.08 
[C(2,4,6,8), CH2-cyclopropyl], 118.37, 129.67, 129. 79, 129.95, 135.08, 136.29 (Ar-C), 
173.85 (NC=O); Mass spectral (En data calcd for C1gH24Cl2N205 mlz (M+): 318.1499 
(-HCl04). Found: 318.1500. Anal. calcd for C1sH24CliN205: C, 51.56; H, 5.77. 
Found: C, 51.34; H, 5.85. 
3-(4-Nitrobenzoyl)-7-isopropyl-3,7-dia7Jlbicyclo[3.3.l]nonane (52a). To a 100-
mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
condenser with N2 inlet, a 25-mL addition funnel and two glass stoppers. To a mixture of 
amine 52j (3.82 g, 22.70 mmol) in H2CC!i (25 mL) and 10% NaOH (22.76 g, 56.80 
mmol) was added dropwise 4-nitrobenzoyl chloride (4.63 g, 24.90 mmol) in H2CCI2 (15 
mL) over a period of 15 min. Stirring (magnetic) of the mixture was continued for an 
additional 3 h under N2. To the heterogenous mixture was added H20 (100 mL) in one 
portion and, after transferring the mixture to a separatory funnel, the two layers were 
separated. Further extracts (H2CC!i, 3 x 50 mL) of the aqueous layer were combined, 
dried (Na2S04, 1 h), filtered and concentrated (rotary evaporator) to give a viscous 
yellow oil which solidified upon standing. This yellow solid was dissolved in ether, and 
the solution was gravity filtered. The filtrate was concentrated (rotary evaporator) and 
then placed on vacuum pump overnight (RT/0.2 mm Hg) to give 6.79 g (94.3 %) of a 
light yellow solid 52a; mp 119-120°C. IR (KBr) 3090, 3005 (Ar-H), 2920, 2880, 2770 
(C-H), 1635 (NC=O), 760 (C-H out of plane, para) cm·l; lH NMR (DCCI3) o 0.56 (d,J = 
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6.7 Hz, 3 H, CH3 isopropyl), 0.69 (d, J = 6.7 Hz, 3 H, CH3 isopropyl), 1.34 [m, 2 H, 
H(9)ax, H(5)], 1.61 [bs, 1 H, H(l)], 2.04-2.32 [m, 3 H, ring protons], 2.67 (dd, J = 11.2 
Hz, 2 H, ring protons), 2.94 (dd, J = 12.9 Hz, 1 H, ring proton), 3.20 {d, J = 12.9 Hz, 1 H, 
ring proton), 3.39 (d, J = 11.2 Hz, 1 H, ring proton), 7.13 (d, 2 H, Ar-H), 7.85 (d, 2 H, Ar-
H); 13C NMR (DCCl3) ppm 15.89, 19.46 (CH3 isopropyl), 28.81 29.57 [C(l,5)], 32.04 
[C(9)], 46.55 [C(2)], 51.79, 52.31, 54.26, 54.85 [C{4,6,8), C-H isopropyl], 123.52, 
127.60, 143.91, 147.62 (Ar-C), 167.58 (NC=O); Mass spectral (El) data calcd for 
C17H23N303 mlz (M+): 317.1739. Found: 317.1750; Anal. Calcd for C17H23N303: C, 
64.33; H, 7.~0; N, 13.24. Found: C, 64.06; H, 7.36; N, 12.97. 
3-[(4-N-Acetyl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.l]nonane (S2b ). In a 
100-mL, three-necked, round-bottomed flask equipped with a magnetic stirrer, 25-mL 
addition funnel, a condenser with N2 inlet and a glass stopper were placed amide 44 (3.50 
g, 12.2 mmol) and NaOH (10%, 12.2 g, 30.50 mmol) in H2CCl2 (25 mL). A solution of 
acetyl chloride (1.05 g, 13.4 mmol) in H2CCl2 (10 mL) was added dropwise over a 
period of 0.5 h under N2. The mixture was allowed to stir for an additional 3 h. Addition 
of H20 (50 mL) was followed by separating the two layers. The organic phase was 
further extracted (H2CClz, 3 x 40 mL), and the combined extracts were dried (Na2S04, 1 
h), filtered, and concentrated (rotary evaporator) to give a light yellow oil. Flash 
chromatography of the oil was performed on neutral alumina (50 g, 60-mL flitted funnel, 
suction) with ethyl acetate as the eluent. The filtrate was concentrated (rotary evaporator) 
and placed on a vacuum pump overnight (RT/0.2 mm Hg) to give 3.44 g (85.5%) of 
amide S2b as a white solid; mp 77-78°C. IR (KBr) 3280 (N-H), 3100, 3060 (Ar-H), 
2980, 2940, 2800 (C-H), 1690 (NHC(O)CH3), 1615 (NC=O) cm-1; lH NMR (DCCl3) B 
0.94 (d, J = 6.2 Hz, 3 H, CH3 isopropyl), 1.03 (d, J = 6.2 Hz, 3 H, CH3 isopropyl), 1.67 
[bd, 1 H, H(9)axl, 1.74 [bd, 1 H, H(9)eq], 1.96 [bs, 2 H, H(l,5)], 2.11 [s, 3 H, 
113 
NHC(O)CH3], 2.42 (d, J = 10.1 Hz, 1 H, ring proton), 2.48 (d, J = 10.1 Hz, 1 H, ring 
proton), 2.56 (m, 1 H, C-H isopropyl), 2.71 (d, J = 10.9 Hz, 1 H, ring proton), 3.04 (m, 1 
H, ring proton), 3.30 (d, J = 12.8 Hz, 1 H, ring proton), 3.79 (d, J = 12.8 Hz, 1 H, ring 
proton), 4.76 (d, J = 12.8 Hz, 1 H, ring proton), 7.17 (d, 2 H, Ar-H), 7.36 (d, 2 H, Ar-H), 
9.24 (bs, 1 H, N-H); 13C NMR (DCCl3) ppm 16.29, 19.24 (CH3 isopropyl), 24.09 
[NHC(O)CH3], 29.05, 29.65 [C(l,5)], 32.20 [C(9)], 46.70 [C(2)], 52.24, 52.85, 54.24, 
54.63 [C(4,6,8), C-H isopropyl], 119.96, 127.19, 132.29, 139.12 (Ar-C), 169.34 
[NHC(O)CH3], 170.19 (NC=O). Benzamide 52b was used without further purification to 
prepare hydro-perchlorate 53a. 
3-[ 4-(Methylsulfonyl)amino ]benzoyl-7-isopropyl-3, 7-div.abicyclo[J.3.l]nonane 
(52c). A 100-mL, three-necked, round-bottomed flask was equipped with a 25-mL 
addition funnel, magnetic stirrer, condenser with N2 inlet, and an ice bath. To a chilled 
(5°C) solution of amide 44 (3.0 g, 10.44 mmol) and pyridine (0.87 g, 10.96 mmol) in 
H2CCl2 (20 mL) was added dropwise methanesulfonyl chloride (1.18 g, 10.34 mmol) in 
H2CC}i (10 mL) over a 15 min period. When the addition was completed, the mixture 
was allowed to stir at RT overnight. Suction filtration of the mixture removed traces of 
pyridine hydrochloride, and the filtrate was transferred to a separatory funnel. Extraction 
(1 N NaOH, 4 x 40 mL) was followed by neutralization (pH-7) of the aqueous phase 
using acetic acid, and the remaining organic layer was discarded. This neutral solution 
was extracted (H2CCl2, 4 x 40 mL), dried (Na2S 04, 2 h) and filtered. After 
concentration (rotary evaporator), there was obtained 3.46 g (90.6%) of an off-white solid 
52c; mp 89-91 °C. IR (KBr) 3140 (N-H), 3040 (Ar-H), 2980, 2930, 2870, 2810 (C-H), 
1610 (NC=O) cm-1; lH NMR (DCCI3) o 0.97 (d, J = 6.1 Hz, 3 H, CH3 isopropyl), 1.08 
(d, J = 6.1 Hz, 3 H, CH3 isopropyl), 1.69 [bs, 1 H, H(5)], 1.79 [bd, 2 H, H(9)], 1.98 [bs, 1 
H, H(l)], 2.42 (d, J = 11.3 Hz, 1 H, ring proton), 2.51 (d, J = 11.3 Hz, 1 H, ring proton), 
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2.60 (m, 1 H, C-H isopropyl), 2.74 (d, J = 11.3 Hz, 1 H, ring proton), 3.03 (m, 5 H, ring 
protons, S02CH3), 3.32 (d, J = 13.0 Hz, 1 H, ring proton), 3.78 (d, J = 13.0 Hz, 1 H, ring 
proton), 4.76 (d, J = 13.0 Hz, 1 H, ring proton), 7.21-7.30 (q, 4 H, Ar-H); 13C NMR 
(DCCl3) ppm 16.26, 1916 (CH3 isopropyl), 28.89, 29.55 [C(l,5)], 32.05 [C(9)], 39.18 
(S02CH3), 46.76 [C(2)], 52.11, 52.52, 54.19, 54.54 [C(4,6,8), C-H isopropyl], 119.80, 
128.05, 128.16, 133.22, 138.21 (Ar-C), 169.63 (NC=O). Sulfonamide 52c was used 
without further purification to prepare salts 41 and 54c. 
3-(4-Fluorobenzoyl)-7-isopropyl-3,7-diazabicyclo[3.3.l]nonane (52d). In a 100-
mL, three-necked, round-bottomed flask equipped with a magnetic stirrer, 25-mL 
addition funnel, a condenser with N2 inlet and a glass stopper were placed amine 52j 
(2.53 g, 15.03 mmol) and NaOH (10%, 15.07 g, 37.58 mmol) in H2CCI2 (25 mL). A 
solution of 4-fluorobenzoyl chloride (2.62 g, 16.54 mmol) in H2CCl2 (15 mL) was added 
dropwise over a period of 0.5 h under N2. The mixture was allowed to stir an additional 
3 h. Addition of H20 (50 mL) was followed by extraction with H2CCI2 (3 x 50 mL). 
Combined extracts were dried (Na2S04, 1 h), filtered, and concentrated (rotary 
evaporator) to give a light yellow oil. Flash chromatography of the oil was performed on 
neutral alumina (50 g, 60-mL fritted funnel, suction) with hexane:ethyl acetate (60:40) as 
the eluent. The filtrate was concentrated (rotary evaporator) and placed on a vacuum 
pump overnight (RT/0.2 mm Hg) to give 3.88 g (89.0%) of amide 52d as a white solid; 
mp 87-88°C. IR (KBr) 3090, 3005 (Ar-H), 2975, 2930, 2860 (C-H), 1630 (NC=O), 750 
(C-H out of plane, mono) cm·l; lH NMR (DCCl3) 6 0.96 (d, J = 5.9 Hz, 3 H, CH3 
isopropyl), 1.07 (d, J = 5.9 Hz, 3 H, CH3 isopropyl), 1.71 [m, 3 H, H(9), H(5)], 1.95 [s, 1 
H, H(l)], 2.41-2.72 (m, 4 H, ring protons, C-H isopropyl), 3.03 (d, J = 12.7 Hz, 2 H, ring 
protons), 3.31 (d, J = 12.7 Hz, 1 H, ring proton), 3.72 (d, J = 12.7 Hz, 1 H, ring proton), 
4.74 (d, J = 12.7 Hz, 1 H, ring proton), 7.08 (m, 2 H, Ar-H), 7.36 (m, 2 H, Ar-H); 13C 
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NMR (DCCl3) ppm 16.26, 19.18 (CH3 isopropyl), 28.97, 29.69 [C(l,5)], 32.16 [C(9)], 
46.59 [C(2)], 52.12, 52.49, 54.65 [C(4,6,8), C-H isopropyl], 114.96, 115.25, 128.77, 
128.88, 133.60, 133.64 (Ar-C), 161.04, 164.33 (J = 248.2 Hz, ArC-F), 169.07 (NC=O); 
15N NMR (DCCl3) ppm 40.78 [N(7)], 119.65 [N(3)]; Mass spectral (El) data calcd for 
C17H23N20F mlz (M+): 290.1794. Found: 290.1790. Anal. Calcd for C17H23N20F: 
C, 70.32; H, 7.98; N, 9.65. Found: C, 70.39; H, 8.03; N, 9.71. 
3-[ 4-(lH-Imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-dia.zabicyclo[J.3.l]nonane 
(52e). A 200-mL, jacketed flask was equipped with a magnetic stirrer, a heating mantle, 
a condenser, a lower take-off condenser with N2 inlet and two glass stoppers. To a 
solution of amide 52d (3.35 g, 11.54 mmol) in DMSO (15 mL) was added imidazole 
(1.18 g, 17.30 mmol), potassium carbonate (anhydrous,1.67 g, 12.12 mmol), and 18-
crown-6 (100 mg). The stirred mixture was heated at l l0°C for 45 h under N2 via the use 
of boiling toluene (bp l l0°C) in the jacket. Cooling the solution to RT was followed by 
the addition of chilled H20 (75 mL). Combined extracts (H2CCl2, 4 x 40 mL) of the 
suspension were washed with H20 (80 mL) and satd NaCl (80 mL); the solution was then 
dried (Na2S04, 2 h). Filtration and concentration (rotary evaporator) gave a light yellow 
solid [which was placed on a vacuum pump overnight (RT/0.2mm Hg)]. Flash 
chromatography (neutral alumina) of the crude solid in solution using ethyl 
acetate:hexane (2:3) caused the starting material to be eluted first. With a more polar 
solvent system [EtOAc:H3COH (30:1)], product 52e could be isolated (1.35 g, 35.1 %) as 
an off white solid. This solid was sensitive to air and became gummy when exposed to 
the atmosphere. IR(film) 3400 (N-H), 3110 (Ar-H), 2975, 2910, 2800 (C-H), 1620 
(NC=O), 735 (para) cm·l; lH (DCCl3) B 0.96-1.14 (dd, J = 5.9 Hz, 6 H, CH3 isopropyl), 
1.68 [bd, 1 H, H(9)], 1.81 [bs, 2 H, H(l,5)], 2.02 [bs, 1 H, H(9)], 2.45 (d, J = 10.8 Hz, 1 
H, ring proton), 2.57 (d, J = 10.8 Hz, 1 H, ring proton), 2.63 (m, 1 H, C-H isopropyl), 
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2.77 (d, J = 10.8 Hz, 1 H, ring proton), 3.09 (d, J = 12.4 Hz, 2 H, ring protons), 3.38 (d, J 
= 12.4 Hz, 1 H, ring proton), 3.76 (d, J = 12.4 Hz, 1 H, ring proton), 4.79 (d, J = 12.4 Hz, 
1 H, ring proton), 7.22 (s, 1 H, C-H imidazole), 7.32 (s, 1 H, C-H imidazole), 7.41-7.54 
(dd, 4 H, Ar-H), 7.89 (s, 1 H, C-H imidazole); 13C NMR (DCC!J) ppm 16.33, 19.41 (CH3 
isopropyl), 29.03, 29.78 [C(l,5)], 32.26 [C(9)], 46.72 [C(2)], 52.15, 52.61, 54.38, 54.82 
[C(4,6,8), C-H isopropyl], 118.07 (C-H imidazole), 121.15, 128.54 (Ar-C), 130.60, 
135.44 (C.:H imidazole), 136.91, 137.43 (Ar-C), 168.80 (NC=O). Because of it's 
hygroscopic nature, benzamide 52e was converted directly to the hydroperchlorate 53c. 
3-[ 4-(Nitro )phenylacetyl]-7-isopropyl-3, 7-diuabicydo[3.3.l]nonane (52f). A 
100-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 25-
mL addition funnel, a condenser with a N2 inlet, and one glass stopper. Initially, the 
amine 52j (2.42 g, 14.38 mmol) in H2CC12 (35 mL) was added followed by NaOH (10%, 
14.42 g, 35.95 mmol) which resulted in formation of a heterogenous mixture. To this 
mixture was added dropwise 4-nitrophenylacetyl chloride (65, 3,16 g, 15.82 mmol) over 
a 15-min period. Stirring was continued for an additional 3 h after which the brown 
mixture was transferred to a separatory funnel, and the layers were separated. The 
aqueous layer was extracted (H2CCii, 3 x 25 mL), and the organic layers were combined. 
After drying (Na2S04, 2 h), the organic solution was filtered and concentrated (rotary 
evaporater) to give 52f as a light brown solid (3.3 g, 69.2 %); mp 93-94°C. IR (KBr) 
3090 (Ar-H), 2960, 2920, 2800, 2740 (C-H), 1625 (NC=O) cm-1; lH NMR (DCC13) 6 
0.94 (dd, J = 6.4 Hz, 6 H, CH3 isopropyl), 1.69 [q, 2 H, H(9)], 1.92 [bs, 2 H, H(l,5)], 2.46 
[m, 3 H, ring protons, C-H isopropyl), 2.79 (d, J = 11.2 Hz, 1 H, ring proton), 2.93 (m, 2 
H, ring protons), 3.39 (d, J = 13.2 Hz, 1 H, ring proton), 3.79 (s, 2 H, CH2-Ar), 3.84 (d, J 
= 13.2 Hz, 1 H, ring proton), 4.57 (d, 1 H, ring proton), 7.44 (d, 2 H, Ar-H), 8.15 (d, 2 H, 
Ar-H); 13c NMR (DCCl3) ppm 16.83, 18.44 (CH3 isopropyl), 28.76, 29.42 [C(l,5)], 
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31.57 [C(9)], 40.62 (CH2-Ar), 46.76 [C(2)], 50.60, 52.78, 54.03, 54.42 [C(4,6,8), C-H 
isopropyl], 123.37, 130.02, 143.58, 146.56 (Ar-C), 167.93 (NC=O). Amide 52f was used 
without further purification to prepare 52g and 53d. 
3-[ 4-(Amino )phenylacetyl]-7-isopropyl-3, 7-diazabicyclo[3.3.l]nonane (52g). To 
a 500-mL, Erlenmeyer flask equipped with a magnetic stirrer was added amide 52f (5.4 g, 
16.3 mmol) in AcOH/H20 (1:1, 80 mL). After obtaining a homogenous solution, TiCl3 
(12%, 135.3 g, 114.1 mmol) was added in one portion, and this purple solution was 
stirred at room temperature for 7 min. Upon cooling (ice bath, 5°C) the reaction mixture, 
20% NaOH was added slowly until a dark blue color persisted (pH-12). Extraction 
(HCCl3, 3 x 100 mL) was followed by washing of the organic layer with H20 (150 mL) 
and satd NaCl (150 mL). The organic layer was dried (Na2S04, 3 h), filtered, and 
concentrated (rotary evaperator) which gave 52g ( 4.03 g, 82.1 % ) as a light yellow, 
viscous oil. IR (film) 3350, 3240 (N-H), 3040 (Ar-H), 2980, 2930, 2800 (C-H), 1630 
(NC=O) cm·l; lH NMR (DCCl3)~ 0.93 (dd, J = 6.5 Hz, 6 H, CH3 isopropyl), 1.61 [q, 2 
H, H(9)], 1.82 [bd, 2 H, H(l,5)], 2.32-2.49 (m, 3 H, ring protons, C-H isopropyl), 2.71 (d, 
J = 11.5 Hz, 1 H, ring proton), 2.86 (d, J = 11.5 Hz, 1 H, ring proton), 2.92 (d, J = 11.5 
Hz, 1 H, ring proton), 3.25 (d, J = 11.5 Hz, 1 H, ring proton), 3.58 (q, 2 H, Ar-CH2), 3.69 
(bs, 2 H, NH2), 3.83 (d, J = 13.0 Hz, 1 H, ring proton), 4.51 (d, J = 13.0 Hz, 1 H, ring 
proton), 6.58 (d, 2 H, Ar-H), 7.01 (d, 2 H, Ar-H); 13C NMR (DCCl3) ppm 16.48, 18.06 
(CH3 isopropyl), 28.46, 29.01 [C(l,5)], 31.15 [C(9)], 40.20 (Ar-CH2), 46.14 [C(2)], 
50.13, 52.52, 53.51, 53.89 [C(4,6,8), C-H isopropyl], 114.75, 125.58, 129.04, 144.71 (Ar-
C), 169.80 (NC=O). Amide 52g was used directly without further purification to prepare 
sulfonamide 52i. 
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3-[ 4-(N -Acetyl)phenylacetyl]-7-isopropyl-3, 7-diambicyclo[3.3.l]nonane (52h). 
A 100-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
condenser with N2 inlet, a 25-mL addition funnel and two glass stoppers. To a mixture of 
amide 52g (2.0 g, 6.63 mmol) in H2CCl2 (25 mL) and 10% NaOH (6.65 g, 16.58 mmol) 
was added dropwise a solution of acetyl·chloride (0.57 g, 7.30 mmol) in H2CCl2 (5 mL) 
over a period of 15 min. Stirring (magnetic) of the mixture was continued for an 
additional 3 h under N2. To the heterogenous mixture was added H20 (100 mL) and the 
two layers were separated. Further extracts (H2CCl2, 3 x 30 mL) of the aqueous layers 
were combined and dried (Na2S04, 1 h), filtered, and concentrated (rotary evaporator). 
The resulting oil was placed on a vacuum pump overnight (RT/0.2 mm Hg) to give 2.03 g 
(89.1 %) of 52h as an light yellow solid; mp 71-72°C. IR (KBr) 3300 (N-H), 3080, 3050 
(Ar-H), 2980, 2930, 2870, 2800 (C-H), 1680 [NC(O)CH3], 1620 (NC=O) cm-1; lH NMR 
(DC03) 6 0.94 (dd, J = 6.0 Hz, 6 H, CH3 isopropyl), 1.68 [bd, 2 H, H(9)], 2.11 [s, 3 H, 
CH3C(O)], 2.40 (d, J = 11.6 Hz, 1 H, ring proton), 2.49 (m, 2 H, ring proton, C-H 
isopropyl), 2.78 (d, J = 11.6 Hz, 1 H, ring proton), 2.87 (d, J = 11.6 Hz, 1 H ring proton), 
2.96 (d, J = 11.6 Hz, 1 H, ring proton), 3.32 (d, J = 13.1 Hz, 1 H, ring proton), 3.64 (m, 2 
H, Ar-CH2), 3.87 (d, J = 13.1 Hz, 1 H, ring proton), 4.55 (d, J = 13.1 Hz, 1 H, ring 
proton), 7.08 (d, 2 H, Ar-H), 7.36 (d, 2 H, Ar-H), 8.70 (s, 1 H, N-H); 13C NMR (DCCl3) 
ppm 16.99, 18.33 (CH3 isopropyl), 24.13 [CH3C(O)], 28.83, 29.39 [C(l,5)], 31.55 
[C(9)], 40.49 (Ar-CH2), 46.75 [C(2)], 50.62, 53.02, 53.99, 54.28 [C(4,6,8), C-H 
isopropyl], 120.28, 129.06, 130.73, 136.86 (Ar-C), 168.89 [NHC(O)CH3], 169.94 
(NC=O). Amide 52h was used directly to prepare hydroperchlorate 53e. 
3-[ 4-(Methylsulfonyl)amino ]phenylacetyl-7-isopropyl-3,7 -diazabicyclo[3.3.1]-
nonane (52i). A 100-mL, three-necked, round-bottomed flask was equipped with a 25-
mL addition funnel, magnetic stirrer, condenser with N2 inlet, and an ice bath. To a 
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chilled (5°C) solution of amide 52g (2.1 g, 6.97 mmol) and pyridine (0.58 g, 7 .32 mmol) 
in H2CCl2 (20 mL) was added dropwise methanesulfonyl chloride (0.79 g, 6.90 mmol) in 
H2CCl2 (10 mL) over a 15 min period. After the addition was complete, the mixture 
stirred at RT overnight. Filtration (suction) of the mixture removed traces of pyridine 
hydrochloride, and the filtrate was transferred to a separatory funnel. Extraction (1 N 
NaOH, 4 x 40 mL) was followed by neutralization (pH-7) of the aqueous phase using 
acetic acid, and the remaining organic layer was discarded. This neutral solution was 
extracted (H2CCl2, 4 x 40 mL), dried (Na2S04, 2 h) and filtered. After concentration 
(rotary evaporator), sulfonamide 52i was obtained 2.32 g (87.4%) as an off-white solid; 
mp 73-74°C. IR (KBr) 3140 (N-H), 3050 (Ar-H), 2980, 2920, 2880, 2800 (C-H), 1630 
(NC=O) cm-1; lH NMR (DCCl3) 6 0.94 (dd, J = 5.9 Hz, 6 H, CH3 isopropyl), 1.69 [m, 2 
H, H(9)], 1.93 [bs, 2 H, H(l,5)], 2.41 (bd, 1 H, ring proton), 2.52 (m, 2 H, ring proton, C-
H isopropyl), 2.84 (d, J = 11.0 Hz, 1 H, ring proton), 2.93 (m, 6 H, ring protons, 
S02CH3), 3.38 (d, J = 11.0 Hz, 1 H, ring proton), 3.66 (s, 2 H, Ar-CH2), 3.90 (d, J = 12.9 
Hz, 1 H, ring proton), 4.59 (d, J = 12.9 Hz, 1 H, ring proton), 7.11 (dd, 4 H, Ar-H), 7.37 
(s, 1 H, S02N-H); 13C NMR (DCCI3) ppm 17.17, 18.31 (CH3 isopropyl), 28.84, 29.47 
[C(l,5)], 31.62 [C(9)], 38.76 (S02CH3), 40.05 (Ar-CH2), 46.89 [C(2)], 50.58, 53.04, 
54.07, 54.30 [C(4,6,8), C-H isopropyl], 121.66, 130.13, 132.44, 135.68 (Ar-C), 169.77 
(NC=O). Amide 52i was used without further purification to prepare hydroperchlorate 
53f. 
3-[ ( 4-N-Acetyl)benzoyl]-7-isopropyl-3, 7-dia7.abicydo-[3.3.l]nonane Hydroper-
chlorate (53a). A 125-mL Erlenmeyer flask was equipped with a magnetic stirrer and an 
ice bath. To a chilled (5°C) solution of amide 52b (1.78 g, 5.40 mmol) in ether (25 mL) 
was added dropwise a solution of HCl04 (60%, 1.13 g, 6.75 mmol) in ether (5 mL) over 
a period of 5 minutes. After stirring an additional 15 min at 5°C, the white precipitate 
was filtered ,and washed with cold ether. Recrystallization (H3COH, 15 mL) of the 
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precipitate gave a new solid which was filtered and dried (Abderhalden, 80°C/0.2 mm 
Hg, 12 h) to .give 1.03 g (76.3%) of salt 53a as white platelettes; mp 166-167°C. IR 
(KBr) 3555 (0-H), 3360 (N-H), 3140 (N-H), 3020 (Ar-H), 2940, 2880 (C-H), 1690 
[NHC(O)CH3], 1630 (NC=O), 1100 (Cl-0) cm-I; lH NMR (D3CCN) 6 1.38 (d, J = 6.1 
Hz, 6 H, CH3 isopropyl), 1.82 [bd, 2 H, H(9)], 2.12 [s, 3 H, NHC(O)CH3], 2.33 [bs, 2 H, 
H(l,5)], 3.16 (bd, 2 H, ring protons), 3.29 (m, 2 H, ring protons), 3.55 (bd, 3 H, ring 
protons, C-H isopropyl), 4.10 (d, J = 13.1 Hz, 2 H, ring protons), 7.22 (d, 2 H, Ar-H), 
7.57 (d, 2 H, Ar-H), 8.61 (bs, 1 H, N-H); 13C NMR (D3CCN) ppm 16.90 (bs, CH3 
isopropyl), 24.46 [NHC(O)CH3], 28.01 [C(l,5)], 29.22 [C(9)], 50.42, 53.92 [bs, 
C(2,4,6,8)], 61.14 (C-H isopropyl), 119.60, 129.36, 130.65, 141.78 (Ar-C), 170.05 
[NHC(O)CH3], 175.02 (NC=O); Anal. Calcd for C19H2gClN306: C, 53.08; H, 6.56. 
Anal. Calcd for C19H2gCIN306·0.8 H20: C, 51.36; H, 6.71. Found: C, 51.27; H, 6.63. 
3-( 4-Fluorobenzoyl)-7-isopropyl-3, 7-diazabicyclo-[3.3.l]nonane Hydroper-
chlorate (53b ). A 250-mL Erlenmeyer flask was equipped with a magnetic stirrer and an 
ice bath. To a chilled (5°C) solution of amide 52d (1.0 g, 3.44 mmol) in ether (25 mL) 
was added, dropwise, HCl04 (60%, 0.72 g, 4.30 mmol) over a period of 5 min. This 
precipitate was filtered and washed with cold ether. Recrystallization (H3COH, 15 mL) 
of the precipitate was followed by filtration and drying (Abderhalden, 80°C/0.2 mm Hg, 
12 h) to give 1.03 g (76.3%) of salt 53b as white platelettes; mp 246-247°C. IR (KBr) 
3120 (N-H), 3010 (Ar-H), 2940, 2880 (C-H), 1625 (NC=O) cm-1; lH NMR (D3CCN) 6 
1.38 (d, J = 6.5 Hz, 6 H, CH3 isopropyl), 1.81 [bd, 1 H, H(5)], 2.29 [bd, 3 H, H(5,9)], 
3.34 (m, 5 H, ring protons, C-H isopropyl), 3.52 (bd, 4 H, ring protons), 7.17 (t, 2 H, Ar-
H), 7.38 (m, 2 H, Ar-II): 13c NMR (D3CCN) ppm 16.72 (CH3 isopropyl), 27.89 [C(l,5)], 
28.99 [C(9)], 50.34, 53.52 [bs, C(2,4,6,8)], 60.96 (C-H isopropyl), 116.29, 116.59, 
118.01, 118.36, 130.65, 130.77, 132.78, 132.82 (Ar-C), 162.59, 165.88 (J = 247.6 Hz, 
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ArC-F), 174.13 (NC=O); Mass spectral (EI) data calcd for C17H24ClN205F mlz (M+): 
290.1855 (-HCl04). Found: 290.1853. Anal. Calcd for C17H24ClN205F: C, 52.24; H, 
6.19. Found: C, 52.46; H, 6.24. 
3-[ 4-(lH-lmidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diuabicyclo[3.3.l]nonane 
Dihydroperchlorate (53c). A 250-mL Erlenmeyer flask equipped with an ice bath was 
added amide 52e (1.44 g, 4.25 mmol) in 40 mL of ether/H3COH (50:50) and was chilled 
to 5°C. To this new solution was added perchloric acid (60%, 1.56 g, 9.56 mmol), and 
. immediately a white precipitate formed. The heterogeneous mixture was allowed to stir 
an additional 15 min at this temperature. After filtering (suction), the solid was 
recrystallized with hot H3COH (35 mL) and the solution was allowed to stand at room 
temperature. The solid formed was filtered (suction) and dried (Abderhalden, 80°C/0.2 
mm Hg, 12 h) to give white needles (1.14 g, 60.9%) of 53c; mp 262-263°C. IR(KBr) 
3200 (N-H), 3005 (Ar-C), 2940, 2880 (C-H), 1645 (NC=O), 1100 (Cl-0) cm·l; lH NMR 
(DMS0-d6) 6 1.33 (d, J = 5.8 Hz, 6 H, CH3 isopropyl), 1.71-1.92 [bd, 2 H, H(9)], 2.34-
2.41 [bs, 2 H, H(l,5)], 3.23 [m, 5 H, H(2,4,6,8)ax, C-H isopropyl], 3.23-3-97 [m, 4 H, 
H(2,4,6,8)eq],3.94 (bs, 1 H, N-H), 7.66 (d, 2 H, Ar-H), 7.94 (s, 1 H, C-H imidazole), 7.96 
(d, 2 H, Ar-H), 8.32 (s, 1 H, C-H imidazole), 9.20 (s, 1 H, C-H imidazole); Be NMR 
(DMSO-d(;) ppm 26.42 [C(l,5)], 27.36 [C(9)], 59.64 [C(2,4,6,8), C-H isopropyl], 120.63, 
121.35, 122.01, 128.74, 135.27, 137.49 (Ar-C), 171.49 (NC=O); Mass spectral (El) data 
calcd for C20H28Cl2N409 m/z (M+): 338.2106 (-2 HCl04). Found: 338.2099. Anal. 
calcd for C20H2sCl2N409: C, 44.54; H, 5.23; N, 10.38. Found: C, 44.75; H, 5.20; N, 
10.20. 
3-[ 4-(Nitro )phenylacetyl]-7-isopropyl-3, 7-diuabicyclo[3.3.l]nonane Hydroper-
chlorate (53d). A solution of amide 52f (0.55 g, 1.66 mmol) in ether (40 ml) contained 
in a 125-mL Erlenmeyer flask equipped with a ice bath and a magnetic stirrer was chilled 
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(5°C) with stirring. Upon dropwise addition of HCl04 (60%, 0.35 g, 2.07 mmol), a white 
precipitate resulted, and the mixture was allowed to stir for 15 min at this temperature. 
After filtering (suction), the solid was recrystallized with a minimum amount of hot 
H3COH (20 mL) and filtered hot through a flutted filter paper. Upon standing at room 
temperature, the solution deposited a new solid which was filtered (suction) and dried 
(Abderhalden, 80°Cn mm Hg) to give 0.52 g (72.6%) of salt 53d; mp 225-226°C. IR 
(l<Br) 3160 (N-H), 3090 (Ar-H), 2980, 2940, 2890 (C-H), 1665 (NC=O), 1100 (Cl-0) 
cm-1; lH NMR (D3CCN) 6 1.31 (d, J = 6.1 Hz, 6 H, CH3 isopropyl), 1.82 [bd, 1 H, 
H(9)axl, 1.95 ~d, 1 H, H(9)eq], 2.36 [s, 2 H, H(l,5)], 3.22 (m, 4 H, ring protons), 3.49 (m, 
3 H, ring protons, C-H isopropyl), 3.94 (bs, 2 H, Ar-CH2), 4.18 (bd, 2 H, ring protons), 
7.47 (d, 2 H, Ar-H), 8.28 (d, 2 H, Ar-H); 13C NMR (D3CCN) ppm 16.79 (CH3 
isopropyl), 27.79 [C(l,5)], 28.53 [C(9)], 41.09 (Ar-CH2), 48.32, 53.81 [bs, C(2,4,6,8)], 
60.95 (C-H iso-propyl), 118.33, 124.17, 132.02, 144.58 (Ar-C), 173.96 (NC=O); Anal. 
Calcd for C1sH26CIN307: C, 50.06; H, 6.07. Found: C, 49.76; H, 6.16. 
3-[ 4-(N-Acetyl)phenylacetyl]-7-isopropyl-3, 7-diauabicyclo[3.3.l]nonane Hydro-
perchlorate (53e). A chilled (5°C, via ice bath) solution of amide 52h (2.03 g, 5.91 
mmol) in H3COH/ether (50:50, 25 mL) was placed in a 125-mL Erlenmeyer flask 
equipped with a magnetic stirrer. Dropwise addition of HCl04 (60%, 0.72 g, 4.30 mmol) 
over a period of 5 min was followed by continual stirring at this temperature for an 
additional 15 min. This precipitate was filtered and washed with cold ether. 
Recrystallization (H3COH, 35 mL} of the precipitate gave a new solid which was filtered 
and dried (Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 1.98 g (75.4%) of salt 53e as 
white platelettes; mp 197-198°C. IR (KBr) 3600 (0-H), 3360 (N-H), 3100 (N-H), 3040 
(Ar-H), 2940, 2860 (C-H), 1675 [NHC(O)CH3], 1645 (NC=O), 1100 (Cl-0) cm-1; lH 
NMR (D3CCN) 6 1.24 (d, J = 5.9 Hz, 6 H, CH3 isopropyl), 1.78 [bd, 1 H, H(9)axl, 1.91 
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[m, 1 H, H(9)eq], 2.06 [s, 3 H, NC(O)CH3], 2.29 [bs, 3 H, H(l,5), ring proton], 3.02-3.26 
(m, 3 H, ring proton, C-H isopropyl), 3.43 (m, 3 H, ring proton), 3.72 (s, 2 H, Ar-CH2), 
4.19 (bd, 2 H, ring protons), 7.18 (d, 2 H, Ar-H), 7.51 (d, 2 H, Ar-H), 8.36 (bs, 1 H, 
CH3C(O)N-H); 13C NMR (D3CCN) ppm 16.75 (CH3 isopropyl), 24.29 [NC(O)CH3], 
27.81 [C(l,5)], 28.60 [C(9)], 41.11 (Ar-CH2), 48.31, 53.95 [bs, C(2,4,6,8)], 60.86 (C-H 
isopropyl), 120.54, 130.72, 131.16, 138.77 (Ar-C), 169.56 [NHC(O)CH3], 175.01 
(NC=O); Anal. Calcd for C20H30ClN306: C, 54.11; H, 6.81. Anal. Calcd for 
C20H30ClN306·0.8 H20: C, 52.41; H, 6.95. Found: C, 52.52; H, 6.92. 
3-[ 4-(Methylsulf onyl)amino ]phenylacetyl-7-isopropyl-3, 7-diazabicyclo[3.3.1]-
nonane Hydroperchlorate (530. To a 125-mL Erlenmeyer flask equipped with a 
magnetic stirrer and an ice bath was added sulfonamide 52i (1.73 g, 4.56 mmol) dissolved 
in H3COH/ether 1:1, 40 mL), and the resulting solution was chilled (5°C). With stirring, 
HCl04 (60%, 0.95 g, 5.70 mmol) was added dropwise over a period of 15 min, and 
stirring was continued an additional 10 min at this temperature. The white precipitate 
was suction filtered and recrystallized from hot H3COH (25 mL) to give 1.54 g (70.7%) 
of 53fas white platelettes; mp 177.5-178.5°C. IR (KBr) 3590 (0-H), 3250 (N-H), 3160 
(N-H), 3020 (Ar-H), 2940, 2920, 2860 (C-H), 1665 (NC=O), 1100 (Cl-0) cm-1; lH NMR 
(D3CCN) o 1.28 (d, J = 6.4 Hz, 6 H, CH3 isopropyl), 1.79 [bd, 1 H, H(9)ax], 1.92 [m, 1 
H, H(9)eq], 2.33 [bs, 2 H, H(l,5)], 2.96 (s, 3 H, S02CH3), 3.11-3.28 (m, 4 H, ring 
protons), 3.44 (m, 3 H, ring protons, C-H isopropyl), 3.78 (bs, 2 H, Ar-CH2), 4.19 (bd, 2 
H, ring protons), 6.58 (bs, 1 H, N-H), 7 .23 (m, 4 H, Ar-H), 7 .60 (s, 1 H, S(hN-H); 13c 
NMR (D3CCN) ppm 16.67 (bs, CH3 isopropyl), 27.79 [C(l,5)], 28.55 [C(9)], 39.56 
(S02CH3), 40.86 (Ar-CH2), 48.30, 53.80 [bs, C(2,4,6,8)], 60.88 (C-H isopropyl), 121.93, 
131.56, 132.88, 137.38 (Ar-C), 174.94 (NC=O); Anal. Calcd for C19H30ClN307S: C, 
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47.55; H, 6.30. Anal. Cale<i for C19H30C1N307S·0.4 H20: C, 46.84; H, 6.37. Found: 
C, 46.55; H, 6.26. 
3-( 4-Aminobenzoyl)-7-isopropyl-3, 7-diazabicyclo[3.3.l]nonane Dihydro-
chloride (54a). A 250-mL Erlenmeyer flask equipped with an ice bath and a magnetic 
stirrer was charged with amide 44 (2.0 g, 6.96 mmol) in ether and chilled to 5°C via ice 
bath. HCl gas (generated as described for 54b) was bubbled (4 bubbles/sec) into the 
system over a period of 10 minutes. The resulting white precipitate was filtered with 
suction and washed with cold ether (10 mL). Recrystallization {H3COH/ether, 50:50, 20 
mL) was followed by filtering (suction) and drying (Abderhalden, 80°C/0.2 mm Hg, 12 
h) to afford salt 54a (1.58 g, 70.2 %); mp 209-210°C. IR (KBr) 3560 (0-H), 3400 (N-H), 
3160 (NH2), 3010 (Ar-H), 2860 (C-H), 1630 (NC=O) cm·l; lH NMR (020) ~ 1.45 (d, J 
= 6.0 Hz, 6 H, CH3 isopropyl), 2.03 [bs, 2 H, H(9)], 2.49 [bs, 2 H, H(l,5)], 3.40-3.67 (m, 
9 H, ring protons, C-H isopropyl), 4.63 {s, 2 H, N-H), 7 .62 (m, 4 H, Ar-H); 13c NMR 
(020) ppm 18.83 (bs, CH3 isopropyl), 29.84 [C(l,5)], 30.14 [C(9)], 52.19, 55.26 [bs, 
C(2,4,6,8)], 63.65 (C-H isopropyl), 124.20, 131.59, 135.29, 139.39 (Ar-C), 177.42 
(NC=O); Mass spectral (El) calcd for C17H21Cl2N30 mlz (M+): 287.1998 (-2 HCl). 
Found: 287.2013. Anal. Calcd for C17H27Cl2N30: C, 63.05; H, 8.09. Anal. Calcd for 
C17H27Cl2N30·0.9 H20: C, 54.23; H, 7.71. Found: C, 54.56; H, 7.62. 
3-( 4-Nitrobenzoyl)-7-isopropyl-3, 7-diazabicyclo-[3.3.l]nonane Hydrochloride 
(54b). Gaseous HCl was generated in a standard setup with a 250-mL collection flask 
containing solid NaCl. The H2S04 (-15 mL) was added dropwise (1 mVmin), and the 
gas generated was passed through a CaCh drying tube. Into a 250-mL Erlenmeyer flask 
equipped with a magnetic stirrer and an ice bath was bubbled HCl(g) to a chilled (5°C) 
solution of amide 52a (2.5 g, 7.88 mmol) in ether (75 mL) over a 15 min period. The 
125 
mixture was allowed to stir an additional 15 min at 0-5°C. A white precipitate was 
filtered and washed with cold ether (30 mL). The solid was recrystallized (H3COH/ether, 
1:1, 60 mL), and the white needles collected were washed with cold ether (25 mL) and 
dried (Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 2.09 g (74.9%) of salt 54b; mp 258-
2590C. IR (KBr) 3400 (N-H), 3100, 3040 (Ar-H), 2980, 2940, 2860 (C-H), 1660 
(NC=O) cm·l; lH NMR (020) 61.44 (d, J = 6.1 Hz, 6 H, CH3 isopropyl), 2.03 [bs, 2 H, 
H(9)], 2.52 [bs, 2 H, H(l,5)], 3.39-3.67 (bm, 9 H, ring protons, C-H isopropyl), 4.45 (s, 1 
H, N-11), 7.71 (d, 2 H, Ar-H), 8.36 (d, 2 H, Ar-H); 13C NMR (DiO) ppm 19.82 (bs, CH3 
isopropyl), 29.36 [bs, C(l,5,9)], 49.42, 54.01 [bs, C(2,4,6,8)], 63.38 (C-H isopropyl), 
126.89, 130.73, 143.84, 151.10 (Ar-C), 175.77 (NC=O); Mass spectral (EI) data calcd for 
C17H24N303Cl mlz (M+): 317.1739 (-HCl). Found: 317.1734. Anal. Calcd for 
C17H24N303Cl: C, 57.70; H, 6.84; N, 11.88. Found: C, 57.86; H, 6.72; N, 11.65. 
3-[ 4-(Methylsulfonyl)amino]benzoyl-7-isopropyl-3, 7-diambicydo[3.3.l]nonane 
Hydrochloride (54c). A 250-mL, Erlenmeyer flask was equipped with a magnetic stirrer 
and an ice bath. Into a chilled (5°C) solution of sulfonamide 52c (3.18 g, 8.70 mmol) in 
H3COH (75 mL) was bubbled (4 bubbles/sec) HCl gas over a period of 15 min, and the 
resulting white precipitate was stirred for an additional 15 min at this temperature. 
Filtration was followed by recrystallization using H3COH (10 mL) which was warmed on 
a hot plate. To the slightly heated solution was added ether (-35 mL) to reach the cloud 
point, and the resulting solution was allowed to cool to room temperature. The 
precipitate was filtered (suction) and dried (Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 
1.13 g (33.8 %) of 54c; mp 203-204°C. IR (KBr) 3575 (0-H), 3420 (N-H) , 3240 (N-H), 
3080, 3020 (Ar-H), 2960, 2880, 2800 (C-H), 1720 (NC=O) cm-1; lH NMR (DMS0'""6) 6 
1.43 (d, J = 6.5 Hz, 6 H, CH3 isopropyl), 1.82 [m, 2 H, H(9)], 2.36 [bs, 2 H, H(l,5)], 3.11 
(s, 3 H, S02CH3), 3.29 (m, 5 H, ring protons, C-H isopropyl), 3.35 (d, J = 13.1 Hz, 2 H, 
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ring protons), 3.60 (d, J = 13.1 Hz, 2 H, ring protons), 7.32 (d, 2 H, Ar-H), 7.94 (d, 2 H, 
Ar-H), 9.72 (bs, 1 H, N-H); 13C NMR (DMS0-d6) ppm 16.92 (CH3 isopropyl), 25.21 
[C(l,5 9)], 43.81 (S02CH3), 50.65, 51.72 [C(2,4,6,8)], 61.09 (C-H isopropyl), 117.56, 
123.77, 130.62, 143.01 (Ar-C), 165.66 (NC=O); Mass spectral (EI) data calcd for 
C1sH28ClN303S mlz (M+): 365.1773 (-HCl). Found: 365.1754. Anal. Calcd for 
C1sH28ClN303S: C, 53.79; H, 7.02. Anal. Calcd for C1sH2gC1N303S·2.5 H20: C, 
48.37; H, 7.44. Found: C, 48.46; H, 7.37. 
3-[ ( 4 '-Fluorobenzoyl)methyl]-7-isopropyl-3, 7-div.abicyclo[3.3.l]nonane (55a). 
To a 100-mL, three-necked, round-bottomed flask equipped with a magnetic stirrer, a 
heating mantle, a 25-mL addition funnel, and a condenser with an N2 inlet were added 2-
chloro-4'-fluoroacetophenone (66, 7.55 g, 43.8 mmol) and NaI (9.85 g, 65.7 mmol) in 
H3CCN (30 mL), the mixture was heated for 30 minutes with stirrring. The new solution 
was allowed to cool to room temperature (30 min) which was followed by dropwise 
addition of amine Slj (6.7 g, 39.8 mmol) to give a light yellow mixture which was stirred 
overnight. Filtration (suction) removed excess NaI, and the filtrate was diluted with H20 
and transferred to a separatory funnel. The resulting homogenous solution (pH-5) was 
extracted (ether, 3 x 75 mL) with the latter being discarded, and the pH of the aqueous 
layer was adjusted to 12 using 10% NaOH. Extraction (ether, 3 x 75 mL) of the aqueous 
layer was followed by another extraction (H2CCl2, 3 x 75 mL) and the ether extracts were 
discarded. The organic layer (H2CCl2) was dried (Na2S 04, 2 h), filtered,. and 
concentrated (rotary evaporator) to give 2.9 g (86.1 % ) of amine 55a as a light yellow 
solid; mp 193-194°C. IR (KBr) 3060, 3040 (Ar-H), 2940, 2805 (C-H), 1700 (C=O) cm·l; 
lH NMR (DCCl3) o 1.45 (d, J = 6.3 Hz, 6 H, CH3 isopropyl), 1.81 [d, J = 10.1 Hz, 1 H, 
H(9)ax], 2.11 [d, J = 10.1 Hz, 1 H, H(9)eq], 2.32 [bs, 2 H, H(l,5)], 2.85 (d, J = 11.4 Hz, 2 
H, ring protons), 3.37 (d, J = 13.2 Hz, 2 H, ring protons), 3.49 (d, J = 11.4 Hz, 2 H, ring 
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protons), 3.86 (m, 3 H, ring protons, C-H isopropyl), 4.18 (s, 2 H, ArC(O)CH2), 7.15 (t, 2 
H, Ar-H), 8.02 (m, 2 H, Ar-H); 13C NMR (DCCl3) ppm 17.01 (CH3 isopropyl), 28.04 
[C(l,5)], 30.05 [C(9)], 53.74, 57.22, 57.34 [C(2,4,6,8), C-H isopropyl)], 62.22 
[ArC(O)CH2], 115.58, 115.88, 130.57, 130.70, 131.22, 131.26 (Ar-C), 164.10, 167.49 (J 
= 265.8 Hz, ArC-F), 194.99 (C=O). Ketone 55a decomposes upon standing, and thus 
was immediately reduced to alcohol 55b. 
(±)-3-[(4'-Fluoro)-1-hydroxy-1-phenylethyl]-7-isopropyl-3,7-diazabicyclo-
[3.3.l]nonane (55b). To a 100-mL, three-necked, round-bottomed flask equipped with a 
magnetic stirrer, a condenser with an N2 inlet, and two glass stoppers was added solid 
LiAll4 (95%, 0,787 g, 19.7 mmol) in one portion. After purging the flask with N2 for 10 
min, dry tetrahydrofuran (10 mL: freshly distilled from Na metal) was poured slowly 
over the LiAlI4 which resulted in a gray slurry. Ketone 55a (2.0 g, 6.57 mmol) was 
added portionwise over a period of 15 min, followed by heating the reaction mixture 
(40°C, 3 h) and then stirring at room temperature overnight. Excess LiAlI4 was 
cautiously destroyed using EtOAc (10 mL) added dropwise to the chilled (5°C) reaction 
mixture. Addition of 5% HCl (-15 mL) adjusted the pH (-2) of aqueous solution which 
was then extracted (ether, 2 x 30 mL) to remove small impurities, and these ether extracts 
were discarded. After making the aqueous phase slightly basic (pH-8) using 10% NaOH 
(-10 mL), extraction (H2CC}z, 3 x 50 mL) was followed by washing the organic layer 
with H20 (75 mL), satd NaCl (75 mL), and dried (Na2S04, 2 h). Filtration and 
concentration (rotary evaporator) resulted in 1.33 g (66.2%) of racemic alcohol SSb as a 
white solid; mp 53-54°C. IR (film) 3225 (OH), 2930, 2800 (C-H), 1600 (C=C) cm-1; lH 
NMR (DCCl3) 6 1.08 (d, J = 5.9 Hz, 6 H, CH3 isopropyl), 1.57 [bs, 2 H, H(9)], 1.87 [bs, 
2 H, H(9)], 2.26 (m, 2 H, ring protons), 2.45 (bd, 2 H, ring protons), 2.55 [dd, J = 13.1 
Hz, J = 4.09 Hz, 2 H, ArCH(OH)CH2], 2.83 (bs, 2 H, ring protons), 3.07 (m, 3 H, ring 
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protons, C-H isopropyl), 4.67 [dd, J = 4.09 Hz, 1 H, ArCH(OH)], 6.23 (bs, 1 H, 0-H), 
7.01 (t, 2 H, Ar-H), 7.35 (m, 2 H, Ar-H); 13c NMR (DCCl3) ppm 18.39, 18.69 (CH3 
isopropyl), 30.17, 30.90 [C(l,5)], 32.54 [C(9)], 54.07, 54.38, 54.61, 55.24 [C(2,4,6,8)], 
59.55 (C-H isopropyl), 64.47 [ArCH(OH)CH2], 68.54 [ArC-H(OH)], 114.71, 114.99, 
127.39, 127.49, 138.97, 139.00 (Ar-C), 160.28, 163.51 (J = 243.9 Hz, ArC-F); Anal. 
Calcd for C1sH27FN20: C, 70.56; H, 8.88. Found: C, 70.28; H, 9.00. 
7-Benzyl-3-thia-7-uabicyclo[3.3.l]nonane Hydrochloride (56). Gaseous HCl 
was generated in a 250-mL collection flask containing solid NaCl as described for 54b. 
The H2S04 (-15 mL) was added dropwise, and the gas generated was passed through a 
CaC}z drying tube. Into a 250-mL, Erlenmeyer flask equipped with a magnetic stirrer 
and an ice bath was bubbled (4 bubbles/sec) HCl(g) to a chilled (5°C) solution of amine 
73 (5.00 g, 20.20 mmol) in ether (150 mL) over a 15 min period. The mixture was 
allowed to stir an additional 15 min at 0-5°C. A white precipitate formed and was filtered 
and washed with cold ether (30 mL). The solid was recrystallized (H3COH/ether, 1:1, 60 
mL), and the white solid collected were washed with cold ether (25 mL) and dried 
(Abderhalden, 80°C/0.2 mm Hg, 12 h) to give 3.31 g (60.7%) of salt 56; mp 246.0-
247.Q°C. IR (KBr) 3040 (Ar-H), 2950 (C-H), 735, 700 (C-H out of plane, mono) cm·l; 
lH NMR (DMSO-dt;) o 1.84 [m, 2 H, H(9)], 2.38 [m, 2 H, H(l,5)], 2.71 [d, J = 11.9 Hz, 2 
H, H(6,8)ax], 3.13 [d, J = 11.9 Hz, 2 H, H(2,4)ax], 3.36 [bs, 2 H, H(6,8)eq], 3.60 [d, J = 
10.3 Hz, 2 H, H(2,4)eq], 4.29 (d, 2 H, CH2Ph), 7.61-7.49 (Ar-H), 9.25 (bs, 1 H, N-H); 
13C NMR (DMS0-d6) ppm 25.96 [C(l,5)], 28.65 [C(9)], 30.91 [C(2,4)], 56.41 [C(6,8)], 
60.82 (CH2Ph), 129.21, 129.82, 130.19, 130.43 (Ar-C); Mass spectral (El) data calcd for 
C14H20NSCl mlz (M+): 233.1238. Found: 233.1239. Anal. Calcd for C14H20NSCl: C, 
62.32; H, 7.47; N, 5.19. Found: C, 62.20; H, 7.38; N, 5.16. 
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Attempted Preparation of 4-(lH-Imidazol-l-yl)benzoyl chloride (61). To a 
100-mL, single-necked, round-bottomed flask equipped with a magnetic stirrer, 
condenser with N2 inlet was added ester 59 (4.2 g, 20.77 mmol) in H3COH (20 mL), H20 
(40 mL) and NaOH pellets (1.67 g, 41.54 mmol). The solution was then flushed with N2. 
After stirring overnight at room temperature, the new solution was chilled (5"C) and 
treated dropwise with cone HCl (20 mL) which resulted in formation of a white 
precipitate. Filtration (suction) was followed by drying (Abderhalden, 80°Cn mm Hg, 12 
h). To a 100-mL, single-necked, round-bottomed flask equipped with a magnetic stirrer, 
a condenser with a N2 inlet containing acid 60 (3.0 g, 15.94 mmol) was added thionyl 
chloride (18.9 g, 159.4 mmol), and the resulting heterogeneous mixture was stirred at 
room temperature overnight. Excess thionyl chloride was removed by distillation 
(aspirator), and the oil was placed on a vacuum pump (RTn mm Hg, 4 h) to remove any 
residual thionyl chloride; 3.01 g (92.1 %). IR (KBr) analysis of the oil revealed 
absorption at 3300, 2600 (0-H), 1755 (C=O) cm·l. This IR analysis indicated the 
presence of the carboxylic acid (0-H) stretching, but the carbonyl absorption is not in the 
range of amide carbonyls (1660-1620 cm·l).71 This implies that mostly starting material 
60 was recovered. The reaction was attempted again but with heating of the starting acid 
and thionyl chloride for 4 h. After the usual workup, only the starting carboxylic acid 60 
could be isolated. 
Attempted Preparation of 4-(lH-lmidazol-l-yl)benzoyl chloride (63). To a 
100-mL, single-necked, round-bottomed flask equipped with a magnetic stirrer, 
condenser with an N2 inlet were added ester 59 (1.42 g, 7.02) in H20:H3COH (2:1, 30 
mL) and NaOH pellets (0.536 g, 14.04 mmol),. The resulting solution was stirred at 
room temperature overnight. Concentration (rotary evaporator) of the solution gave a 
off-white solid 62 which was dried (Abderhalden, 80°Cn mm Hg, overnight). Into a 
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200-ml, three-necked, round-bottomed flask equipped with a magnetic stirrer, a 
condensor with an N2 inlet, and an ice bath was added sodium salt 62 (5.87 g, 27.92 
mmol), benzene (50 mL), and pyridine (3.31 g, 41.88 mmol), and the resulting mixture 
was cooled (5°C, via ice bath). Dropwise addition of oxalyl chloride (35.28 g, 277 .93 
mmol) over a period of 15 min was followed by continual stirring at this temperature and 
then at room temperaure overnight. Concentration (rotary evaporator) resulted in 
formatiom of 5.5 g (94.8%) of an off-white solid; IR (KBr) 3300, 2600 (0-H), 1755 
(C=O) cm-1. IR analysis indicated the presence of the carboxylic acid (0-H) stretching, 
but the carbonyl (C=O) absorption is not in the range of amide carbonyls (1660-1620 cm-
1 ). 71 Thus, mostly starting material 62 was recovered. The experiment was performed 
again using the same procedure except that after stirring the mixture in the presence of 
oxalyl chloride for 4 h, another portion of the oxalyl chloride (35.28 g, 277 .93 mmol) was 
added dropwise. Stirring of the resulting mixture was continued overnight at room 
temperature. After the usual workup, IR analysis of the isolated product revealed that 
only the starting sodium salt 62 was present. 
4-Nitrophenylacetyl chloride (65). To a 250-mL, round-bottomed-flask equipped 
with a magnetic stirrer and a condenser with a N2 inlet. The flask was initially charged 
with 4-nitrophenylacetic acid (64, 15.0 g, 82.8 mmol) followed by addition of thionyl 
chloride (98.5 g, 828 mmol), and the resulting solution was allowed to stir at room 
temperature overnight. This light brown solution was distilled under vacuum (35°C/40 
mm Hg) to remove excess thionyl chloride, and the resulting oil was then placed on a 
vacuum pump (RTn mm Hg). The acid chloride 65 was used immediately without any 
further purification to prepare amide 52f. 
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Attempted Preparation of 3-[ 4 '-(lH-Imidazol-1-yl)benzoylmethyl]-7-isopropyl-
3, 7-diambicyclo[3.3.l]nonane (67). Method A: A 50-mL, jacketed flask was equipped 
with a magnetic stirrer, a heating mantle, a condenser, a lower take-off condensor with N2 
inlet and two glass stoppers. To a solution of ketone 55a (0.100 g, 0.33 mmol) in DMSO 
(10 mL) was added imidazole (0.027 g, 0.396 mmol), potassium carbonate (anhydrous, 
0.068 g, 0.495 mmol), and 18-crown-6 (50 mg). The stirred mixture was .heated at l l0°C 
for 8 h under N2 via the use of boiling toluene (bp l l0°C) in the jacket. Cooling the 
solution to RT was followed by the addition of chilled H20 (75 mL). Combined extracts 
(H2CCh, 4 x 40 mL) of the suspension were washed with H20 (80 mL) and satd NaCl 
(80 mL); the solution was then dried (Na2S04, 2 h). Filtration and concentration (rotary 
evaporator) gave 0.091 g (78.4%) of a light yellow solid [which was placed on a vacuum 
pump overnight (RTn.omm Hg)]. IR, lH, and t~c NMR signals of the obtained product 
matched those of the starting ketone 55a. The above reaction was attempted several 
times using different conditi9ns. Variations were utilized in terms of the amounts of 
imidazole (1.2, 1.5, 2.5, and 4.0 equivalents) and potassium carbonate (0.95, 1.1, 1.5 
equivalents). The end result to all of these modified conditions was the isolation of only 
starting material 55a from a mixture. 
Method B: A 50-mL, jacketed flask was equipped with a magnetic stirrer, a heating 
mantle, a condenser, a lower take-off condensor with N2 inlet and two glass stoppers. To 
a solution of ketone 55a (0.100 g, 0.33 mmol) in DMSO (10 mL) was added imidazole 
(0.027 g, 0.396 mmol), 2,2,6,6-tetramethylpiperidine (0.044 g, 0.314 mmol), and 18-
crown-6 (50 mg). The stirred mixture was heated at l l0°C for 8 h under N2 via the use 
of boiling toluene (bp l l0°C) in the jacket Cooling the solution to RT was followed by 
the addition of chilled H20 (75 mL). Combined extracts (H2CCh, 4 x 40 mL) of the 
suspension were washed with H20 (80 mL) and satd NaCl (80 mL); the solution was then 
dried (Na2S04, 2 h). Filtration and concentration (rotary evaporator) gave 0.095 g 
(81.9%) of a light yellow solid [ which was placed on a vacuum pump overnight 
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(RT/0.2mm Hg)]. IR, lH and 13C NMR signals of the obtained product matched those of 
the starting ketone 55a. This particular reaction was attempted because it was felt that the 
potassium carbonate was extracting one of the alpha protons next to the carbonyl. It was 
anticipated that the use of a large, hindered base such as 2,2,6,6-tetramethylpiperidine 
might alleviate this problem. Unfortunately, the final result was unchanged in that after 
workup, only starting ketone 55a was recovered. 
Attempted Preparation of 3-[ ( 4' -Fluorobenzoyl)methyl]-7-isopropyl-3, 7-diua-
bicyclo[3.3.l]nonane Hydroperchlorate (68). A 100-mL Erlenmeyer flask was 
equipped with a magnetic stirrer and an ice bath. To a chilled (5°C) solution of amine 
55a (1.0 g, 3.29 mmol) in H3COH/ether (50:50, 25 mL) was added dropwise HCl04 
(60%, 0.72 g, 0.689 mmol) over a period of 5 min. The resulting oil was isolated via 
decantation of the mother liquor. Crystallization of the oil was attempted using hot 
H3COH (15 mL) from which, after cooling to RT, the product oiled out of solution. 
Trituration (ether, 15 mL) of the oil was uneffective to induce formation of a solid. IR 
and 1 H analyses of the crude oil indicated the presents of an 1, 1-diol at the I '-position on 
the side chain (no carbonyl). Formation of the diol presumably prevented solidification 
of the salt. 1,1-Diol formation at the C-9 position of certain DHBCNs via, for example, 
reaction of 3,7-diheterabicyclo[3.3.l]nonan-9-one and HCl04 are known.8 
Attempted Preparation of (±)-3-[(4'-Fluoro)-1-hydroxy-1-phenylethyl]-7-
isopropyl-3,7-diazabicyclo[3.3.l]nonane Hydroperchlorate (69). A 100-mL 
Erlenmeyer flask was equipped with a magnetic stirrer and an ice bath. To a chilled 
(5°C) solution of alcohol 55b (0.10 g, 0.328 mmol) in H3COH/ether (50:50, 25 mL) was 
added dropwise HCl04 (60%, 0.068 g, 0.408 mmol) over a period of 5 min. The 
resulting oil was isolated via decantation of the mother liquor. Crystallization of the oil 
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was attempted using hot H3COH (15 mL) from which a product precipitated. Trituration 
(ether, 15 mL) of the oil did not induce formation of a solid. IR analysis indicated the 
presence of an 0-H stretch (3600-3100 cm·l) and the conclusion was that starting alcohol 
was present in large quantities. Unfortunately, it was not possible to crystallize 
compound 69 from this reaction mixture. 
Attempted Preparation of 3-[ ( 4' -Nitrobenzoyl)methyl]-7-isopropyl-3, 7-diaza-
bicyclo[3.3.l]nonane (71). To a 100-mL, ~-necked, round-bottomed flask equipped 
with a magnetic stirrer, a heating mantle, a 25-mL addition funnel, and a condenser with 
an N2 inlet were added 2-bromo-4'-nitroacetophenone (70, 5.55 g, 22.7 mmol) and NaI 
(5.11 g, 34.1 mmol) in H3CCN (30 mL). The resulting mixture was heated for 30 
minutes with stiming. The resulting dark brown mixture was allowed to cool to room 
temperature (30 min) which was followed by dropwise addition of amine 52j (3.47 g, 
20.64 mmol) to give a dark brown mixture which was stirred overnight. Filtration 
(suction) removed excess NaI and the filtrate was diluted with H20 and transferred to a 
separatory funnel. The resulting acidic (pH-5) heterogeneous solution was adjusted to 
pH 12 using 10% NaOH. Extraction (ether, 3 x 75 mL) of the aqueous layer was 
followed by another extraction (H2CCl2, 3 x 75 mL) and the ether extracts were 
discarded. The organic layer (H2CCl2) was dried (Na2S 04, 2 h), filtered, and 
concentrated (rotary evaporator) to give 2.86 g (41.9 %) of dark brown oil. IR, lH, and 
13C NMR analyses of this product matched those of the starting amine 52j. 
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SPECTRAL LJHES FOR fH• 14. 70 
RFL• 3262.6 RFP• 2979.5 
INDEX FREO PPN INTEN!ITV 
... lf295.6 136.494 29.555 ~ 
12 9754.4 129.319 91.166 
11!3 9684. 7 129.394 86.872 
14 9622.6 127.572 40.463 
05 4637.9 61.486 34.192 
16 4567.9 60.559 36.637 N + CI04· 
07 4299.9 57.005 73.911 E 
IB 4291.5 56.894 67.033 H 
09 3042.S 40.336 23.564 
19 3021.2 40.054 67 .090 
11 3000.4 39.777 135.308 N 
12 2979. 4 39.499 155.640 
13 2958.1 39.217 133.310 0 
14 2937.2 39.940 66.161 
IS 2916.3 30.662 23.134 
16 2231.4 29.592 30.391 37 --
17 201, . 2 27. 459 75. 058 y I 
10 457.9 6.070 311!.9!5 
19 291.6 3.865 54.521 ~ 
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PPH INTENSI Tl" 
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SPECIRftL LINES FOR IH• 18. 79 
RFL• 6099. 3 RFP• 5898.1 
INDEX FREO PPN INTENSIIY 
II 5839.8 77 .422 41 .569 
12 5807. 9 76. 998 43.986 
13 5775. 7 76. 572 43,742 
.. 5296.4 79.217 29,949 
15 4121 .4 54 .639 74. 348 
16 3943.8 52,285 148,435 
97 3119.9 41,231 89. 376 
18 2963. 9 39. 294 86.487 
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15.000 41 1.750 
------ ,,.. Mtt .... I 76'5.3 -13721.B i YYY I ""' ____.. Ohet .. Midi 1,067 5.000 9 ._ r ... ____ Dltar • ......_ ... __ 
15,0 SC 0 _____ ,._ ,,._.____ ------
120 
..... 0 .. 
0 






=1 ••--• '"-"' m __ • lij 4.000 --- ---- .. ___.. ., ___ a;o __ _ 
E 1u5,3 -24a.3 
~ ____.. ,.,.. 911,1 ___ ... ,... 
I 
------------
15N NMR Spectrum of 39 
60 
Nw!ifq,anm~ 







20 0 PPM 
....... 
Nl5COC 












SPECTRftl LINES FDR TH• 







































































41 , I 
~ 
NHS02CH3 
140 120 100 BO 
...... l,HI 
-
111,1,. I FN----1!1 •-==• CD-.:=• - n, - • • ll---1.:..H! ... ·--==-- a:n--== ----· .... 7901,. ..,.. 19019,~,- Sllrt---' Hrlllrffl NII WIIMl--1!.:.!. ,._ ....... --==... 
-
nc NMR Spectrum of 41 
60 40 20 PPM 
--....l!ll.lK .!!!!!!... ~-.!il-Ii fiAaOD ____ UIIIAN •L-300 ... ___ C I IK OOIEll'll 
-
..... •c ,----1!:!l:JI 
- -
11 XLU 310 
-~ 
Plate XV 
2.5 3 MICRONS 4 5 6 7 8 9 10 12 14 16 20 25 5C 
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